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 SUMMARY 
 
Chimica e fitotossicità di metaboliti secondari da piante della flora mediterranea 
L’ecologia chimica è definita come “la comprensione ecologica dell’origine, della 
funzione e del significato delle sostanze chimiche che mediano l’interazione tra 
organismi differenti” (Anon, 2001). Lo studio ecologico di un organismo vegetale 
considera in che modo la pianta risente delle stimolazioni esterne e come queste ultime 
possano causare una mutazione del suo metabolismo. Le piante infatti, per 
competizione, difesa o empatia possono variare e indirizzare la propria produzione 
metabolica. L’accumulo di metaboliti tossici in particolari parti della pianta è uno dei 
possibili meccanismi deterrenti attivati dall’organismo vegetale per garantire la propria 
sopravvivenza. In casi opposti la pianta attiva la produzione di metaboliti in grado di 
attirare gli insetti impollinatori e salvaguardare la diffusione della propria specie. 
Meccanismi di interazione pianta-pianta sono altresì noti  e descritti con il termine 
allelopatia, che considera le interazioni positive o negative che una pianta esercita su di 
un’altra mediante la produzione metabolica secondaria. Juglone, sulcotrione, 
scopoletina, 1,4-cineolo sono solo alcuni esempi di metaboliti fitotossici che, prodotti 
da una pianta, le consentono il predominio vegetale del proprio habitat. Alcuni dei 
composti allelochimici isolati presentano una bioattività tale da poter essere impiegati in 
campo agronomico come erbicidi naturali. Erbicidi di origine naturale potenzialmente 
possiedono caratteristiche di biocompatibilità (maggiore biodegradabilità e basso grado 
di bioaccumulo) difficilmente riscontrabili in un erbicida industriale. A ciò si aggiunge 
la maggiore specificità dei metaboliti naturali, perfezionati dall’evoluzione per  agire in 
maniera altamente selettiva su targets di interesse. La natura come fonte inesauribile di 
strutture molecolari  possiede la più immediata risposta alla ricerca di nuovi erbicidi 
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verso i quali le piante infestanti non abbiano sviluppato resistenza in seguito all’uso 
indiscriminato e continuativo. 
In questa ottica il gruppo di ricerca presso il quale ho svolto il mio lavoro di tesi, ha 
negli anni studiato i metaboliti secondari prodotti da piante infestanti dell’area 
mediterranea. In particolare nel corso del mio ciclo di dottorato ho condotto l’analisi 
sistematica dei metaboliti secondari prodotti da tre piante spontanee dell’area 
mediterranea: Brassica fruticulosa, Chenopodium album, Malva silvestris. 
Per ciascuna delle tre piante è stata realizzata l’estrazione dei metaboliti mediante 
diverse metodiche (infusione, estrazione in continuo), seguita da un  processo di 
frazionamento degli estratti mediante tecniche cromatografiche (cromatografia su 
colonna di silice, cromatografia liquido-liquido in controcorrente, TLC e HPLC in fase 
diretta e inversa). L’impiego di tali tecniche ha consentito la purificazione delle frazioni 
e l’isolamento dei metaboliti. La caratterizzazione strutturale delle molecole isolate e’ 
stata realizzata con tecniche spettroscopiche, tra cui NMR mono e bidimensionale 
(1H1H COSY, HMBC, HSQC, NOESY, ROESY), spettroscopia UV-VIS, dicroismo 
circolare e tecniche di spettrometria di massa (EI, ESI, MALDI). 
Brassica fruticulosa è una pianta infestante appartenente alla famiglia delle 
Brassicaceae, che include più di 2000 specie distribuite in tutto il mondo e ampiamente 
diffuse in Italia.  Le specie presenti nel nostro paese sono un’importante risorsa 
economica, sono infatti adoperate come ortaggi, foraggi per animali, fertilizzanti o per 
l’estrazione di oli da condimento o industriali. Alcune varietà presentano proprietà 
farmacologiche (antiscorbuto, emetiche, diuretiche, antiallergiche).     
L’estrazione dei metaboliti da Brassica fruticulosa è stata realizzata ponendo la pianta 
fresca in infusione in una soluzione idroalcolica (10% MeOH/H2O) e successivamente 
in metanolo. Gli infusi ottenuti sono stati sottoposti ad estrazione con solventi a polarità 
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crescente, in modo da realizzare un primo frazionamento dei metaboliti, 
successivamente purificati attraverso le metodiche cromatografiche descritte. 
 Da Brassica fruticulosa sono stati isolati tredici lignani (Cutillo et al. 2003) e cinque 
nor-terpeni (Cutillo et al. 2005). 
I lignani sono metaboliti costituiti da unità di tipo fenilpropanico legate tra loro in 
strutture polimeriche costituenti le lignine. Le lignine sono polimeri naturali coinvolti 
nel processo di lignificazione della parete cellulare e responsabili delle strutture rigide 
delle piante e degli alberi, esse inoltre partecipano ai meccanismi difensivi degli 
organismi vegetali in condizioni di stress biotico. E’ nota l’attività antimicrobica, 
antivirale, erbicida e antifeedant di numerosi lignani (Russell et al. 1976), si è 
dimostrato inoltre un effetto preventivo anticancro dei lignani assunti con la dieta 
(Thompson et al. 1996). 
I nor-terpeni sono molecole a tredici atomi di carbonio, probabilmente derivanti dalla 
degradazione di carotenoidi. Essi sono responsabili dell’aroma di frutti, ortaggi, spezie, 
tabacco e di vari tipi di tè. 
Chenopodium album appartiene alla famiglia delle Chenopodiaceae, è una pianta 
annuale infestante delle colture estivo-autunnali, diffusa non solo nell’area 
mediterranea, ma anche nel continente americano.  
Anche l’estrazione dei metaboliti da C. album è stata realizzata attraverso processi 
infusivi, e procedure cromatografiche sono impiegate per la purificazione e 
l’isolamento. Sono state così isolate sette ammidi cinnamiche (Cutillo et al. 2003) 
variamente funzionalizzate con gruppi ossidrilici ed esterei, un’ammide cinnamica  
legata ad un residuo alcaloidico di tipo protoberberinico (Cutillo et al. 2004), diciotto 
nor-isoprenoidi (Della Greca et al. 2004), tredici derivati fenolici e otto lignani (Cutillo 
et al. in press).                                                                                                                                         
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Malva silvestris è una pianta spontanea del Mediterraneo appartenente alla famiglia 
delle Malvaceae, nota fin dall’antichità per le sue proprietà antinfiammatorie, emollienti 
e lassative, trova largo impiego in fitoterapia.  
L’estrazione dei metaboliti è stata realizzata con acqua adoperando un estrattore 
automatico in continuo, l’estrattore Naviglio (2003). Quest’ultimo è un estrattore solido-
liquido che applica una serie di cicli di lavoro in cui il solvente è successivamente 
pompato a moderata pressione nella camera di estrazione contenente la pianta.   
L’infuso acquoso è concentrato e frazionato con tecniche cromatografiche. Sono stati in 
tal modo isolati undici derivati fenolici e dieci terpenoidi.  
Alcuni dei metaboliti isolati dalle tre piante sono stati sottoposti a saggi di fitotossicità 
su un organismo vegetale di riferimento Lactuca sativa (lattuga) allo scopo di valutare 
l’effetto inibente o stimolante la germinazione, l’allungamento radicale e 
l’allungamento dell’ipocotile dell’organismo vegetale testato. I saggi sono stati condotti 
in accordo alla procedura ottimizzata da Macias et al. (2000).  
Durante il mio dottorato ho avuto modo di approfondire la conoscenza di tecniche di 
spettrometria di massa, grazie ad un periodo di formazione speso presso l’Università di 
Warwick (UK), usufruendo di una borsa di studio europea Marie Curie.  
Presso tale Università ho operato su uno spettrometro di massa ciclotronico a 
trasformata di Fourier (FTICR, Fourier Transform Ion Cyclotron Resonance) 
accoppiato ad una sorgente electrospray (ESI) o nanospray (nano-ESI). Tale strumento 
consente di raggiungere alti valori di sensibilità, risoluzione e accuratezza nella misura 
di spettri, tali da rendere la tecnica ideale per lo studio di un ampio spettro di substrati, 
da biomolecole ad alto peso molecolare a molecole organiche di dimensioni ridotte 
(Amster 1996). Il funzionamento dello strumento è basato sulla possibilità di rivelare il 
moto ciclotronico di una popolazione di ioni. Gli ioni generati nella sorgente ESI 
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raggiungono, attraverso un sistema di ottiche, l’analizzatore (Infinity Cell) dello 
spettrometro di massa. Esso è costituito da una cella cilindrica esternamente alla quale è 
applicato un campo magnetico (B) di direzione parallela all’asse del cilindro. Le 
molecole di massa m e carica q sotto l’azione del campo magnetico iniziano un moto 
circolare (ciclotronico) di frequenza pari a: 
 
f = qB \ 2pim 
 
 L’applicazione di un circuito elettrico consente di rivelare la frequenza del moto ionico. 
La trasformata di Fourier dell’ interferogramma fornisce lo spettro di massa.  
La spettrometria di massa FTICR è stata da me applicata per lo studio della 
Calmodulina e dei suoi stati conformazionali in soluzione acquosa  e organica. La 
calmodulina è una proteina costituita da 148 residui aminoacidici, legati a costituire una 
molecola a forma di manubrio, avente due domini globulari legati da una α-elica. 
Ciascuno dei due domini ospita due siti specifici per il calcio, che rendono la 
calmodulina una proteina coinvolta in numerosi processi calcio-regolati, responsabili 
della trasmissione dei segnali cellulari. Mediante spettrometria di massa sono state 
anche analizzate le modalità di interazione della calmodulina con il peptide RS20, un 
peptide sintetico ottenuto come analogo derivato del sito di fosforilazione della Myosina 
Light Chain Kinase, enzima coinvolto nel processo di contrazione muscolare. Lo studio 
di massa mostra come l’interazione tra RS20 e calmodulina preveda dapprima uno 
stadio in cui in la calmodulina lega il peptide, seguita da una fase in cui il complesso 
lega quattro atomi di calcio (Hill et al. 2000). 
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         INTRODUCTION 
 
Observation of  plants ecosystem clearly suggested that plant survival is affected 
by many factors, including resources competition, defence from herbivores and 
climate threats,  and defence from other plant attacks. The common perception of 
a plant being a passive organism, only responding to fluctuations in the resources 
it requires, has been long since discounted. It is widely accepted that plants  can 
interact with other plants, microbes or animals by releasing and receiving 
chemicals (Inderjit and Duke  2003). 
In 1937 Molish coined the term Allelopathy to describe the phenomenon  that one 
plant can influence another.  A more extensive definition was given by Rice in 
1984, who defined Allelopathy as the effect of a plant (including microorganism) 
on the growth of another plant through the release of chemical compounds in the 
environment. Both positive and negative effects are included in this definition, 
which is generic enough to cover many aspects of the chemical ecology of plants.  
The criteria for establishing evidence of allelopathy are still a matter of debate, 
the six principles proposed by Willis et al. (1985) were successively summarized 
(Blum et al. 1999) in the three following characteristics that an allelopathic 
organism is required to have: 
1. The allegedly allelopathic plant must produce and release chemicals that 
modify the growth of other plants. 
2. The amount of inhibiting substances produced  must be sufficient to 
affect vital processes of the sensitive plants, like nutrient and water uptake  by 
roots  or energy fixation. 
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3. Physical or biotic factors cannot be sufficient to explain the observed 
plant inhibition in field patterns. 
Demonstrating that a plant has the described criteria is not an easy task. Inderjit 
and Nielsen (2003) have discussed the problems related to allelochemical 
collection and quantification, interactions between allelochemicals and other 
chemicals, selection and concentration of these compounds in bioassays, 
bioassays fitting in fields.  
Nevertheless many experiments have been carried out to identify an allelopathic 
organism.  Inhibition zones around the plant, wide spontaneous monoculture area, 
and root segregation are realistic ecological features in which to investigate 
allelopathy (Inderjit and Callaway, 2003). The finding of phytotoxins in the 
rhizosphere, density-dependent experiments to distinguish allelopathy and 
resource competition effects (Weidenhamer et al., 1989), reduction of the 
negative power of one plant on the others by using substances with organic 
adsorptive capacity (activated carbon, gel filters) (Mahall and Callaway, 1992) to 
alter the rhizosphere chemistry, are just some of the more persuasive experiments 
that provide a deeper insight into allelopathy. 
Allelochemical action is launched when the allelochemicals are released in the 
environment. This may happen through different processes, including foliar 
leaching, root exudation, residue decomposition, volatilisation and debris 
incorporation into soil (Inderjit and Weston 2003). Once released, phytotoxins 
diffuse in the soil transported by water. It has also been demonstrated that 
allelopathic interaction can occur between organisms through root to root contact 
(Inderjit and Weston 2003). 
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Allelochemicals so far identified belong to different classes of chemical 
compounds, as terpenoids, quinones, saponins, coumarins, tannins, flavonoids, 
cinnamic  and benzoic acids, alkaloids.  
Terpenoid class includes a wide range of mono-, di-, tri-, sesqui-, and 
tetraterpenoids. Macias et al. (1999) have described an impressive array of 
terpenoids all isolated from sunflower that are responsible for inhibiting activity.  
Mechanisms of action have been studied for some chemicals having a well-
proved allelopathic activity,  but no unique way of interaction with cells has been 
found for structural related compounds. 
One of the first mechanisms of action described for allelochemicals was reported 
by Muller (1965), showing that the volatile 1,8-cineole and camphor reduce cell 
division causing a shorter root cells elongation and the generation of cells with 
irregular nuclear and large internal globules. It was successively reported that 
these monoterpenes cause structural modifications of small cellular organelles 
and the disruption of the nuclear membrane and other internal membranes.  
O
1,4-cineole1,8-cineole
O
 
A natural analogue of 1,8-cineole is 1,4-cineole, which has been shown to be a 
potent inhibitor of asparigine synthetase, which is involved in nitrogen 
metabolism.  The displacement of the oxygen bridge within the two 
monoterpenes described, deeply modifies the  biological effects. 
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Two significant examples of bioactive quinones are juglone and sorgoleone 
(Einhelling 2001) . They are described as having a role in black walnut and 
Sorghum allelopathy, respectively. They are both active at very low 
concentrations, several orders of magnitude lower than many allelochemicals 
from higher plants. It has been reported that both compounds affect plant energy 
metabolism, but it is still unclear what the target sites are. 
O
O
OH
H3CO
O
O
sorgoleone
juglone
 
Many bioactive coumarins were isolated from plants and their action mechanisms 
are broadly distributed, including an internal role in seed dormancy by retarding 
cellular development (Aliotta et al., 1994). Coumarin and scopoletin both 
decrease mitosis, and an inhibiting action on indoleacetic acid oxidation by 
scopoletin has been demonstrated.  Einhellig et al (1970) proved that roots-
absorbed scopoletin was transferred to shoots, where it decreased the 
photosyntesis rate, probably by stomatal closure. 
O O O O
H3CO
HO
coumarin scopoletin
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Cinnamic and benzoic acids production has been reported for many allelopathic 
plants. In their mode of action these compounds do not have a specific molecular 
target. Effects have been reported on several phytormone interactions, ion uptake 
and content, photosynthesis, respiration, chlorophyll maintenance, membrane 
structures and  ATPases transport, patterns of carbon flow, and a variety of 
enzymes. All these effects are said to be caused by  ferulic acid, one of the better-
studied phenolic acids, in higher plants (Einhelling 1986, Reigosa et al. 1999). 
O
OH
O
OH
HO
OCH3
cinnamic acid ferulic acid
 
Secondary metabolites produced by plants and having biological activity have 
been broadly described in literature but only a small subset has been studied in 
connection with allelopahty, and their action mechanism is still far from being 
understood. Thus there is still a wide array of natural compounds to be 
investigated for a more complete view of  allelopathy. 
Allelochemicals produced by a plant may act as phytotoxins on the plant itself. 
Two possible mechanisms might prevent a plant from poisoning itself: a) 
resistance at the molecular target site b) processes that avoid the allelochemical to 
interact with the molecular target site. While there is no evidence for the first  
mechanism, the second one is supported by several examples. Phytotoxins are 
kept away from the molecular target through sequestration and chemical 
protection. Sequestration is realized by the compartmentalization of the toxic 
chemicals in cell areas which are not in contact with vital centres, as in vacuoles 
 13 
and trichomes. In some cases phytotoxins are modified by enzymatic processes 
that bond sugars or other moieties. In this way the modified phytotoxins can be 
transported to a vacuole. The modified compounds are usually less phytotoxic, 
and their negative activity is even weaker when they are stored within vacuoles.  
These compounds usually become phytotoxic only after they are released into the 
soil, where they are probably activated by the enzymatic removal of the function 
employed to ensure vacuole sequestration. 
Chemical modification of allelochemicals is sometimes performed by plants, 
according to a species selected process, in order to lessen the phytotoxic effects 
of other species.  Detoxification processes include oxidation, carbohydrate or 
other chemical conjugation, and segregation in depository cell compartments 
before excretion. These kinds of plant reactions are also observed in response to 
herbicide treatments.  
Toxic activity of  allelochemicals  suggests the use of these compounds in weed 
management. The natural origin of these chemicals often means eco-
compatibility, low bioaccumulation, highly specific mechanisms of action. For all 
these features allelochemicals are suitable for use as herbicides, both directly or 
after chemical modification that implements physico-chemical properties.   
Herbicides designed by chemical synthesis have quite unspecific  molecular 
target sites, usually aimed at undermining generic vital functions of the cell, 
causing drawbacks also to crops. Evolution, instead,  selected a broad array of 
efficient and selective phytotoxins, which can be used as templates for  new 
herbicides. Increasing the weeds resistance to common herbicides has aroused 
deep interest in the discovery of new molecular target sites for herbicides. 
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Most  phytotoxins are too weakly allelophatic to be considered for the direct use 
as herbicides. They often show a very weak activity at millimolar concentration 
in bioassays, and much higher concentrations would be required in soil. 
However, many plant-produced phytotoxins preserve their  bioactivity at a 
micromolar level, making them potential candidates for industrial applications.    
An interesting example is tentoxin (Duke et al. 1987), a cyclic tetrapeptide from 
the plant pathogen Alternaria alternata. This compound has a really attractive 
soil behaviour. In fact, it shows high stability with good residual soil activity 
which is mainly exerted against an important spectrum of weed species. Several 
major crops are completely resistant to tentoxin toxicity. The only obstacle for 
tentoxin industrial application is its structural complexity, and all the efforts to 
find a simpler analogue with the same desirable properties, have been vain.   
N
N
H
N
H
N
O
O
O
O
tentoxin
 
Another interesting natural compound is sorgoleone, which is a plant-produced 
quinone, structurally related to plastoquinone. Together with many of its 
analogues, sorgoleone inhibits photosystem II of photosynthesis, apparently by 
preventing the binding of plastoquinone to the D-1 protein of PSII (Rimando et 
al. 1998). Unfortunately  it does not show proper physico-chemical properties 
required to be applied directly as a herbicide. 
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In spite of the wide array of  phytotoxic natural compounds isolated, just a few of 
them can be effectively applied as herbicides. This is mainly due to the structural 
complexity of natural molecules, which requires multi-step synthesis and 
considerable production costs. In many cases the slightest simplification of the 
natural structure nullifies biological activity; so analogue planning does not 
always guarantee efficient results. 
Nevertheless there are many commercial herbicides deriving structurally from 
allelopathic compounds. 
An interesting example is provided by a herbicide widely used in Europe and 
Asia, cynmethylin. This herbicide is structurally similar to 1,4-cineole, a natural 
monoterpen, which acts on a target plant by inhibiting asparigine synthetase 
(Romagni et al. 2000), a previously unexploited molecular action site. The 
inhibition of this enzyme causes an interruption of plant growth. It seems that 
Cynmethylin is a pro-herbicide that requires metabolic bioactivation in soil by 
cleavage of the benzyl-ether side chain, giving a molecule with a 1,4-cineole 
structure, responsible for the allelopathic activity (Romagni et al. 2000). 
 
O
O
cinmethylin
 
 
For agricultural purposes different kinds of triketone herbicides structurally 
derived from the natural compound leptospermone are widely used. Two 
interesting examples are sulcotrione and mesotrione (Lee at al. 1997, Knudsen et 
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al. 2000). These kinds of triketone herbicides act on the enzyme p-
hydroxyphenylpyruvate dioxygenase, which is an enzyme involved in the 
biosynthesis of carotenoids and plastoquinone. The inhibition of its activity 
causes foliage bleaching in the treated plants, due to  the loss of chlorophyll. 
 
O
O
O Cl
SO2Me
O
O
O NO2
SO2Me
sulcotrione mesotrione
 
Recently another interesting application of allelopathic studies has been 
proposed. Biotechnology researches are aimed at designing crops in which 
genetic modifications induce allelochemical production, or implement an already 
existing allelopathic activity. Even though this approach to the use of herbicides 
seems to be possess many advantages, a serious and extensive research is 
required if we are to be totally aware of all the consequences related to the 
genetic engineering of crops.  
The investigation of allelopathic compounds is just a small part of the studies of 
natural compounds. Nature still represents an infinite source of unknown 
molecules having new structures and functionalities that evolution refined for 
high specific biological roles. The functional-group diversity and architectural  
models of carbon skeletons designed by nature continue to provide lessons for 
synthetic and medicinal chemists in their strategies for making biological active 
mimics. Biosynthetic pathways of natural compounds also provide interesting 
suggestions for monomer assembling and  the tailoring of  the growing product, 
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which can be used to create new strategies for synthesising  variants of natural 
products (Clardy et al. 2004).  
During my PhD project I have been working in a research group that has studied 
different plants of the Mediterranean area for many years, trying to detect and 
investigate their allelopathic activity (Della Greca et al. 1994, Della Greca et al. 
2004, Della Greca et al 2003).  Personally I have been concerned with the 
isolation and identification of secondary metabolites produced by three 
spontaneous plants of the Mediterranean area: Brassica fruticulosa, 
Chenopodium album and Malva silvestris. The extraction of metabolites from 
these plants was realized by infusion in hydro-alcoholic solution for Brassica 
fruticulosa and Chenopodium album. Instead, an automatic extractor (Naviglio 
extractor) (Naviglio 2003) was used for Malva silvestris. Fractionation and 
purification of the extracts were realized by different chromatographic techniques 
(CC, HPLC, TLC, DCCC), while pure compound identification was possible 
with spectroscopic techniques (1H and 13C NMR, UV-VIS, CD, IR) and 
spectrometric techniques (ESI-MS, GC-MS, MALDI-MS). Characterized 
compounds have been tested on seeds of target plants to detect their bioactivity, 
in accordance with a procedure defined by Macias et al. (2000). 
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MATERIALS AND METHODS 
 
General Experimental Procedures. Nuclear magnetic resonance (NMR) spectra are 
recorded at 500 MHz for 1H and 125 MHz for 13C on a Varian 500 Fourier transform 
NMR spectrometer. Electronic impact mass spectra (EI-MS) are obtained with a HP 
6890 spectrometer equipped with an MS 5973 N detector. Matrix Assisted Laser 
Desorption Ionization (MALDI) mass spectra are recorded using a Voyager-DE 
MALDI-TOF mass spectrometer. UV/Vis spectra are recorded in ethanol on a Perkin-
Elmer Lambda 7 spectrophotometer. The CD curves are measured with Jasco J-715 
dichrograph. The preparative DCCC apparatus consists of a Tokyo Rikakikai Ltd 
system equipped with 300 tubes (400 x 2.0 mm). The analytical HPLC apparatus 
consists of an Agilent 1100 HPLC system equipped with a UV detector. The column is 
a 250 mm x 4.6 mm i.d., 5 µm Hibar LiChrosorb RP-18 (Merck). The preparative 
HPLC apparatus consists of a Shimadzu LC-10AD pump, a Shimadzu RID-10A 
refractive index detector, and a Shimadzu Chromatopac CR-6A recorder. Preparative 
HPLC is performed using a 250 mm x 10 mm i.d., 10 µm Luna NH2, RP-8 and RP-18 
column (Phenomenex). Analytical TLC is made on Kieselgel 60 F254 or RP-18 F254 
plates with 0.2 mm layer thickness (Merck). Spots are visualized by UV light or by 
spraying with H2SO4/AcOH/H2O (1:20:4). The plates are then heated for 5 min at 110 
°C. Preparative TLC is performed on Kieselgel 60 F254 plates with 0.5 or 1 mm film 
thickness (Merck). Flash column chromatography (FCC) is conducted on Kieselgel 60, 
230-400 mesh (Merck), at medium pressure. Column chromatography (CC) is 
performed on Kieselgel 60, 70-240 mesh (Merck), or on Sephadex LH-20 (Pharmacia).  
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Extraction and Isolation of Compounds from Brassica fruticulosa .  B. fruticulosa 
was collected in Italy (Caserta) during Spring and identified by Professor Assunta 
Esposito of Dipartimento di Scienze della Vita of II University of Naples (CE 38).  
Fresh leaves (15 kg) were infused with 10% MeOH/ H2O for 7 days and then with 
methanol for 5 days.  
The MeOH/ H2O extract was reduced in volume and partitioned between CH2Cl2 and 
H2O. The CH2Cl2 extract (20 g) was subjected to silica gel column chromatography, 
using CHCl3 and successively increasing ethyl acetate (EtOAc) by 5, 25, 50, 80, and 
100% in CHCl3. Fractions of 200 mL were collected and the fractions with similar TLC 
profiles were combined to produce 35 fractions. Fractions eluted with 5% EtOAc were 
purified by flash silica gel column chromatography with CHCl3/EtOAc (7:3) and then 
on a Sephadex LH-20 column with hexane/CHCl3/MeOH (3:1:1) to give pure 1. Two 
fractions were eluted with 50% EtOAc, fractions A and B. Fraction A was purified by 
DCCC [CHCl3/MeOH/H2O (11:10:9)] using the more polar upper layer as mobile 
phase.  Fractions 51-80 were chromatographed by reverse phase C-8 HPLC 
[H2O/CH3CN (7:3)] to give pure 2 and 4. The fraction eluted with 80% EtOAc was 
purified by DCCC [CHCl3/MeOH/H2O (11:10:9)].  Fraction B was chromatographed on 
silica gel column with  CHCl3/EtOAc (3:2), fractions 12-23 obtained were purified by 
TLC Hexane/EtOAc (6:4) to give pure 14. 
Fractions 40-60 were chromatographed by reverse phase C-8 HPLC 
[H2O/MeOH/CH3CN (7:2:1)] to give pure 5.  
Fractions 61-85 were purified by HPLC on a NH2 column [CHCl3/MeOH (9:1)], giving 
pure 9 and 12. 
Purification of fractions 86-112 was made with preparative TLC [CHCl3/MeOH/H2O 
(33:30:35)], using the organic lower layer as mobile phase to give pure 6 and 8.  
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 Fractions 113-150 were separated by Sephadex LH-20 column chromatography with 
20% MeOH in CHCl3 and subsequently purified by preparative TLC 
[EtOAc/MeOH/H2O (8:1:10)] to give pure 11.  
The fraction eluted with 100% EtOAc was purified by DCCC [CHCl3/MeOH/H2O 
(11:10:9)] using the more polar upper layer as mobile phase.  Fractions 31-50 were 
chromatographed by preparative TLC [EtOAc/CHCl3 (1:1:)] to give pure 15. 
The concentrated water layer (2 L) was chromatographed on Amberlite XAD-2 with 
water and methanol. The MeOH fraction (100 g) was rechromatographed on Sephadex 
LH-20 with H2O and increasing MeOH by 20, 30, 50 and 80% in H2O up to 100%. 
 Fractions eluted with 100% H2O were purified by silica gel column cromatography, 
using the organic layer of the solution CHCl3/MeOH/H2O (13:6:5) as mobile phase. 
Fractions 10-20 were chromatographed by HPLC on a C-18 column 
[H2O/MeOH/CH3CN (6:3:1)] to give pure 17. 
Fractions eluted with 20% MeOH were purified by silica gel flash column 
chromatography with CHCl3/MeOH/H2O (13:6:5) and then by reverse phase C-8 HPLC 
[H2O/MeOH/CH3CN (3:1:1)], to give pure 7.  
Fractions eluted with 30% MeOH were purified by DCCC [CHCl3/MeOH/H2O 
(13:6:5)] using the more polar upper layer as mobile phase. Fractions 35-60 were 
chromatographed by HPLC on a NH2 column [CH3CN/H2O (9:1)] to give pure 3.  
Preparative TLC, CHCl3/MeOH (9:1) of purified fractions 61-85 gave pure 13. 
Fractions eluted with 50% MeOH were purified by DCCC [CHCl3/MeOH/H2O 
(7:13:9)] using the more polar upper layer as mobile phase. Fractions 55-74 were 
chromatographed by reverse phase C-8 HPLC [H2O/MeOH/CH3CN (7:2:1)] to give 
pure 10.  
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The methanol extract was reduced in volume and partitioned between EtOAc and water. 
The ethyl acetate extract (20 g) was subjected to silica gel column chromatography, 
using CHCl3 and successively increasing the acetone. Fractions eluted with 10% 
acetone were purified by C18-HPLC [H2O/MeOH/CH3CN (3:5:2)] to give pure 16. 
The water extract was concentrated and then partitioned between CH2Cl2 and water. 
Concentrated water portions were chromatographed on Amberlite XAD-2, eluing with 
water and increasing methanol. Fraction eluted with 50% MeOH in water was 
fractioned on Sephadex LH-20 with water, fractions 10-20 were purified by  preparative 
TLC [MeOH/CHCl3 (1:4)] to give pure 18. 
 
Extraction and Isolation of Compounds from Malva silvestris. Aerial part of plants 
of M. silvestris were collected near Caserta (Italy) in the Spring of 2003 and identified 
by Professor Antonino Pollio of the Dipartimento di Biologia Vegetale of University of 
Naples. Voucher specimens (HERBNAQA650) are deposited at the Dipartimento di 
Biologia Vegetale of University Federico II of Naples.  Fresh leaves (10.0 kg) of the 
plant were extracted with H2O at room temperature using Naviglio extractor. The water 
was reduced in volume and partitioned between ethyl acetate and water. The organic 
extract (19 g) was subjected to silica gel column chromatography, using CHCl3 and 
successively increasing the ethyl acetate by 25, 50 and 80% in CHCl3. Fractions of 200 
mL were collected and the fractions with similar TLC profiles were combined. The first 
fraction eluted with 100% CHCl3 was purified by flash silica gel column 
chromatography with hexane-ethyl ether (1:1) to give fractions containing compounds 
32-35, 14, 16 and 17. The fraction containing crude 32 was purified by reverse phase C-
18 HPLC with MeOH-CH3CN-H2O [(1:6:3)]. Compounds  14 , 33 and 34 were purified 
by preparative TLC with CHCl3-acetone (7:3). The fraction containing crude 35 was 
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purified by preparative TLC with CH2Cl2-MeOH-H2O (11:10:9). Compounds 16, and 
17 were purified by preparative TLC CHCl3-MeOH (19:1). The second fraction eluted 
with 100% CHCl3 was extracted with NaOH 2 N and the water fraction, after 
neutralization, was extracted with ethyl acetate to give 600 mg of residual material. 
Column chromatography on silica gel gave a fraction containing 22, 26 and 31. 
Compound 22 was purified by preparative TLC with CH2Cl2-MeOH-H2O (33:30:35) 
lower layer. Compounds 26 and 31 were purified by C-18 HPLC with H2O-MeCN-
MeOH (7:2:1). Fractions eluted with 50% EtOAc were purified by flash silica gel 
column chromatography using CH2Cl2 and successively increasing acetone by 0, and 50 
% in CH2Cl2. Fractions eluted with 100% CH2Cl2 were rechromatographed on silica gel 
under the same conditions. Subfraction eluted with 10% acetone was purified by C-18 
HPLC with MeOH-H2O (4:3) to give compounds 19, 20, 25, 28 and 29. Subfraction 
eluted with 15% acetone was purified by C-18 HPLC with MeOH-H2O (4:3) to give 
compounds  21,  23. Subfraction eluted with 50% acetone was purified by C-18 HPLC 
with MeOH-MeCN-H2O (4:1:5) to give compound 24. Fraction eluted with 50% 
acetone was rechromatographed on silica gel using CH2Cl2 and successively increasing  
the acetone by 20, 40, and 50% in CH2Cl2. Fraction eluted with 20% acetone was 
purified by C-18 HPLC with MeOH-MeCN-H2O (3:2:5) to give 36. Fraction eluted 
with 40% acetone was purified by C-18 HPLC with MeOH-MeCN-H2O (4:1:5) to give  
30. Fraction eluted with 50% acetone was purified by preparative TLC with EtOAc –
acetone (19:1) to give 27.  
 
Extraction and Isolation of Compounds from Chenopodium album. Plants of C. 
album L. were collected near Caserta (Italy) during the  Autumn of  2002 and Professor 
Antonino Pollio of the Dipartimento di Biologia Vegetale dell’Università Federico II di 
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Napoli identified them. Voucher specimens (HERBNAPY620) are deposited at the 
Dipartimento di Biologia Vegetale dell’Università di Napoli.  
Leaves (15 kg) and twigs (9 kg) were separately and sequentially extracted with 10% 
MeOH/ H2O and methanol at room temperature for 7 days. The extracts were frozen 
and stored at -80°C until used.  
Hydroalcoholic leaf extract fractionation. Cold acetone (1.0 L) was added to the 
aqueous suspension (750 mL) of the hydroalcoholic extract (180 g), and the mixture 
was placed on a stir plate in a cold room overnight. The acetone
 
addition produced 
heavy precipitation, consisting mostly of proteinaceous material, which was removed by 
centrifugation. 
The solution was concentrated under reduced pressure and extracted with 
dichloromethane (1.0 L). The organic phase was concentrated and subjected to Flash 
Column Chromatography (FCC), giving ten different fractions. 
Fraction 2 (12 g) eluted with dichloromethane was rechromatographed on FCC. 
Subfraction 4 (1.5 g), eluted with n-hexane: dichloromethane (4:1), was 
rechromatographed on FCC and, the 1st fraction eluted with n-hexane : ethyl acetate 
(19:1) gave 45. Subfraction 5 (377 mg), eluted with n-hexane : acetone (4:1), was 
rechromatographed on FCC. Fraction 4, eluted with n-hexane : acetone (4:1) was 
purified by preparative TLC [n-hexane : acetone (4:1)] to give pure 39. Subfraction 9 
(275 mg), eluted with n-hexane : acetone (1:1), was rechromatographed on Sephadex 
LH-20 using n-hexane : chloroform : methanol (1:3:1) to give 5 fractions. The 4th  (121 
mg) was rechromatographed on FCC. The fraction eluted with dichloromethane : 
acetone (9:1) was purified by RP-18 HPLC with methanol : water (1:1) to give 1. The 
5th (25 mg), containing compounds 42 and 43, was purified by RP-18 HPLC with 
methanol : water [(3:7), 5 and  4 mg, respectively]. Subfraction 10 (456 mg), eluted 
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with dichloromethane was fractionated into acidic and neutral fractions with aqueous 
NaOH 2M. The neutral fraction, washed with water and concentrated under vacuum 
(380 mg), was purified by FCC eluting with chloroform : ethanol (49:1) to give pure 38. 
Subfraction 11 (587 mg), eluted with dichloromethane : acetone (9:1) was fractionated 
into acidic and neutral fractions with aqueous NaOH 2M. The neutral fraction (250 mg) 
was rechromatographed on FCC eluting with dichloromethane : acetone (9:1) to give 
pure 47. Subfraction 13 (180 mg), eluted with dichloromethane : acetone (7:3), was 
fractionated into acidic and neutral fractions with aqueous NaOH 2M. The aqueous 
alkaline solution was cooled and acidified with HCl 4 M, and the liberated solids were 
extracted with ethyl acetate, washed with water, and concentrated under vacuum, 
yielding 110 mg of residual material. This  was then purified by RP-18 HPLC with 
methanol : acetonitrile : water (4:1:5), to give pure 50 and 51. 
Fraction 4 (340 mg), eluted with dichloromethane : acetone (7:3), was 
rechromatographed on FCC.  
Subfraction 5 (32 mg), eluted with dichloromethane : ethyl acetate (49:1), was purified 
by preparative TLC [dichloromethane : acetone (22:3), 41 and 21]. Subfraction 9 (1.5 
g), eluted with dichloromethane : acetone (7:3), was rechromatographed on FCC. The 
fraction eluted with dichloromethane : acetone (4:1) was purified by preparative TLC 
[dichloromethane : methanol (9:1)], to give pure 28  and 29. 
Fractions 5, 6, 7, 8 and 9 were eluted with EtOAc-CH2Cl2- petrol ether gradient. 
Fraction 5 (1.0 g) contained 60,  which was purified using HPLC with MeOH-CH3CN-
H2O (2:1:2), and 61 was purified on silica gel column [CHCl3-acetone (9:1)]. Fraction 6 
(1.2 g) contained 34, which was purified using HPLC with MeOH-CH3CN-H2O (2:1:2).  
Fraction 7 (750 mg) contained 68, which was purified by semipreparative TLC [CHCl3-
EtOAc (19:1)]. Fraction 8 (6.0 gr) was washed with 2N NaOH and the organic phase, 
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after neutralization, gave a crude residue (320 mg) which was repeatedly 
chromatographed on silica gel column acetone-CHCl3-petrol ether gradient to afford a 
mixture of eight compounds. 71 was purified by semipreparative TLC [petrol ether-
CHCl3-acetone (8:11:1)].  66  was purified by semipreparative TLC [petrol ether-
acetone (4:1)]. 33 was purified using HPLC with MeOH-CH3CN-H2O (5:1:4). 72 and 
70 were purified by semipreparative TLC [CHCl3-acetone (4:1)]. 67, 69 and 73 were 
separated using HPLC with  MeOH-CH3CN-H2O (3:2:5). The aqueous alkaline solution 
was acidified in the cold with conc. HCl and liberated solids were extracted with 
EtOAc. The solution was washed with H2O, dried and the solvent removed in vacuum. 
The  crude residue (315 mg) was repeatedly chromatographed on silica gel column 
acetone-CH2Cl2 gradient to afford a mixture of four compounds. 62 and 16 were 
purified by HPLC with MeOH-H2O (9:11). 64 was purified using HPLC with MeOH-
CH3CN-H2O (2:1:2). 14 was purified by HPLC with MeOH-CH3CN-H2O (4:1:5). 
Fraction 9 (700 mg) contained 63 and 65, that were purified using HPLC with MeOH-
CH3CN-H2O (6:1:13).  
The concentrated water layer (2.0 L) was chromatographed on Amberlite XAD-2 with 
water, methanol, and acetone. The methanol fraction was concentrated and suspended in 
water and extracted with chloroform (1.0 L). The organic layer (4.3 g) was 
chromatographed on FCC.  
Fraction 2 (300 mg), eluted with n-hexane : chloroform : acetone (14:6:5), was 
rechromatographed on Sephadex LH-20 eluting with n-hexane : chloroform : methanol    
(3:1:1), to give three fractions. The 2nd (71 mg) was purified by preparative TLC 
[chloroform : acetone (17:3)] to give pure 37.  
Fraction 5 (240 mg), eluted with n-hexane : chloroform : acetone (7:3:10), was 
rechromatographed on Sephadex LH-20 eluting with n-hexane : chloroform : methanol    
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(1:3:1) to give three fractions. The 1st (60 mg) was purified by preparative TLC 
[dichloromethane : acetone (7:3)] to give pure 4. 
Fraction 7 (270 mg), eluted with dichloromethane : acetone (1:1), was 
rechromatographed on Sephadex LH-20 eluting with n-hexane : chloroform : methanol  
(3:1:1) to give four fractions. The 2nd (22 mg) was purified by RP-18 HPLC with 
methanol  : acetonitrile : water (1:1:3) to give pure 49. 
Hydroalcoholic twig extract fractionation. An aqueous solution of the hydroalcoholic 
extract (200 g), after precipitation of proteinaceous material was extracted with 
dichloromethane (1.0 L). The organic phase was concentrated and subjected to FCC. 
Fraction 1 (700 mg), eluted with chloroform, was rechromatographed on FCC. 
Subfraction 3, eluted with n-hexane : ethyl acetate (9:1), contained pure 44 and 
subfraction 6, eluted with n-hexane : ethyl acetate (3:1) contained pure 40.  
Fraction 6 (294 mg), eluted with chloroform : acetonitrile (17:3), was 
rechromatographed on FCC. Subfraction 4 (34 mg) was purified by preparative TLC 
[chloroform :  ethanol (19:1)] and by RP-18 HPLC with methanol  : acetonitrile : water 
(4:1:5) to give 46 and 48. 
 
Methanolic leaf extract fractionation. Cold acetone was added (1.0 l) to an aqueous 
suspension  (700 ml) of the MeOH extract (150 g), and the mixture placed on a stir plate 
overnight in a cold room. The acetone addition produced heavy precipitation, consisting 
mostly of proteinaceous materials, which were removed by centrifugation. The acetone 
was removed by evaporation and the clear aqueous extract, reduced to 200 ml, was 
extracted with EtOAc.  The organic layer was extracted with 2 N HCl and the organic 
phase was neutralized. After removal of the solvent, the crude residue (32 g) was 
chromatographed on silica gel column to give fractions A - Z.  
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Fraction P (455 mg) eluted with CHCl3 - MeOH (9:1) was filtered on Sephadex LH-20 
using hexane - CHCl3 - MeOH (1:3:1) to give fractions 1-3. Fraction 1 (68 mg) 
consisted of a mixture of 55 and 58, which were separated by TLC [CHCl3 - acetone 
(22:3)].  
Fraction 2 (132 mg), was rechromatographed on silica gel column. The fractions eluted 
with CHCl3 - MeOH (95:5) gave the crude of 52, 54 and 56. Compound 54 was purified 
by preparative TLC [petrol – acetone  (3:2)].  Compound 52 was purified by flash 
column chromatography [CHCl3 - MeOH (9:1)]. Compound 56 was purified by reverse 
phase C-18 HPLC with MeOH - CH3CN - H2O (3:2:5).  Fraction 3 (214 mg), was 
rechromatographed on silica gel column. The fraction eluted with CHCl3 - acetone 
(17:3) consisted of a mixture of 53 and 57, which was resolved by reverse phase C-18 
HPLC with MeOH - CH3CN - H2O (3:2:5) to give pure 53 and pure 57. 
Methanolic root extract fractionation. Cold acetone was added (1.0 l) to an aqueous 
suspension  (700 ml) of the MeOH extract (100 g), and the mixture placed on a stir plate 
overnight in a cold room. The acetone addition produces heavy precipitation consisting 
mostly of proteinaceous materials, which were removed by centrifugation. The acetone 
was removed by evaporation and the clear aqueous extract, reduced to 200 ml, was 
extracted with EtOAc.  The organic layer was extracted with 2 N HCl and the organic 
phase was neutralized. After removal of the solvent, the crude residue (32 g) was 
chromatographed on silica gel column to give fractions A which was eluted with 
benzene/acetone
 
7:3 (86 mg). Fraction A was rechromatographed on silica gel column. 
The fractions eluted with CHCl3 /EtOH 19:1 gave crude 59, which was purified by 
reverse phase C-18 HPLC with MeOH/CH3CN/H2O 2:1:2 .   
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Bioassays. Pure Glyfosate was purchased from Sigma-Aldrich. Pendimethalin, 
bioassayed as commercial mixture (Pendulum®) supplied by Ingegnoli Spa (Milano, 
Italy). 
Seed of Lactuca sativa L. (cv Cavolo di Napoli), Lycopersicon esculentum M. (cv 
Napoli V. F.), Allium cepa L. (cv Ramata di Milano) and Lepidium sativum L., collected 
during 2001, were obtained from Ingegnoli Spa. All undersized or damaged seeds were 
discarded and the assay seeds were selected for uniformity.  For the bioassays we used 
Petri dishes in two sizes: 90 mm (tomato, cress and onion) and 50 mm (lettuce) 
diameter with one sheet of Whatman No. 1 filter paper as support. In four replicate 
experiments, germination and growth were conducted in aqueous solutions at controlled 
pH. Test solns. (10-4 M) were prepared using MES (2-[N-Morpholino]ethanesulfonic 
acid, 10 mM, pH 6) and the rest (10-5  – 10-9 M) were obtained by dilution. Parallel 
controls were performed. After adding 25 seeds and 5 mL test solutions for 90 mm 
dishes and 2.5 mL test solutions for 50 mm dishes, the Petri dishes were sealed with 
Parafilm to ensure closed-system models. Seeds were placed in a KBW Binder 240 
growth chamber at 25 °C in the dark. Germination percentage was determined daily for 
5 days for lettuce and tomato, 3 days for cress and for 7 days for onion  (no more 
germination occurred after this time). After growth, the plants were frozen at –20 °C to 
avoid subsequent growth until the measurement process.  
Data are reported as percentage differences from control in the graphics. Thus, zero 
represents the control; positive values represent stimulation of the parameter studied and 
negative values represent inhibition. Germination rate of the control solution: 75% 
onion, 90% tomato, 89% lettuce and 95% cress. Root length of the control: 2.4 cm 
onion, 3.8 tomato, 2.9 lettuce and 2.8 cress. Shoot length of the control: 4.5 cm onion, 
2.7 tomato, 2.4 lettuce and 2.5 cress.   
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Spectroscopic data of  isolated compounds 
Compound 1. (-)-Pinoresinol (24 mg). [α]D25 –10.0o (c 9.0, CHCl3). MS: m/z 358 [M]+. 
1H NMR (CDCl3): δ 6.82 (6H, m, H-6 and H-6’, H-5 and H-5’, H-2 and H-2’), 4.74 
(2H,d, J=4.0 Hz, H-7 and H-7’), 4.25 (2H, dd, J=9.0 and 7.0 Hz, H-9a and H-9’a), 3.88 
(2H, dd, J=9.0 and 4.0 Hz, H-9b and H-9’b), 3.10 (2H, m, H-8 and H-8’), 3.91 (6H, s, 3-
OMe and 3’-OMe). 13C NMR (MeOD): δ 146.7 (C-3 and C-3’), 145.2 (C-4 and C-4’), 
132.9 (C-1 and C-1’), 118.9 (C-6 and C-6’), 114.3 (C-5 and C-5’), 108.6 (C-2 and C-
2’), 85.8 (C-7 and 7’), 71.6 (C-9 and C-9’), 54.1 (C-8 and C-8’), 55.9 ( 3-OMe and 3’-
OMe). 
Compound 2. (-)-Isolariciresinol (37 mg). [α]D25 -30.0o (c 12.0, MeOH) .1H NMR 
(MeOD): δ 6.74 (1H, d, J=8.1 Hz, H-5), 6.65 (1H, s, H-5’), 6.67 (1H, d, J=1.8 Hz, H-2), 
6.62 (1H, dd, J=8.1 and 1.8 Hz, H-6), 6.19 (1H, s, H-2’), 3.82 (3H, m, H-9b, H-9’a, H-
9’b), 3.83 (1H, d, J=10.0 Hz, H-7), 3.40 (1H, dd, J=11.0 and 3.0 Hz, H-9a), 2.77 (2H, d, 
J=7.2 Hz, H-7’), 2.00 (1H, m, H-8’), 1.74 (1H, tt, J=10.0 and 3.0 Hz, H-8), 3.76  (3H, s, 
3-OMe), 3.80 (3H, s, 3’-OMe).13C NMR (MeOD): δ 149.6 (C-3’), 147.7 (C-3), 146.5 
(C-4’), 145.7 (C-4), 139.2 (C-6’), 134.7 (C-1), 129.6 (C-1’), 123.7 (C-6), 117.8 (C-5’), 
116.5 (C-5),  114.3 (C-2), 112.9 (C-2’), 66.5 (C-9’), 62.8 (C-9), 56.8 (3-OMe and 3’-
OMe), 48.6 (C-7), 48.5 (C-8), 40.5 (C-8’), 34.1(C-7’).  
Compound 3. (+)-Secoisolariciresinol (8 mg). [α]D25 +28.1o (c 10.0, MeOH). MS: m/z 
362 [M]+. 1H NMR (MeOD): δ 6.65 (2H, d, J=8.0 Hz, H-5 and H-5’), 6.59 (2H, d, J=2.0 
Hz, H-2 and H-2’), 6.54 (2H,dd, J=8.0 and 2,0 Hz, H-6’ and H-6), 3.60 (4H, m, H-9’a 
and b, H-9a and b), 2.67 (2H, dd, J=14.0 and 5.0 Hz, H-7a and H-7’a), 2.56 (2H, dd, 
J=14.0 and 5.0 Hz, H-7b and  H-7b’), 3.73 (6H, s, 3’-OMe and 3-OMe), 1.90 (2H, m, 
H-8 and H-8’).13C NMR (MeOD): δ 149,3 (C-3 and C-3’), 145.9 (C-4 and C-4’), 134.1 
(C-1 and C-1’), 123.2 (C-6 and C-6’), 116.3 (C-5 and C-5’), 113.9 (C-2 and C-2’), δ 
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62.6 (C-9 and C-9’), 56.7 (3-OMe and 3’-OMe), 44.6 (C-8 and C-8’), 36.0 (C-8 and C-
8’).   
Compound 4. (±)-Lariciresinol  (30 mg). [α]D25 0° (c 1.0, MeOH). 1H NMR (MeOD): δ 
6.72 (1H, d, J=8.1 Hz, H-5’), 6.65 (1H, dd, J=8.1 and 1.8 Hz, H-6’), 6.78 (2H, m, H-5 
and H-6), 6.90 (1H, bs, H-2’), 6.41 (1H, bs, H-2), 4.80 (1H, d, J=6.0 Hz, H-7’), 4.00 
(1H, dd, J=8.1 and 6.0 Hz, H-9b), 3.74 (2H, m, H-9’a and H-9’b), 3.80 (1H, dd, J=8.1 
and 6.0 Hz, H-9a ), 3.82 (6H, s, 3’-OMe and 3-OMe), 2.87 (1H, dd, J=13.0 and 5.0 Hz, 
H-7a), 2.74  (1H, m, H-8), 2.45 (1H, dd, J=13.0 and 10.0 Hz, H-7b), 2.35 (1H, m, H-
8’).13C NMR (MeOD): δ 146,9 (C-3’ and C-3), 145.1 (C-4’), 143.9 (C-4), 118.1 (C-6’), 
133.7 (C-1), 131.6 (C-1’), 120.5 (C-6), 114.4 (C-5’), 114.6 (C-5),  111.6 (C-2), 108.7 
(C-2’), 59.1 (C-9’), 72.1 (C-9), 55.1 (3-OMe and 3’-OMe), 32.3 (C-7), 42.1 (C-8), 52.2 
(C-8’), 82.3 (C-7’). 
Compound 5. (-)-Tanegol (11 mg). [α]D25 –10.0o (c 2.5, MeOH). MS: m/z 376 [M]+. 1H 
NMR (MeOD): δ 6.75 (1H, d, J=8,0 Hz, H-5), 6.73 (2H, m, H-5’ and H-6’), 6.92 (1H, 
d, J=1.8 Hz, H-2), 6.79 (1H, dd, J=8.0 and 1.8 Hz, H-6), 6.87 (1H, s, H-2’), 4.62 (1H, d, 
J=7.0 Hz, H-7), 4.47 (1H, d, J=9.0 Hz, H-7’), 4.24 (1H, dd, J=9.0 and 4.0 Hz, H-9’β), 
3.93 (1H, dd, J=7.0 and 9.0 Hz, H-9’α), 3.29 (1H, dd, J=11.0 and 4.0 Hz, H-9a), 2.51 
(1H, m, H-8’), 1.87 (1H, m, H-8), 3.21  (1H, dd, J=11.0 and 6.0 Hz, H-9b), 3.82  (3H, s, 
3’-OMe), 3.84 (3H, s, 3-OMe).13C NMR (MeOD): δ 147.8 (C-3’),145.9 (C-3), 134.8 
(C-4’), 137.5 (C-4), 119.6 (C-6’), 137.4 (C-1), 133.0 (C-1’), 119.6 (C-6), 114.7 (C-5’), 
δ 114.7 (C-5), 110.3 (C-2), 109.8 (C-2’), 83.8 (C-7), 75.4 (C-7’), 70.3 (C-9’), 61.1 (C-
9), 55.2 (3-OMe and 3’-OMe), 52.3 (C-8’), 49.5 (C-8).  
Compound 6. (±)-Dehydrodiconiferyl alcohol (35 mg). [α]D25 0o (c 9.0, MeOH). MS: 
m/z 358 [M]+. 1H NMR (MeOD): δ 6.93 (2H. m, H-2’ and H-6’), 6.82 (1H, dd, J=8.1 
and 1.8 Hz, H-6), 6.79 (1H, d, J=1.8 Hz, H-2), 6.75 (1H, d, J=8.1 Hz, H-5), 6.55 (1H, d, 
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J=15.8 Hz, H-7’), 6.18 (1H, dt, J=15.8 and 6.0 Hz, H-8’), 5.58 (1H, d, J=7.2 Hz, H-7), 
4.29 (2H, d, J=6.0 Hz, H-9’), 3.85 (6H, s, 3’-OMe and 3-OMe), 3.79 (2H, m, H-9), 3.50 
(1H, m, H-8).13C NMR (MeOD): δ 147.3 (C-3’), 149.3 (C-3), 141.4 (C-4’), 140.2 (C-4), 
127.6 (C-7’), 126.5 (C-8’), 116.2 (C-6’), 132.4 (C-1), 127.2 (C-1’), 122.0 (C-6), 135.3 
(C-5’), 116.8 (C-5), 115.3 (C-2), 109.6 (C-2’), 88.2 (C-7), 65.6 (C-9’), 63.2 (C-9), 56.3 
(3-OMe and 3’-OMe), 50.4 (C-8). 
Compound 7. (±)-Threo-guaiacylglycerol-β-O-4’-coniferyl ether. (11 mg). [α]D25 0o (c 
1.5,  MeOH). MS: m/z 376 [M]+. 1H NMR (MeOD): δ 7.00 (2H, m, H-5’ and H-6’), 
6.87 (2H, s, H-2 and H-2’), 6.83 (1H, dd, J=8.0 and 2.0 Hz, H-6), 6.72 (1H, d, J=8.0 Hz, 
H-5), 6.51 (1H, d, J=15.8 Hz, H-7’), 6.23 (1H, dt, J=15.8 and 5.8 Hz, H-8’), 4.83 (1H, 
d, J=6.0 Hz, H-7), 4.36 (1H, m, H-8), 4.20 (2H, d, J=6.0 Hz, H-9’a and b), 3.84 (1H, dd, 
J=11.8 and 5.8 Hz, H-9a), 3.76 (1H, dd, J=11.8 and 4.0 Hz, H-9b), 3.80 (3H, s, 3’-OMe, 
3-OMe).13C NMR (MeOD): δ 150.9 (C-3), 150.5 (C-3’), 146.0 (C-4’), 139.9 (C-4), 
133.8 (C-7’), 133.0 (C-1’), 131.7 (C-1), δ 122.2 (C-8’),  119.8 (C-5) 119.5(C-6), 119.7 
(C-6’), 118.8 (C-5’), 112.4 (C-2), 110.2 (C-2’), 80.0 (C-8), 73.8 (C-7), 65.0 (C-9’), 62.9 
(C-9),  56.6 (3-OMe), 55.8 ( 3’-OMe).  
Compound 8. (+)-Threo-guaiacylglycerol-β-O-4’-sinapyl ether (12 mg). [α]D25 +9.17o 
(c 2.5, MeOH). CD (EtOH): [θ]234= -23100, [θ]275= - 3300. MS: m/z 406 [M]+. 1H NMR 
(CD3OD): δ 6.99 (1H, d, J=2.0 Hz, H-2), 6.80 (1H, dd, J=8.0 and 2.0 Hz, H-6), 6.74 
(1H, d, J=8.0 Hz, H-5), 6.73 (2H, s, H-6' and H-2'), 6.55 (1H, d, J=15.8 Hz, H-7'), 6.30 
(1H, dt, J=15.8 and 5.8 Hz, H-8'), 4.92 (1H, d, J=5.1 Hz, H-7), 4.22 (3H, m, 2H-9' and 
H-8), 3.87 (1H, dd, J=11.0 and 7.0 Hz, H-9a), 3.84  (9H, s, 3'-OMe, 3-OMe and 5'-
OMe), 3.55 (1H, dd, J=11.0, 4.0 Hz, H-9b). 13C NMR (MeOD): δ 154.9 (C-3' and C-5'), 
148.9 (C-4'), 147.2 (C-3), 136.7 (C-4), 135.1 (C-1'), 134.1 (C-1), 131.7 (C-7'), 130.1 (C-
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8'), 120.9 (C-6), 116.0 (C-5), 111.7 (C-2), 105.2 (C-2' and C-6'), 87.9 (C-8), 74.3 (C-7), 
63.8 (C-9'), 61.7 (C-9), 56.0 (3-OMe), 56.2 ( 3'-OMe and 5'-OMe). 
 Compound 9. (±)-Erythro-syringylglycerol-β-O-4-sinapyl ether (3 mg). [α]D25 0o (c 
2.0, MeOH). MS: m/z 436 [M]+. 1H NMR (CD3OD): δ 6.69 (2H, s, H-2 and H-6), 6.58 
(2H, s, H-2' and H-6'), 6.57 (1H, d, J=15.8 Hz, H-7'), 6.36 (1H, dt, J=15.8, 5.8 Hz, H-
8'), 4.99 (1H, d, J=4.0 Hz, H-7), 4.36 (2H, dd, J=5.8, 1.5 Hz, H-9'), 4.12 (1H, m, H-8), 
3.92, 3.90, 3.89 and 3.88 (12H, s, 3'-OMe, 3-OMe, 5-OMe, 5'-OMe), 3.86 (1H, partially 
obscured, H-9a), 3.49 (1H, dd, J=12.0, 3.0 Hz, H-9b). 13C NMR (CD3OD): δ 154.9 (C-
3' and C-5'), 148.9 (C-4'), 147.2 (C-3 and C-5), 136.7 (C-4), 135.1 (C-1'), 134.1 (C-1), 
130.2 (C-7'), 128.6 (C-8'), 103.1 (C-6), 102.1 (C-2), 98.3 (C-2’ and C-6'), 86.9 (C-8), 
72.3 (C-7), 55.9 (3-OMe and 5-OMe), 55.8 (3'-OMe and 5'-OMe), 63.1 (C-9'), 60.2 (C-
9).  
Compound 10. 1-Feruloyloxy-2-methoxy cinnamic acid (15 mg). MS: m/z 370 [M]+. 1H 
NMR (CD3OD): δ 7.59 (1H, d, J=8.5 Hz, H-5), 7.57 (1H, d, J=15.5 Hz, H-7), 7.19 (1H, 
d, J=2.0 Hz, H-2), 6.81 (1H, dd, J=8.5 and 2.0 Hz, H-6), 6.36 (1H, d, J= 15.5 Hz, H-8), 
3.80 (3H, s, 3-OMe).  
Compound 11. (8 mg). [α]D25 0o (c 2.5, CHCl3). MALDI-MS: m/z 833 [M+Na]+. 1H 
NMR (CDCl3): δ 6.97 (2H, d, J=2.0 Hz, H-2" and H-2"'), 6.86 (2H, d, J=8.0 Hz, H-5" 
and H-5"'), 6.74 (2H, dd, J=8.0, 2.0 Hz, H-6" and H6"'), 6.64 (4H, s, H-2, H-6, H-2' and 
H-6'), 5.00 (2H, d, J=4.0 Hz, H-7" and H-7"'), 4.79 (2H, brs, H-7 and H-7'), 4.34 (2H, 
m, H-9a and H-9'a), 4.14 (2H, m, H-8" and H-8"'), 3.98 (2H, dd, J=7.6, 2.2 Hz, H-9b 
and H-9'b), 3.92, 3.91 and 3.90 (18H, s, 3-OMe, 5-OMe, 3'-OMe, 5'-OMe, 3"-OMe and 
3"'-OMe), 3.88 (2H, m, H-9"a and H-9"'a), 3.51 (2H, dd, J=10.0, 2.0 Hz, H-9"b and H-
9"'b), 3.14 (2H, m, H-8 and H-8').13C NMR (CDCl3): δ 153.5 (C-3, C-5, C-3' and C-5'), 
146.6 (C-3" and C-3"'), 144.8 (C-4" and C-4"'), 137.6 (C-4 and C-4'), 134.3 (C-1 and C-
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1'),  131.3 (C-1" and C-1"'), 118.7 (C-6" and C-6"'), 114.1 (C-5" and C-5"'), 108.3 (C-2" 
and C-2"'), 102.8 (C-2, C-6, C-2' and C-6'), 87.1 (C-8" and C-8"'), 85.8 (C-7 and C-7'), 
72.5 (C-7" and C-7"'), 71.9 (C-9 and C-9'), 60.7 (C-9" and C-9"'), 56.2 and 56.0 (3-
OMe, 5-OMe,  3'-OMe, 5'-OMe, 3"-OMe and 3"'-OMe), 54.4 (C-8 and C-8').  
Compound 12. (±)-Erythro-guaiacylglycerol-β-O-4'-dehydrodisinapyl ether (10mg). 
[α]D25 0o (c 2.5, CHCl3). MS: m/z 584 [M]+. 1 H NMR (CDCl3): δ 6.95 (1H, d, J=2.0 Hz, 
H-6), 6.90 (2H, s, H-2 and H-2"), 6.87 (1H, dd, J=8.0, 2.0 Hz, H-6"), 6.75 (1H, d, J=8.0 
Hz, H-5"), 6.70 (2H, s, H-2' and H-6), 6.51 (1H, d, J=15.8 Hz, H-7), 6.25 (1H, dt, 
J=15.8, 5.8 Hz, H-8), 5.65 (1H, d, J=8.5 Hz, H-7'), 4.99 (1H, d, J=4.5 Hz, H-7"), 4.32 
(2H, dd, J=5.8, 1.0 Hz, H-9), 4.10 (1H, m, H-8"), 4.00 (1H, m, H-9"a), 3.92 (5H, m, 3-
Ome, H-9'a and H-9’b), 3.89 (3H, s, 3"-OMe), 3.85 (6H, s, 3'-OMe and 5'-OMe), 3.67 
(1H, m, H-8'), 3.50 (1H, dd, J=11.0, 2.0 Hz, H-9"b).13C NMR (CD3OD): δ 153.7 (C-5'), 
153.6 (C-3'), 148.4 (C-4), 146.8 (C-3"), 145.1 (C-4"), 144.7 (C-3), 137.9 (C-4'),  134.9 
(C-1'), 131.5 (C-1"), 131.4 (C-1 and C-5), 127.9 (C-7), 126.9 (C-8), 118.9 (C-6 and C-
6"),  114.9 (C-6), 114.4 (C-2' and C-6'), 110.7 (C-2),108.6 (C-2"),103.3 (C-5"), 88.3 (C-
7'), 87.3 (C-8"), 72.7 (C-7"), 64.3 (C-9'), 63.9 (C-9), 60.7 (C-9"), 56.5 (3-OMe and 3"-
OMe), 56.2 (3'-OMe and 5'-OMe), 53.8 (C-8').  
Compound 13. (-)-Threo-guaiacylglycerol-β-O-4-lariciresinol ether (9 mg): [α]D25 -
3.4o (c 2.0, MeOH). MALDI/MS: m/z 579 [M+Na]+. 1H NMR (CD3OD): δ 6.97 (1H, d, 
J=2.0 Hz, H-2"), 6.93 (1H, s, H-2'), 6.87 (1H, dd, J=8.0, 2.0 Hz, H-6"), 6.82 (2H, m, H-
2 and H-6'), 6.80 (1H, d, J=8.0 Hz, H-5") 6.76 (1H, d, J=8.0 Hz, H-5), 6.72 (1H, d, 
J=8.0 Hz, H-5'), 6.64 (1H, dd, J=8.0, 1.5 Hz, H-6), 4.77 (1H, d, J=6.0 Hz, H-7"), 4.69 
(1H, d, J=6.5 Hz, H-7'), 4.27 (1H, m, H-8"), 3.93 (1H, dd, J=8.3 Hz, 6.4, H-9a), 3.84 
(3H, s, 3'-OMe), 3.83 (1H, m, H-9"a), 3.80 (4H, s, 3"-OMe and H-9'a), 3.78 (3H, s, 3-
OMe), 3.77 (1H, m, H-9"b), 3.72 (1H, dd, J=8.3, 5.8 Hz, H-9b), 3.61 (1H, dd, J=11.0, 
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6.4 Hz, H-9'b), 2.89 (1H, dd, J=12.5, 5.0 Hz, H-7a), 2.67 (1H, m, H-8), 2.46 (1H, dd, 
J=12.5, 11.5 Hz, H-7b), 2.33 (1H, m, H-8'). 13C NMR (CD3OD): δ 152.1 (C-3), 149.1 
(C-3'), 148.9 (C-3"), 147.7 (C-4), 147.3 (C-4"), 147.2 (C-4'), 136.8 (C-1), 135.8 (C-1'), 
134.3 (C-1"), 122.5 (C-6), 121.2 (C-6"), 120.1 (C-6'), 119.8 (C-5'), 116.3 (C-5), 115.9 
(C-5"), 114.5 (C-2), 112.0 (C-2"), 110.9 (C-2'), 86.7 (C-8"), 84.3 (C-7'), 74.4 (C-7"), 
73.8 (C-9), 62.5 (C-9"), 60.7 (C-9'), 56.9 (3-OMe and 3"-OMe), 56.4 (3'-OMe), 54.2 
(C-8'), 43.9 (C-8), 34.0 (C-7).  
Compound 14. (6R,7E,9S)-9-Hydroxy-4,7-megastigmadien-3-one. (5 mg). [α]D25 +200o 
(c 2.0, CHCl3). MS: m/z 208 [M]+ . 1H NMR (CDCl3): δ 5.89 (1H, s, H-4), 5.67 (1H, dd, 
J=6.0 e 16.0 Hz, H-8), 5.53 (1H, dd, J=16.0 and 8.6 Hz, H-7), 4.35 (1H, m, H-9), 2.52 
(1H, d, J=8.6 Hz, H-6), 2.34 (1H, d, J=17.0, H-2), 2.08 (1H, d, J=17.0 Hz, H-2), 1.90 
(3H, s, H-13), 1.30 (3H, d, J=6.4 Hz, H-10), 1.03 (3H, s, H-11), 0.97 (3H, s, H-12).13C 
NMR (CDCl3): δ 199.0 (C-3), 161.7 (C-5), 138.5 (C-8), 126.6 (C-4), 125.7 (C-7), 68.2 
(C-9), 55.3 (C-6), 47.4 (C-2), 36.0 (C-1), 27.7 (C-12), 26.9 (C-11), 23.5 (C-10), 23.4 
(C-13). 
Compound 15. (3S,4R,7E,9S)-3,4,9-Trihydroxy-5,7-megastigmadiene (7 mg). [α]D25-
40.9o (c 1.8, CH3OH). MS: m/z 226 [M]+. 1H NMR (CD3OD): δ  6.03 (1H, d, J=16.0 
Hz, H-7), 5.55 (1H, dd, J= 6.5 and 16.0 Hz, H-8), 4.30 (1H, quintuplet, J=6.5 Hz, H-9), 
3.85 (1H, d,  J=3.0 Hz, H-4), 3.75 (1H, dt, J=12.0 and 3.0  Hz, H-3), 1.84 (3H, s, H-13), 
1.80 (1H, dd, J=12.5 and 12.0 Hz, H-2α), 1.43 (1H, dd, J=12.5 and 3.0 Hz, H-2β), 1.26 
(3H, d, J=6.5 Hz, H-10), 1.06 (3H, s, H-12), 1.04 (3H, s, H-11).13C NMR (MeOD): δ 
142.9 (C-6), 141.0 (C-8), 129.4 (C-5), 127.3 (C-7), 73.1 (C-4), 69.8 (C-3), 69.9 (C-9), 
42.1 (C-2), 38.2 (C-1), 30.8 (C-11), 28.2 (C-12), 24.3 (C-10), 20.3 (C-13).  
R-MPTA derivatives of compound 15 (1 mg) . 1H NMR (CDCl3): δ 6.10 (1H. d, 
J=15.5 Hz, H-7), 5.45 (1H, dd, J= 6.0 and 15.5 Hz, H-8), 5.62(1H, quintuplet, J=6.0 Hz, 
 35 
H-9), 4.06 (1H, d,  J=3.1 Hz, H-4), 5.22  (1H, dt, J=12.0 and 3.0  Hz, H-3), 2.12 (1H, 
dd, J= 12.5 and 12.0 Hz, H-2α), 1.62 (1H, dd, J=12.5 and 3.0 Hz, H-2β), 1.46 (3H, d, J= 
6.0 Hz, H-10), 1.00 (3H, s, H-11), 1.09 (3H, s, H-12), 1.75 (3H, s, H-13).  
S-MPTA derivatives of compound 15 (1 mg). 1H NMR (CDCl3): δ 6.19 (1H, d, J=16.0 
Hz, H-7), 5.54 (1H, dd, J= 6.5 and 16.0Hz, H-8), 5.64(1H, quintuplet, J=6.5Hz, H-9), 
4.17 (1H, d,  J=4.1 Hz, H-4), 5.19  (1H, dt, J=12.0 and 3.9  Hz, H-3), 1.95(1H, dd, J= 
12.5 and 12.0 Hz, H-2α), 1.59 (1H, dd, J=12.5 and 3.9 Hz, H-2β), 1.42 (3H, d, J= 6.5 
Hz, H-10), 1.00 (3H, s, H-11), 1.12 (3H, s, H-12), 1.81 (3H, s, H-13).  
Compound 16. Blumenol A (4 mg). [α]D25 +50.9o (c 2.1, CHCl3). CD (MeOH): ∆ε241 
=+9.3, ∆ε319 = -0.7. MS: m/z 224 [M]+. 1H NMR (CDCl3): δ 5.89 (1H, s, H-4), 5.78 (1H, 
d, J=15.0 Hz, H-7), 5.84 (1H, m, H-8),  4.41 (1H, m, H-9), 2.43 (1H, d, J=17.0 Hz, H-
2a),  2.24 (1H, d, J=17.0, H-2), 1.92 (3H, s, H-13), 1.30 (3H, d, J=6.5 Hz, H-10), 1.10 
(3H, s, H-11), 1.03 (3H, s, H-12).13C NMR (CDCl3): δ 199.0 (C-3), 161.7 (C-5), 131.5 
(C-8), 126.6 (C-4), 131.7 (C-7), 70.2 (C-9), 78.9 (C-6), 49.6 (C-2), 41.2 (C-1), 22.8 (C-
12), 24.6 (C-11), 20.5 (C-10), 18.9 (C-13). 
Compound 17. (3S,5R,6R,7E,9R)-5,6-Epoxy-3,9-dihydroxy-7-megastigmene (2 mg) 
[α]D25 0 (2.5, CHCl3). 1H NMR (CDCl3): δ 5.90 (1H, d, J=16.5 Hz, H-7), 5.76 (1H, dd, 
J=16.5 and 6.5 Hz, H-8), 4.38 (1H, m, H-9), 3.89 (1H, m, H-3), 2.36 (1H, dd, J= 9.3 and 
5.2 Hz, H-4eq), 1.60 (2H, m, H-2ax and H-4ax), 1.37 (1H, dd, J=12.3 and 10.1, H-2eq), 
1.28 (1H, d, J=6.5 Hz, H-10), 1.19 (3H, s, H-13), 1.12 (3H, s, H-11), 0.97 (3H, s, H-12). 
13C NMR (CDCl3):  δ 137.8 (C-8), 124.9 (C-7), 69.5 (C-6),68.2 (C-9),  66.3 (C-5), 64.2 
(C-3), 47.0 (C-4), 40.8 (C-2), 34.9 (C-1), 29.5 (C-11), 24.7 (C-12), 23.6 (C-10), 19.8 
(C-13).  
Compound 18. Corchoinoside C (3 mg). [α]D25 0o (c 3.1, MeOH). MS: m/z 409 [M]+. 
1H NMR (CD3OD): δ 5.98 (1H, d, J=16.0 Hz, H-7), 5.86 (1H, br s, H-4), 5.75 (1H, dd, 
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J= 6.5 and 16.0 Hz, H-8), 4.54 (1H, m, H-9), 4.27 (1H, d, J=7.4 Hz, H-1’), 3.86 (1H, dd, 
J=12.0 and 2.1 Hz, H-6’), 3.66 (1H, dd, J=12.0 and 6.3 Hz, H-6’), 3.12-3.40 (4H, m, 2’, 
3’, 4’, H-5’), 2.63 (1H, d, J=17.0 Hz, H-2β), 2.18 (1H, d, J=17.0 H-2α), 1.95 (3H, s, H-
13), 1.29 (3H, d, J= 6.5 Hz, H-10),  1.04 (3H, s, H-12), 1.02 (3H, s, H-11). 13C NMR 
(CD3OD): δ 201.3 (C-3), 167.1 (C-5), 134.2 (C-7), 134.0 (C-8), 127.3 (C-4), 101.6 (C-
1’), 78.8 (C-5’), 78.6 (C-3’), 75.4 (C-2’), 75.0 (C-9), 72.1 (C-4’), 63.1 (C-6’), 50.9 (C-
2), 42.5 (C-1), 22.0 (C-12), 24.7 (C-12), 23.3 (C-11), 20.1 (C-13). 
Compound 19. 4-Hydroxybenzoic acid (5 mg). EI-MS: m/z 138 [M]+, 94 [M-CO2]+. IR 
νmax 3280, 3000 and 1708 cm-1. 1H NMR (CD3OD): δ 7.96 (2H, d, J = 8.4 Hz, H-2 and 
H-6), 6.94 (2H, d, J = 8.4 Hz, H-3 and H-5). 13C NMR (CD3OD): δ 123.2 (C-1), 131.5 
(C-2 and C-6), 115.6 (C-3 and C-5), 162.5 (C-4), 172.0 (C-7).  
Compound 20. p-Methoxybenzoic acid (3 mg). EI-MS: m/z 152 [M]+, 108 [M-CO2]+. 
IR νmax 3000 and 1710 cm-1. 1H NMR (CD3OD): δ 7.85 (2H, d, J = 7.5 Hz, H-2 and H-
6), 6.85 (2H, d, J = 7.5 Hz, H-3 and H-5), 3.86 (OCH3). 13C NMR (CD3OD): δ 122.9 
(C-1), 131.1 (C-2 and C-6), 114.0 (C-3 and C-5), 167.2 (C-4), 172.0 (C-7), 56.0 
(OCH3).  
Compound 21. 4-Hydroxy-3-methoxybenzoic acid (2 mg). MS: m/z 152 [M]+. 1H NMR 
(CD3OD): δ 7.57 (1H, s, H-2), 7.45 (1H, d, J=8.0 Hz, H-6), 6.76 (2H, d, J=8.0 Hz, H-5), 
3.88 (3H, s, 3-OMe). 
Compound  22. 2-Hydroxy benzoic acid (salicilic acid) (20 mg)  EI-MS: m/z 138 [M]+, 
94 [M-CO2]+. IR νmax 3300, 3000 and 1710 cm-1. 1H NMR (CD3OD): δ 7.84 (1H, d, 
J=7.6 Hz, H-6), 7.32 (1H, dd, J=6.8 and 8.1 Hz, H-4), 6.82 (1H, d, J=8.1 Hz, H-3), 6.80 
(1H, dd, J=6.8 and 7.6 Hz, H-5). 13C NMR (CD3OD): δ 117.8 (C-1), 118.3 (C-2), 115.6 
(C-3), 135.1 (C-4), 121.0 (C-5), 131.5 (C-6), 172.8 (C-7).  
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Compound 23. 4-Hydroxy-2-methoxybenzoic acid  (2 mg). MS: m/z 152 [M]+. 1H NMR 
(CD3OD): δ 7.57 (1H, d, J=1.8 Hz, H-3), 7.49 (1H, dd, J=8.2 and 1.8 Hz, H-5), 6.75 
(1H, d, J=8.2, H-6), 3.89 (3H, s, 2-OMe).  
Compound 24. 4-Hydroxybenzyl alcohol (5 mg). EI-MS: m/z 124 [M]+, 107 [M-OH]+. 
IR νmax 3300 cm-1. 1H NMR (CD3OD): δ 7.11 (2H, d, J=7.6 Hz, H-2 and H-6), 6.69 
(2H, d, J=7.6 Hz, H-3 and H-5), 4.86 (2H, s, H-7). 13C NMR (CD3OD): δ 133.5 (C-1), 
128.7 (C-2 and C-6), 115.9 (C-3 and C-5), 156.2 (C-4), 68.5 (C-7).  
Compound 25. 4-Hydroxy-dihydrocinnamic acid (20 mg). 1H NMR (CD3OD): δ 7.08 
(2H, d, J=8.0 Hz, H-2 and H-6), 6.77 (2H, d, J=8.0 Hz, H-3 and H-5), 3.11 (2H, t, J=7.0 
Hz, H-8), 2.80 (2H, t, J=7.0 Hz, H-7). 13C NMR (CD3OD): δ 177.1 (C-9), 154.8 (C-4), 
133.2 (C-1), 130.4 (C-2 and C-6), 116.0 (C-3 and C-5), 37.3 (C-8), 32.1 (C-7).    
Compound 26. 4-Hydroxy-3-methoxy-dihydrocinnamic acid (40 mg). 1H NMR 
(CD3OD): δ 6.79 (1H, d, J=2 Hz, H-2), 6.69 (1H, d, J=7.5 Hz, H-5), 6.64 (1H, dd, J= 
7.5 and 2.0 Hz, H-6), 2.82 (2H, t, J=7.5 Hz, H-8), 2.54 (2H, t, J=7.5 Hz, H-7). 13C 
NMR: δ 178.9 (C-9), 146.4 (C-4), 144.0 (C-3), 132.1 (C-1), 120.8 (C-6), 114.4 (C-5), 
110.9 (C-2), 36.0 (C-8), 30.3 (C-7).  
Compound  27. Tyrosol (12 mg). 1H NMR (CD3OD): δ 7.02 (2H, d, J=8.0 Hz, H-2 and 
H-6), 6.89 (2H, d, H=8.0 Hz, H-3 and H-5), 3.67 (2H, t, J=7.5 Hz, H-8), 2.71 (2H, t, 
J=7.5 Hz, H-7).   
Compound  28. 4-Hydroxy-cinnamic acid (5 mg) 1H NMR (CD3OD): δ 7.60 (1H, d, 
J=15.5 Hz, H-7), 7.44 (2H, d, J=8.0 Hz, H-2 and H-6), 6.80 (2H, d, J=8.0 Hz, H-3 and 
H-5), 6.30 (1H, d, J=15.5 Hz, H-8). 
Compound  29. Ferulic acid (5 mg). 1H NMR (CD3OD): δ 7.56 (1H, d, J=15.5 Hz, H-
7), 7.17 (1H, d, J=1.5 Hz, H-2), 7.05 (1H, dd, J=8.5 and 1.5 Hz, H-6), 6.80 (1H, d, 
J=8.5Hz, H-4), 6.18 (1 H, d, J=15.5 Hz, H-8), 3.88 (3H, s, 3-OMe). 
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Compound 30. Linalool or (2E,6S)-2,6-dimethyl-2,7-octadien-1,6-diol (20 mg). [α]D25 
+17.5o (c 0.79, CH3OH). EI-MS: m/z 170 [M]+, 152 [M-H2O]+. IR νmax 3600 and 3420 
cm-1. 1H NMR (CD3OD): δ 5.92 (1H, dd, J =10.5 and 17.5 Hz, H-7), 5.42 (1H, t, J=7.0 
Hz, H-3), 5.22 (1H, dd, J=1.5 and 17.5 Hz, H-8), 5.08 (1H, dd, J=1.5 and 10.5 Hz, H-8), 
3.99 (2H, s, H-1), 2.10 (2H, m, H-4), 1.66 (3H, s, H-9), 1.55 (2H, m, H-5), 1.29 (3H, s, 
H-10). 13C NMR (CD3OD): δ  68.3 (C-1), 134.9 (C-2), 125.7 (C-3), 22.4 (C-4), 41.8 (C-
5), 73.3 (C-6), 144.9 (C-7), 111.8 (C-8), 13.7 (C-9), 27.6 (C-10).  
Compound 31. Linalool-1-oic acid or (2E,6S)-2,6-dimethyl-2,7-octadien-6-ol acid (10 
mg). [α]D25 -12.5o (c 0.50, CHCl3). EI-MS: m/z 184 [M]+, 156 [M-C2H4]+, 144 [M-
CO2]+. IR νmax 3400, 3050 and 1680 cm-1. 1H NMR (CDCl3) δ: 6.84 (1H, t, J=7.0 Hz, 
H-3), 5.86 (1H, dd, J=10.7 and 17.3 Hz, H-7), 5.20 (1H, dd, J=1.0 and 17.3 Hz, H-8a), 
5.06 (1H, dd, J=1.0 and 10.7 Hz, H-8b), 2.20 (2H, t, J=6.8 Hz, H-4), 1.78 (3H, s, H-9), 
1.62 (2H, t, J = 6.8 Hz, H-5), 1.28 (3H, s, H-10). 13C NMR (CDCl3): δ 171.5 (C-1), 
127.4 (C-2), 143.5 (C-3), 23.5 (C-4), 40.4 (C-5), 72.9 (C-6), 144.3 (C-7), 112.1 (C-8), 
27.5 (C-9), 12.0 (C-10). 
Compound 32. (5 mg): [α]D25 -2.0o (c 5.0 CHCl3). MS: m/z 262 [M]+. IR νmax 3300 and 
1600 cm-1. 1H NMR (CDCl3):  δ 6.69 (1H, s , H-5), 4.00 (1H, dd, J=8.3 and 2.4 Hz, H-
14), 3.45 (2H, m, H-10 and H-14), 3.81 (3H, s, -OMe), 2.43 (1H, q, J=6.8 Hz, H-11), 
2.32 (1H, s, H-15), 2.12 (1H, m, H-8), 1.97 (1H, m, H-9), 1.49 (1H, m, H-9), 1.30 (1H, 
m, H-8), 1.14 (1H, d, J=6.8 Hz, H-12), 1.13 (1H, d, J=6.8 Hz, H-13), 13C NMR 
(CDCl3):  δ 144.0 (C-3), 142.9 (C-2), 139.5 (C-6),127.0 (C-4),125.1 (C-1), 115.8 (C-5), 
74.7 (C-7), 67.9 (C-14), 60.7 (-OMe), 31.2 (C-11), 27.8 (C-10), 27.3 (C-8), 23.6 (C-9), 
18.5 (C-12), 17.8 (C-13), 16.1 (C-15). 
Compound 33. (+)-Dehydrovomifoliol (14 mg). [α]D25 +260.0o (c 0.30, CHCl3). 1H 
NMR (CDCl3): δ 6.83 (1H, d, J=15.5 Hz, H-7), 6.46 (1H, d, J=15.5 Hz, H-8), 5.93 (1H, 
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s, H-4), 2.58 and 2.27 (1H, d, J=17.4 Hz, H-2), 2.29 (1H, s, H-10), 1.88 (3H, s, H-13), 
1.09 (3H, s, H-11), 1.01 (3H, s, H-12).  
Compound 34. (3R,7E)-3-Hydroxy-5,7-megastigmadien-9-one (19mg). [α]D25 +19.0o (c 
0.080, CHCl3). EIMS m/z 208 [M]+ (20), 193 [M-Me]+ (100); 175 [M-Me-H2O]+ (50). 
1H NMR (CDCl3): δ 1.09 (3H, s, H-11), 1.11 (3H, s, H-12), 1.78 (3H, s, H-13), 1.49 
(1H, t, J=12.0 Hz,  H-2ax), 1.80 (1H, ddd, J=12.0 and 3.9, 2.0 Hz, H-2eq), 2.08 (1H, dd, 
J=16.4 and 10.0 Hz, H-4ax), 2.30 (3H, s, H-10),  2.44 (2H, dd, J=16.4 and 8.0 Hz,  H-
4eq), 4.05 (1H, m, H-3), 6.14 (1H, d, J=16.3 Hz,  H-8), 7.20 (1H, d, J=16.3 Hz, H-7). 13C 
NMR (CDCl3): δ 198.4 (C-9), 142.2  (C-7), 135.5 (C-6), 132.2 (C-8),  132.0 (C-5), 64.3 
(C-3), 48.2 (C-2), 42.6 (C-4), 36.7 (C-1), 29.9 (C-11), 28.4 (C-12), 21.4 (C-13), 27.2 
(C-10). 
Compound 35.  (3S,5R,6R,7E,9R)-3,5,6,9-Tetrahydroxy-7-megastigmene (5 mg). [α]D25 
0o (2.0, CHCl3). 1H NMR (CDCl3): δ 5.90 (1H, dd, J= 15.5 and 1.5 Hz, H-7), 5.66 (1H, 
dd, J=15.5 and 6.0 Hz, H-8), 4.28 (1H, m, H-9), 3.74 (1H, m, H-3), 2.27 (1H, dd, J= 9.3 
and 5.0 Hz, H-4eq), 1.62 ( 1H, dd, J=11.5 and 9.3 Hz, H-4ax), 1.59 (1H, dd, J= 11.4 and 
4.2 Hz, H-2eq), 1.30 (1H, m, H-2ax), 1.22 (1H, d, J= 6.5 Hz, H-10), 1.18 (3H, s, H-13), 
1.12 ( 3H, s, H-11), 0.96 (3H, s, H-12). 13C NMR (CDCl3): δ 139.6 (C-7), 126.4 (C-8), 
71.6 (C-6), 69.1 (C-9), 68.5 (C-5),  65.0 (C-3), 48.5 (C-4), 42.1 (C-2), 36.4 (C-1), 30.5 
(C-11), 25.4  (C-12), 24.3 (C-10), 20.6 (C-13).  
 Compound 36. (2 mg). [α]D25 +21.0o (c 0.005, CH3OH). MS: m/z 340 [M]+. 1H NMR 
(CD3OD): δ 5.94 (1H, dd, J= 17.0 and 10.5 Hz H-2), 5.34 (1H, brt, J=7.0  H-6), δ 5.19 
(1H, dd, J=17.0 and 1.5 Hz, H-1), 5.16 (1H, brt, J=7.0, H-10), 5.03 (1H, dd, J=10.5 and 
1.5 Hz, H-1), 3.93 (1H, t, J=6.8 Hz, H-8), 3.23 (1H, dd, J=2.0 and 10.4 Hz, H-14), 2.24 
(2H, m, H-9, H-12), 2.08 (2H, ddd, J=8.0 ,7.6 and 7.0 Hz, H-5), 2.05 (1H, m, H-12), 
1.70 (1H, m,  H-13), 1.63 (1H, s, H-18), 1.60 (1H, s, H-19), 1.52 (1H, dd, J=8.0 and 7.6 
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Hz H-4), 1.34(1H, m, H-13), 1.25 (1H, s, H-20), 1.16(1H, s, H-16), 1.15 (1H, s, H-17), 
13C NMR (CD3OH): δ 146.7 (C-2), 138.4 (C-7), 138.2 (C-11), 127.9 (C-6),122.4 (C-
10), 112.6 (C-1), 79.5 (C-14), 79.2 (C-8), 74.3 (C-3 and C-15 ), 43.5 (C-4), 38.5 (C-12), 
35.2 (C-9), 31.2 (C-13), 28.1 (C-20), 26.1 (C-17), 25.5 (C-16), 23.8 (C-5), 16.9 (C-18), 
11.9 (C-19). 
Compound 37. Cinnamic acid. (40 mg) 1H NMR (CDCl3): δ  7.61 (1H, d, J=15.5 Hz, 
H-7), 7.30 (2H, d, J=7.6 Hz, H-2 and H-6),7.21 (2H, dd, J=7.6 and 2.0 Hz, H-3 and H-
5), 7.14 (1H, t, J=7.6 Hz, H-4), 6.41 (1H, d, J=15.5 Hz, H-8). 13C NMR (CDCl3): δ 
170.6 (C-9), 148.3 (C-7), 128.7 (C-3 and C-5), 128.0 (C-4), 126.4 (C-2 and C-6), 115.6 
(C-8).   
Compound 38. 4-Hydroxy-3-metoxy-methyl cinnammate (36 mg). MS: m/z 208 [M]+ , 
m/z 177 [M-31]+. 1H NMR (CDCl3): δ 7.62 (1H, d, J=16.0 Hz, H-7), 7.07 (1H, dd, J=8.2 
and 1.8 Hz, H-6), 7.02 (1H, d, J=1.8 Hz, H-2), 6.91 (1H, d, J=8.2 Hz, H-5), 6.29 (1H, d, 
J=16.0 Hz, H-8), 3.92 (3H, s, 3-OMe), 3.72 (3H, s, 9-OMe). 
Compound  39. 4-Hydroxy-3,5-dimethoxy cinnammic acid (17 mg). MS: m/z 238 [M]+ . 
1H NMR (CDCl3): δ 6.75 (2H, s, H-2 and H-6), 7.58 (1H, d, J=15.8 Hz, H-7), 6.28 (1H, 
d, J=15.8 Hz, H-8), 3.89 (6H, s, 3-OMe and 5-OMe). 
Compound 40. 4-Hydroxy-3-methoxy methyl dihydrocinnammate (5 mg). MS: m/z 210 
[M]+ . 1H NMR (CDCl3): δ 6.79 (1H, dd, J=8.0 and 2.0 Hz, H-6), 6.64 (1H, d, J=8.0 Hz, 
H-5), 6.70 (1H, d, J=2.0 Hz, H-2), 2.88 (2H, t, J=8.4 Hz, H-8), 2.59 (2H, t, J=8.4 Hz, H-
7), 3.88 (3H, s, 3-OMe), 3.80 (3H, s, 9-OMe). 
Compound 41. 4-(1-Hydroxyethyl)-2-methoxyphenol (4 mg). [α]D25 0o (4.2, CHCl3).  
MS: m/z 168 [M]+ . 1H NMR (CDCl3): δ 6.58 (1H, dd, J=8.0 and 20 Hz, H-6), δ 6.55 
(1H,d, J= 8.0 Hz, H-5), δ 6.53 (1H, d, J= 2.0 Hz, H-2), δ 4.68 (1H, q, J=6.5, H-7), δ 
3.73 (3H, s, 3-OMe), δ 1.49 (3H, d, J=6.5 Hz, H-8). 13C NMR: δ 151.6 (C-3), 144.6 (C-
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4), 134.3 (C-1), 120.9 (C-6), 117.1 (C-5), 112.6 (C-2), 76.0 (C-7), 56.2 (3-OMe), 22.9 
(C-8).    
Compound 42. 2-(-4-Hydroxy-3-metoxyphenyl)-ethanol. (5 mg) MS: m/z 168 [M]+ . 1H 
NMR (CDCl3 ): δ 7.56 (1H, dd, J=8.0 and 2.0 Hz, H-6), δ 6.86 (1H,d, J= 8.0 Hz, H-5), 
δ 7.53 (1H, d, J= 2.0 Hz, H-2), δ 4.00 (2H, t, J=6.0 , H-8), δ 3.18 (2H, t, J=6.0 Hz, H-7), 
δ 3.95 (3H, s, 3-OMe). 
Compound 43.  4-Hydroxy-3-methoxy-benzylic alcohol. (5 mg). MS: m/z 154[M]+. 1H 
NMR (CDCl3): δ 6.90 (1H, d, J=7.6 Hz, H-5), 6.88 (1H, d, J=2.0 Hz, H-2), 6.84 (1H, 
dd, J=7.6 and 2.0 Hz, H-6), 4.60 (2H, s, H-7), 3.90 (3H, s, 3-OMe). 13C NMR (CDCl3): 
δ 146.7 (C-3), 145.3 (C-4), 132.9 (C-1), 120.2 (C-6), 114.2 (C-2), 109.9 (C-5), 95.4 (C-
7).   
Compound 44. p-Hydroxystirene (36 mg). MS: m/z 120 [M]+ . 1H NMR (CDCl3): δ 
7.29 (2H, d, J=8.0 Hz, H-2 and H-6), δ 6.78 (2H, d, J=8,0 Hz, H-3 and H-5), δ 6.64 (1H, 
dd, J=17.6 and10.8 Hz, H-7), δ 5.59 (1H, d, J=17.6 Hz, H-8a), δ 5.12 (1H, d, J=10.8  
Hz, H-8b).  
Compound  45. 4-Methylbenzaldehyde. (60 mg). MS: m/z 108 [M]+. 1H NMR (CDCl3): 
δ 9.95 (1H, s, H-1), 7.77 (2H, d, J=8.1 Hz, H-2 and H-6), 7.32 (2H, d, J=8.1 Hz, H-3 
and H-5), 2.43 (3H, s, 4-Me).     
Compound 46. Acetyl tryptamine (30 mg). 1H NMR (CDCl3): δ 7.61 (1H, d, J=8.0 Hz, 
H-7), 7.39 (1H, d, J=8.0 Hz, H-4), 7.22 (1H, t, J=8.0 Hz, H-5), 7.14 (1H, t, J=8.0 Hz, H-
6), 3.61 (2H, dd, J=17.5 and 6.0 Hz, H-9), 2.98 (2H, t, J= 6.0 Hz, H-8), 1.29 (3H, s, 
COCH3).  13C NMR δ 170.7 (C=O), 137.1 (C-1a), 128.0 (C-3a), 122.9 (C-6), 122.7 (C-
2), 120.2 (C-5), 119.4 (C-4), 113.7 (C-3), 112.0 (C-7), 40.4 (C-9), 26.0 (C-8), 24.0 
(CH3).     
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Compound 47. (±)-Syringaresinol (52 mg). [α]D25  0o (c 3.5, CHCl3). MS: m/z 418 
[M]+. 1H NMR (CDCl3): δ 6.57 (4H, s, H-2,H-5, H-2’ and H-5’), 4.72 (2H, d, J=4Hz, 
H-7 and H-7’), 4.26 (2H, m, H-9exo and H-9’exo), 3.61 (2H, m, H-9endo and H-
9’endo), 3.09 (2H, m, H-8 and H-8’), 3.89 (12H, s, 3-OMe, 3’-OMe,5-OMe, 5’-OMe).   
Compound 48. (±)-5,5’-Dimethoxylariciresinol (2 mg) [α]D25 0o (c 4.0, MeOH). 1H 
NMR (CD3OD): δ 6.59 (2H, s, H-2’ and H-6’), 6.43 (2H, s, H-2 and H-6), 4.80 (1H,d, 
J=6.0 Hz, H-7’a), 4.06 and 3.85 (2H, dd, J=8.1 and 6.0 Hz, H-9’), 3.90 (12H, s, 3-OMe, 
3’-OMe, 5-OMe, 5’-OMe), 3.80 (2H,m, H-9’), 2.93 (1H, dd, J=13.0 and 5.0 Hz, H-7’b), 
2.73 (1H,m, H-8’), 2.54 (1H, dd, J=13.0 and 10.0, H-7’), 2.43 (1H, m, H-8). 13C 
NMR(CD3OH): δ 147.0 (C-3 and 5), 146.9 (C-3’ and 5’), 145.1(C-4’), 143.9 (C-4), 
133.7 (C-1), 131.6 (C-1’), 120.5 (C-2 and 6), 118.1 (C-2’ and 6’), 82.7 (C-7’), 72.1 (C-
9), 59.1 (C-9’), 54.1(3 and 5-OMe), 54.0 (3’ and 5’-OMe), 52.2 (C-8’), 42.1 (C-8), 32.3 
(C-7).              
Compound 49. (3mg). [α]D25 +4.0o (c 0.12, CHCl3). ESIMS (m/z) 615 [M+H]+. UV 
λmax (CHCl3) nm (log ε): 256 (3.92), 220 (4.49). CD (CHCl3) [θ]220 +67000, [θ]257 
+16600. 1H NMR (CDCl3): δ  6.98 (1H, d, J=1.5 Hz, H-2”), 6.86 (1H, d, J = 7.6 Hz, H-
5”), 6.75 (1H, dd, J=1.5 and 7.6 Hz, H-6”), 6.65 (2H, s, H-2' and H-6'), 6.60 (2H, s, H-2 
and H-6), 5.01 (1H, d, J=6.9 Hz, H-7”), 4.77 (2H, m, H-7 and H-7'), 4.32 (2H, m, H-9), 
4.13 (1H, m, H-8”), 3.96 (2H, m, H-9’), 3.92 (15H, s, MeO-3, MeO-5, MeO-3’, MeO-
5’, and MeO-3”), 3.88 (1H, m, H-9”a), 3.50 (1H, m, H-9”b), 3.12 (2H, m, H-8 and H-
8’). 13C NMR (CDCl3): δ 153.6 (C-3, C-5, C-3’, C-5’), 146.7(C-3”), 145.1(C-4”), 
134.8(C-4) , 137.7 (C-4’), 132.1 (C-1’), 131.6 (C-1, C-1”), 118.9 (C-6”), 114.3 (C-5”), 
108.8 (C-2”), 103.3 (C-2, C-6,C-2’, C-6’), 89.2 (C-8”), 86.6 (C-7’), 84.9 (C-7), 72.8 (C-
7”), 72.1 (C-9’, C-9), 60.7 (C-9”), 56.4 (MeO-7”, MeO-3, MeO-5, MeO-3”, MeO-3’, 
MeO-5’), 54.5 (C-8’, C-8).  
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Compound 50. (3mg). [α]D25 +13.0o (CHCl3, c 0.07). ESIMS (m/z) 629 [M+H]+. UV 
λmax (CHCl3) nm (log ε): 257 (3.90), 220 (4.52). CD (CHCl3) [θ]220 +89600, [θ]257 
+11300. 1H NMR [(CD3)2CO]: δ  6.98 (1H, d, J = 1.5 Hz, H-2”), 6.81 (1H, d, J= 7.5 Hz, 
H-5”) 6.84 (1H, dd, J= 1.5 and 7.5 Hz, H-6”), 6.70 (2H, s, H-2,H-6), 6.68 (2H, s, H-2’, 
H-6’),  4.71 (1H, d, J= 3.9 Hz, H-7’), 4.67 (1H, d,J= 3.9 Hz, H-7)4.56 (1H, d, J= 6.8 Hz, 
H7”), 4.24 (2H, dd, J= 7.1 and 15.0, H-9’, H-9), 4.13 (1H, m,H-8”), 3.90 (2H, obscured, 
H-9, H-9’), 3.86 (3H, s, MeO-3”), 3.84 (6H, s, MeO-3’, 5’), 3.82 (6H, s, MeO-3, 5) 3.80 
(1H, obscured, H-9”), 3.52 (1H, dd , J=2.9 and 11.7 Hz, H-9”), 3.22 ( 3H, s, MeO-7”), 
3.09 (2H, m, H-8’, H-8),  13C NMR [(CD3)2CO]: δ 152.8 (C-3, C-5), 152.0 (C-3’, C-5’), 
146.9 (C-4”), 148.5 (C-3”), 148.3 (C-4) , 136.7 (C-4’), 134.3 (C-1’), 134.1 (C-1), 129.5 
(C-1”), 121.7 (C-6”), 115.1 (C-5”), 111.9 (C-2”), 104.5 (C-2, C-6), 104.2 (C-2’, C-6’), 
86.8 (C-7), 86.6 (C-7’), 86.5 (C-8”), 83.5 (C-7”), 72.3 (C-9’, C-9), 60.6 (C-9”), 58.1 
(MeO-7”), 57.4 (MeO-3, 5), 57.0 (MeO-3”), 56.8 (MeO-3’, 5’), 55.4 (C-8’), 55.2 (C-8).  
Compound 51. (5mg). [α]D25 +18.0o (c 0.04, CHCl3). ESI MS (m/z) 659 [M+H]+. UV 
λmax (CHCl3) nm (log ε): 265 (3.00), 226 (4.60). CD (CHCl3) [θ]225 +9590, [θ]267 
+12500. 1H NMR (CD3OD): δ 6.66 (2H, s, H-2’ and H-6’), 6.62 (2H, s, H-2 and H-6), 
6.58 (2H, s, H-2’’ and H-6’’), 4.73 (2H, d, J=3.8 Hz, H-7’ and H-7), 4.60 (2H, dd, J=7.0 
and 14.8 Hz, H-9 and H-9’), 4.43 (1H, d, J=6.7 Hz, H-7”), 4.22 (1H, m,H-8”), 3.90 (3H, 
obscured, H-9, H-9’ and H-9’’), 3.84 (6H, s, MeO-3” and MeO-5”),  3.81 (6H, s, MeO-
3’ and MeO-5’),  3.80 (6H, s, MeO-3, 5), 3.77 (3H, s, MeO-7”), 3.70 (1H, dd, J=2.0 and 
11.0 Hz, H-9’’), 3.13 (2H, m, H-8, H-8’). 13C NMR (CD3OD): δ 154.2 (C-3 and C-5), 
154.0 (C-3’ and C-5’), 150.2 (C-3” and C-5”), 148.9 (C-4),  146.0 (C-4’’), 138.2 (C-4’), 
136.0 (C-1), 135.0 (C-1’), 131.1 (C-1”), 106.6 (C-2” and C-6”), 105.0 (C-2’ and C-6’), 
104.7 (C-2 and C-6), 88.1 (C-7’), 87.7 (C-7), 86.7 (C-8”), 84.5 (C-7”), 73.4 (C-9 and C-
 44 
9’), 62.4 (C-9”), 58.2 (MeO-7”), 58.0 (MeO-3” and MeO-5”), 57.3 (MeO-3 and MeO-
5), 57.1 ( MeO-3’ and MeO- 5’), 56.2 (C-8 and C-8’). 
Compound 52. N-trans-feruloyl 4’-O-methyldopamine (12 mg). 1H NMR (CD3OD): δ 
7.50 (1H, d, J=15.6 Hz, H-7), 6.95 (1H, s, H-2), 7.00 (1H, dd, J=8.1 and 2.1 Hz, H-6), 
6.80 (1H, s, H-2’), 6.88 (1H, d, J=8.1 Hz, H-5), 6.79 (1H, d, J=8.1 Hz, H-5’), 6.68 (1H, 
dd, J=8.1 and 2.0 Hz, H-6’), 6.19 (1H, d, J=15.6, H-8), 3.85 (6H, s, 4’-OMe and 3-
OMe), 3.59 (2H, t, J=7.1, H-8’), 2.76 (2H, t, J=7.1, H-7’).13C NMR (CD3OD) : δ 166.4 
(C-9), 145.7 (C-4’), 146.8 (C-3), 145.7 (C-4’), 145.4 (C-4), 141.1 (C-7), 132.1 (C-1’), 
127.3 (C-1), 122.1 (C-6), 120.2 (C-6’), 118.2 (C-8), 115.0 (C-2’), 114.8 (C-5), 110.9 
(C-5’), 109.7 (C-2), 55.9 (3-OMe), 56.0 (4’-OMe), 40.8 (C-8’), 34.9 (C-7’). 
Compound 53. N-trans-feruloyl 3’-O-methyldopamine (5 mg). MS: m/z 343 [M]+. 1H 
NMR (CD3OD): δ 7.44 (1H, d, J=15.8 Hz, H-7), 7.21  (1H, d, J=1.8 Hz, H-2), 7.03 (1H, 
dd, J=7.7 and 1.8 Hz, H-6), 6.82 (1H, d, J=1.8 Hz, H-2’), 6.80 (1H, d, J=7.7 Hz, H-5), 
6.73 (1H, d, J=8.2 Hz, H-5’), 6.67 (1H, dd, J=8.2, 1.8 Hz, H-6’), 6.41 (1H, d, J=15.8 
Hz, H-8), 3.90 (3H, s, 3-OMe), 3.82 (3H, s, 4’-OMe), 3.49 (2H, t, J=7.1 Hz, H-8’), 2.77 
(2H, t, J=7.1, H-7’). 13C NMR (CD3OD): 169.2 (C-9), 149.9 (C-3), 149.3 (C-3’), 149.0 
(C-4), 146.1(C-4’), 142.0 (C-7), 132.1 (C-1’), 128.3 (C-1), 123.2 (C-6), 122.3 (C-6’), 
118.8 (C-8), 116.5 (C-5), 116.2 (C-5’), 113.5 (C-2’), 111.6 (C-2), 56.4 (3-OMe, 
3’OMe), 42.5 (C-8’), 36.2 (C-7’).  
Compound 54. N-trans-feruloyl tyramine (10 mg). MS: m/z 313 [M]+. 1H NMR 
(MeOD): δ 7.45 (1H, d, J=15.2, H-7), 7.13 (1H, s, H-2),  7.06 (2H, d, J=8.0 Hz, H-2’, 
H-6’), 7.01 (1H, dd, J=8.4 and 1.0 Hz, H-6), 6.79 (1H, d, J=8.0Hz, H-5), 6.74 (2H,d, 
J=8.0 Hz,  H-3’and H-5’), 6.42 (1H, d, J=15.2 Hz, H-8), 3.89 (3H, s, 3-OMe), 3.48 (1H, 
t, J=8.0 Hz, H-8’), 2.77 (1H, t, J=8.0 Hz, H-7’). 13C NMR (CD3OD): 168.7 (C-9), 156.4 
(C-4’), 149.3 (C-3), 148.7 (C-4), 141.6 (C-7), 130.8 (C-1’), 130.3 (C-2’, C-6’), 127.8 
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(C-6), 122.7 (C-1), 118.2 (C-8), 116.1 (C-5), 115.8 (C-3’ and C-5’), 111.0 (C-2), 55.9 
(3-OMe), 42.1 (C-8’), 35.9 (C-7’). 
Compound 55. N-trans-4-O-methylferuloyl 3’,4’-O-dimethyldopamine (20 mg). MS: 
m/z 371 [M]+. 1H NMR (CDCl3): δ 7.56 (1H, d, J=15.2, H-7), 7.00 (1H, s, H-2),  6.76 
(1H, dd, J=8.0 and 2.0 Hz, H-6’), 6.75 (1H, s, H-2’), 7.06 (1H, dd, J=8.4 and 1.0 Hz, H-
6), 6.82 (1H, dd, J=8.0 and 2.0 Hz, H-5), 6.84 (1H,d, J=8.0 Hz, H-5’), 6.19 (1H, d, J= 
15.2 Hz, H-8), 3.89 (6H, s, 3-OMe and 3’-OMe), 3.87 (6H, s, 4-OMe and 4’-OMe), 
3.65 (2H, d, J= 8.0 Hz, H-8’), 2.82 (1H, t, J= 8.0 Hz, H-7’).  13C NMR (CDCl3): δ 166.1 
(C-9), 150.5 (C-4), 149.1(C-3 and C-3’), 147.7 (C-4’), 140.9 (C-7), 131.4 (C-1’), 127.7 
(C-1), 121.9 (C-6), 120.6 (C-6’), 118.4 (C-8), 111.9 (C-2’), 111.3 (C-5’), 111.0 (C-5), 
109.5 (C-2), 55.9 ( 3-OMe, 4-OMe, 3’-OMe and 4’-OMe), 40.8 (C-8’), 35.1 (C-7’).  
Compound 56. N-trans-4-O-methylcaffeoyl 3’-O-methyldopamine (7 mg). MS: m/z 337 
[M]+. 1H NMR (CD3OD):  7.45 (1H, d, J=15.5 Hz, H-7), 7.13 (1H, d, J=1.6 Hz, H-2’), 
7.04 (1H, dd, J=8.0, 1.6 Hz, H-6’), 6.95 (1H, d, J=2.0 Hz, H-2), 6.85 (1H, d, J=8.0 Hz, 
H-5), 6.81 (1H, d, J=8.0 Hz, H-5’), 6.69 (1H, dd, J=8.0 and 2.0 Hz, H-6), 6.42 (1H, d, 
J=15.5 Hz, H-8), 3.89 (3H, s, 4’-OMe), 3.83 (3H, s, 3-OMe), 3.48 (2H, t, J=7.6 Hz, H-
8’), 2.76 (2H, t, J=7.6, H-7’). 13C NMR (CD3OD): δ 169.2 (C-9), 149.9(C-3), 149.3 (C-
3’), 147.6 (C-4), 147.5 (C-4’), 142.0 (C-7), 133.5 (C-1’), 128.2 (C-1), 123.2 (C-6), 
120.9(C-6’), 118.7 (C-8), 116.4 (C-5’), 116.5 (C-5), 113.0 (C-2’), 111.5 (C-2), 56.5 ( 4-
OMe, 3’-OMe), 42.4 (C-8’), 36.0 (C-7’).  
Compound 57. N-trans-feruloyl tryptamine (5 mg). MS: m/z 336 [M]+. 1H NMR 
(CDCl3/CD3OD 4/1):  7.51 (1H, dd, J=7.6, 2.0 Hz, H-6’), 7.36 (1H, d, J=15.6 Hz, H-
7), 7.29 (1H, dd, J=7.4, 2.2 Hz, H-3’), 7.07 (1H, m, H-5’), 6.98 (1H, m, H-4’), 6.97 (1H, 
s, H-2’), 6.90 (1H, dd, J=8.6 and 1.4 Hz, H-6), 6.88 (1H, d, J=1.4 Hz, H-2), 6.72 (1H, d, 
J=8.6 Hz, H-5), 6.13 (1H, d, J=15.6 Hz, H-8), 3.77 (3H, s, 3-OMe), 3.56 (2H, t, J=7.8 
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Hz, H-8’), 2.92 (2H, t, J=7.8, H-7’). 13C NMR [CDCl3:CD3OD (4:1)]: δ 167.0 (C-9), 
147.6 (C-4), 147.2(C-3), 140.7 (C-7), 136.2 (C-3a’), 127.1 (C-1a’), 126.7 (C-1),  122.2 
(C-2’), 121.8 (C-6), 121.4 (C-5’), 118.1(C-6’), 117.5 (C-8), 114.9 (C-4’, C-5), 111.9 (C-
1’), 111.1 (C-3’), 109.8 (C-2), 55.4 (3-OMe), 39.7 (C-8’), 24.9 (C-7’). 
Compound 58. N-trans-4-O-methylferuloyl 3’-O-methyldopamine (7 mg). EI-MS: m/z 
357 [M]+. 1H NMR (CDCl3): δ 7.60 (1H, d, J=15.0 Hz, H-7), 7.11 (1H, dd, J=8.0, 1.5 
Hz, H-6), 7.06 (1H, d, J=1.5 Hz, H-2), 6.90 (1H, d, J=8.0 Hz, H-5), 6.86 (1H, d, J = 7.8 
Hz, H-5’), 6.84 (1H, d, J=1.5 Hz, H-2’), 6.76 (1H, dd, J=7.8, 1.5 Hz, H-6’), 6.25 (1H, d, 
J=15.0 Hz, H-8), 3.90 (6H, s, 3-OMe, 4-OMe), 3.88 (3H, s, 3’-OMe), 3.62 (2H, t, J=7.0 
Hz, H-8’), 2.79 (2H, t, J=7.0, H-7’). 13C NMR: (CDCl3): δ 166.1 (C-9), 150.5 (C-4), 
149.1 (C-3), 145.7 (C-3’), 145.3(C-4’), 140.9 (C-7), 132.1 (C-1’), 127.8 (C-1), 122.0 
(C-6), 120.2 (C-6’), 118.5 (C-8), 114.9 (C-2’), 111.0 (C-5), 110.9 (C-5’), 109.5 (C-2), 
55.9 (3-OMe, 4-OMe, 4’-OMe), 40.8 (C-8’), 35.0 (C-7’).  
Compound 59. Chenoalbicin (32 mg). [α]D25 00 (c 0.02, CH3OH). UV (MeOH): 196 
(4.20), 227 (3.10), 283 (2.60). MALDI: 645 [M + K]+. 1H NMR (CD3OD): δ 7.43 (1H, 
d, J=15.5 Hz, H-7), 7.11 (1H, d, J=1.1 Hz, H-2), 7.06 (2H, d, J=8.0, H-6’and H-9’’), 
7.02 (2H, d, J= 8.5 Hz, H-6 and H-4’’), 6.91 (1H, d, J=1.2 Hz, H12’’), 6.79 (1H, H-2’’), 
6.76 (1H, H-1’), 6.75 (2H, H-2’and H-3’’),  6.74 (2H, H-5 and H-10’’), 6.72 (1H, H-5’), 
6.38 (1H, d, J=15.5, H-8), 5.89 (1H, d, J=8.0Hz, H-13’’), 4.14 (1H, d, J=8.0 Hz, H-
13a’’), 3.89 (1H, s, 3-OMe), 3.82 (1H, s, 4’-OMe), 3.54 (1H, dd, J=13.2 and 6.3 Hz, H-
6’’), 3.45 (1H, dd, J= 13.2 and 6.8 Hz, H-6’’ ), 3.45 (1H, H-8’), 2.76 (1H, H-7’), 2.75 
(1H, m, H-5’’),13C NMR: (CDCl3): 172.9 (C-8’’), 169.4 (C-9), 157.3 (C-3’), 151.4 (C-
3), 149.4(C-4’), 148.2 (C-11’’), 146.2 (C-4), 141.8 (C-7), 132.9 (C-12a’’), 131.4 (C-1), 
131.2 (C-4a’’), 130.7 (C-9’’), 130.6 (C-4’’, C-6, C-6’), 130.4 (C-1’), 129.6 (C-1a’’), 
120.4 (C-8a’’), 120.3 (C-2’’),119.4 (C-8), 118.3 (C-3’’), 116.8 (C-5, C-5’), 116.7 (C-
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1’’, C-2’, C-10’’), 113.4 (C-2), 110.6 (C-12’’), 90.0 (C-13’’), 59 (C-13a’’), 57.0 (3-
OMe), 56.5 (4’-OMe), 42.8 (C-6’’), 42.4 (C-8’), 36.0 (C-7’), 35.7 (C-5’’). 
Compound 60. (3R,6R,7E,9E,11E)-3-Hydroxy-13-apo-α-caroten-13-one (7 mg). [α]D25 
+251.0o (c 0.006, CHCl3). UV (CHCl3) λmax (log ε) 329 (4.3) nm. CD (CHCl3) λ (∆ε) 
313.0 (+12.0) nm. EIMS m/z 274 [M]+ (60), 259 [M-Me]+ (40), 256 [M-H2O]+ (100). 1H 
NMR (CDCl3): δ 7.58 (1H, dd, J = 11.5 and 15.0 Hz, H-11), 6.20 (2H, d, J= 15.0 Hz, H-
8 and H-12), 6.18 (1H, d, J= 11.5 Hz, H-10), 5.69 (1H, dd, J= 9.5 and 15.0 Hz, H-7), 
5.58 (1H, brs, H-4), 4.26 (1H, brs, H-3), 2.44 (1H, d, J= 9.5 Hz, H-6), 2.30 (3H, s, H-
14), 2.01 (3H, s, H-18), 1.84 (1H, dd, J = 6.4 and17.5 Hz, H-2eq), 1.62 (3H, s, H-17), 
1.40 (1H, dd, J= 5.8, 17.5, H-2ax), 1.01 (3H, s, H-15), 0.86 (3H, s, H-15). 13C NMR 
(CDCl3): δ 198.6 (C-13), 144.5 (C-9), 139.0 (C-11), 137.2 (C-5), 136.9 (C-8), 133.6 (C-
7), 129.8 (C-12), 127.8 (C-10), 125.0 (C-4), 65.8 (C-3), 54.9 (C-6), 44.5 (C-2), 34.0 (C-
1), 29.5 (C-15), 27.7 (C-14), 22.8 (C-17), 13.5 (C-18).  
Compound 61. (6S,7E,9E,11E)-3-Oxo-13-apo-α-caroten-13-one (8 mg). [α]D25 
+165.0o (c 0.008, CHCl3). UV (CHCl3) λmax (log ε) 323 (3.3) nm. CD (CHCl3) λ (∆ε) 
320.0 (+43.0) nm. EIMS m/z 288 [M]+ (50), 273 [M-Me]+ (100), 245 [M-MeCO]+ (30). 
1H NMR (CDCl3): δ 7.55 (1H, dd, J=11.5 and 15.5 Hz, H-11), 6.47 (1H, d, J=15.9 Hz, 
H-8), 6.26 (1H, d, J=11.5 Hz, H-10), 6.24 (1H, d, J=15.5 Hz, H-12),  5.96 (1H, d, 
J=15.9 Hz, H-7), 5.94 (1H, s, H-4), 2.50 (1H, d, J=17.5 Hz, H-2eq), 2.30 (1H, d, J=17.5 
Hz, H-2ax), 2.30 (3H, s, H-14), 2.02 (3H, s, H-18), 1.91 (3H, s, H-17), 1.11 (3H, s, H-
15), 1.03 (3H, s, H-16). 13C NMR (CDCl3): δ 198.4 (C-3, C-13), 161.0 (C-5), 143.2 (C-
9), 138.4 (C-11), 134.6 (C-8), 132.0 (C-7), 130.3 (C-10, C-12), 127.1 (C-4), 80.1 (C-6), 
49.7 (C-2), 41.6  (C-1), 28.5 (C-14), 24.3 (C-16), 23.1 (C-15), 18.9 (C-17), 14.0 (C-18).  
Compound 62. S-(+)-Abscisic alcohol (13 mg). [α]D25 +210.0o (c 0.012, CHCl3). EIMS 
m/z 250 [M]+ (80), 235 [M-Me]+ (100).  1H NMR (CDCl3): δ 7.74 (1H, d, J= 15.5 Hz, 
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H-7), 6.34 (1H, d, J=15.5 Hz, H-8), 5.92 (1H, s, H-4), 5.74 (1H, d, J=15.5 Hz, H-7), 
5.73 (1H, obscured, H-10), 4.35 (2H, bs, H-11), 2.45 (1H, d, J=16.6 Hz, H-2a), 2.27 
(1H, d, J=16.6 Hz, H-2b), 1.91 (3H, s, H-14), 1.81 (3H, s, H-15), 1.10 (3H, s, H-12), 
1.01 (3H, s, H-13). 13C NMR (CDCl3): δ  198.0 (C-3), 163.0 (C-5), 137.0 (C-9), 134.8 
(C-8), 131.6 (C-10), 128.4 (C-7), 126.9 (C-4), 78.0 (C-6), 59.3 (C-11), 49.8 (C-2), 42.0 
(C-1), 23.0 (C-13), 23.0 (C-12), 18.8 (C-14), 12.9 (C-15).        
Compound 63. Grasshopper ketone (12 mg). [α]D25 –62.0o (c 0.012, CHCl3). EIMS m/z 
224 [M]+ (10), 209 [M-Me]+ (100). 191 [M-Me-H2O]+ (20). 1H NMR (CDCl3): 
δ 5.84 (1Η, s, H-8), 4.35 (1H, m, H-3), 2.30 (2H, overlapped, H-2),  2.17 (3H, s, H-10), 
2.00 and 1.39 (1H, m, H-4), 1.42 (3H, s, H-13), 1.37 (3H, s, H-11), 1.15 (3H, s, H-12).  
13C NMR (CDCl3): δ 209.2 (C-9), 198.6 (C-7), 118.9 (C-6), 101.1 (C-8),  72.4 (C-5), 
63.9 C-3), 49.2 (C-4), 48.9 (C-2), 31.9 (C-11), 36.4 (C-1), 31.2 (C-10), 29.3 (C-13), 
26.5 (C-10).   
Compound 64. (5 mg). [α]D25 –32.0o (c 0.018, CHCl3). EIMS m/z 224 [M]+ (30), 209 
[M-Me]+ (100). 191 [M-Me-H2O]+ (40). 1H NMR (CDCl3): δ  5.85 (1H, s, H-8), 4.34 
(1H, m, H-3), 1.48 and 2.29 (2H, m, H-2), 1.42 and 2.00 (2H, m, H-4),  1.16 (3H, s, H-
11), 1.38 (3H, s, H-12), 1.43 (3H, s, H-13), 2.19 (3H, s, H-10). 13C NMR (CDCl3): 
δ 209.7 (C-9), 198.3 (C-7), 118.8 (C-6), 100.8 (C-8), 72.3 (C-5), 63.9 (C-3), 49.0 (C-2), 
48.7 (C-4), 36.1 (C-1), 31.7 (C-12), 30.9 (C-13), 29.1 (C-11), 26.3 (C-10).  
Compound 65. (8 mg). [α]D25 –28.0o (c 0.052, CHCl3). EIMS m/z 224 [M]+ (30), 209 
[M-Me]+ (100), 191 [M-Me-H2O]+ (10). 1H NMR (CDCl3): δ  1.10 (3H, s, H-11), 1.39 
(3H, s, H-12), 1.41 (3H, s, H-13), 2.25 (3H, s, H-10), 1.98 (2H, m, H-2), 1.91 and 2.20 
(2H, m, H-4), 4.30 (1H, m, H-3), 5.97 (1H, s, H-8). 13C NMR (CDCl3): δ 209.4 (C-9), 
199.1 (C-7), 118.7 (C-6), 100.1 (C-8), 72.4 (C-5), 63.9 (C-3), 48.7 (C-2 and C-4), 35.9 
(C-1), 31.9 (C-12), 30.9 (C-13), 29.1 (C-11), 27.1 (C-10).  
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Compound 66. (3R,6R,7E)-3-Hydroxy-4,7-megastigmadien-9-one (5 mg). [α]D25 +37.0o 
(c 0.05, MeOH). CD ∆ε239= +24. 1H NMR (CD3OD): δ 6.51 (1H, dd, J= 15.5 and 5.3, 
H-7), 6.10 (1H, d, J=15.5, H-8), 5.60 (1H, s, H-4), 4.27 (1H, bs, H-3), 2.50 (1H, d, 
J=5.3 Hz, H-6), 2.27 (1H, s, H-10), 1.80 (1H, dd, J=13.5 and 6.3, H-2), 1.35 (1H, dd, 
J=13.5 and 5.8, H-2), 1.24 (3H, s, H-13), 1.02 (3H, s, H-11), 0.88 (3H, s, H-12). 13C 
NMR (CD3OD): δ 199.0 (C-9), 147.0 (C-7), 135.4 (C-5), 133.5 (C-8), 126.0 (C-4), 65.6 
(C-3), 54.3 (C-6), 44.0 (C-2), 33.9 (C-1), 29.2 (C-11), 27.0 (C-10), 24.7 (C-12), 22.8 
(C-13).  
Compound 67. (3R,6R,7E,9R)-3,9-Dihydroxy-4,7-megastigmadiene (7 mg). [α]D25 0o (c 
0.05, MeOD).  1H NMR (CD3OD): δ  5.59 (1H, dd, J= 15.5 and 5.4 Hz, H-8), 5.38 (1H, 
dd, J=15.5 and 8.1 Hz, H-7), 5.52 (1H, bs, H-4), 4.33 (1H, m, H-9), 4.21 (1H, brs, H-3), 
2.32 (1H, d, J= 8.1 Hz, H-6), 1.82 (1H, dd, J=13.5 and 5.8 Hz, H-2ax), 1.61 (3H, s, H-
13), 1.36 (1H, dd, J=13.5 and 6.3 Hz, H-2eq), 1.28 (1H, d, J= 6.5 Hz, H-10), 0.99 (3H, 
s, H-11), 0.84  (3H, s, H-12). 13C NMR (CD3OD): δ 137.6 (C-8), 137.4 (C-5), 129.1 (C-
7), 124.6 (C-4), 68.7 (C-9), 65.8 (C-3), 54.0 (C-6), 44.4 (C-2), 33.4 (C-1), 29.4 (C-12), 
24.0 (C-11), 23.6 (C-10), 22.6 (C-13).      
Compound  68. (6R,7E)-4,7-Megastigmadien-3,9-dione (10 mg). [α]D25 +200.0o (c 
0.012, CHCl3). EIMS m/z 206 [M]+ (10), 108 [C7H8O]+ (100).  1H NMR (CDCl3): 
δ 6.68 (1H, dd, J=15.5 and 5.6 Hz, H-7), 6.17 (1H, d, J=15.5 Hz, H-8), 5.99 (1H, s, H-
4), 2.70 (1H, d, J=16.8 Hz, H-2),  2.39 (1H, s, H-6), 2.30 (1H, s, H-10), 2.18 (1H, d, 
J=16.8 Hz, H-2), 1.90 (3H, s, H-13), 1.10 (3H, s, H-11), 1.02 (3H, s, H-12).    
Compound 69. (6R,9R)-9-Hydroxy-4-megastigmen-3-one (5 mg). [α]D25 +84.0o (1.0, 
CHCl3). 1H NMR (CDCl3): δ  5.84 (1H, s, H-4), 3.78 (1H, m, H-9), 2.39 and 2.04 (2H, 
d, J=16.9, H-2), 1.99 (3H, d, J=1.3, H-13), 1.21 (3H, d, J=6.3, H-10), 1.07 (3H, s, H-
11), 1.02 (3H, s, H-12), 1.00-1.90 (3H, overlapped, H-6, H-7 and H-8). 13C NMR 
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(CDCl3): δ 199.6 (C-3), 165.8 (C-5), 125.1(C-4), 68.0 (C-9), 51.1 (C-6), 47.1 (C-2), 
38.6 (C-8), 36.2 (C-1), 26.2 (C-7), 28.8 (C-12), 27.2 (C-11), 24.6 (C-10), 23.7 (C-13).   
Compound 70. 3,9-Dihydroxy-4-megastigmene (2 mg). [α]D25 +80.0o (c 0.08, CH3OH). 
1H NMR (CD3OD): δ  5.38 (1H, bs, H-4), 3.78 (1H, m, H-9), 4.28 (1H, m, H-3), 2.00 
(1H, t, J= 8.1 Hz, H-6), 1.82 (1H, dd, J=13.5 and 5.8 Hz, H-2), 1.61 (3H, s, H-13), 1.36 
(1H, dd, J=13.5 and 6.3 Hz, H-2), 1.21 (3H, d, J=6.3, H-10), 0.99 (3H, s, H-11), 0.84  
(3H, s, H-12). 13C NMR (CD3OD): δ 137.4 (C-5), 124.6 (C-4), 68.0 (C-9), 65.8 (C-3), 
56.0 (C-6), 44.4 (C-2), 38.6 (C-8), 33.4 (C-1), 29.4 (C-12), 26.2 (C-7),  24.0 (C-11), 
24.6 (C-10), 22.6 (C-13).      
Compound 71. 4-Megastigmen-3,9-dione (12 mg). [α]D 25 –1.5o (c 0.050, CHCl3). 
EIMS m/z 208 [M]+ (40), 193 [M-Me]+ (100). 165 [M-MeCO]+ (50). 1H NMR (CDCl3): 
δ  1.01 (3H, s, H-11), 1.05 (3H, s, H-12), 1.24 (2H, m, H-7), 1.74 (1H, m, H-6), 1.99 
(3H, s, H-13), 2.15 (3H, s, H-10), 2.29 and 2.52 (2H, d, J=8.4 Hz, H-2), 2.29 and 2.54 
(2H, m, H-8), 5.84  (1H, s, H-4). 13C NMR (CDCl3): δ 207.0 (C-9), 199.1 (C-3), 164.8 
(C-5), 125.6 (C-4), 50.1 (C-6), 47.0 (C-2), 42.5 (C-1), 28.8 (C-10 and C-11), 27.3 (C-
12), 24.6 (C-7) 23.4 (C-8 and C-13).  
Compound 72. 3,6,9-Trihydroxy-4-megastigmene (1mg). [α]D25 +66.0o (c 0.020, 
CH3OH). EIMS m/z 228 [M]+ (20), 213 [M-Me]+ (100). 195 [M-Me-H2O]+ (40). 1H 
NMR (CD3OD): δ 5.35  (1H, s, H-4), 4.10 (1H, m, H-3), 3.65 (1H, m, H-9), 1.73 (3H, s, 
H-13), 1.47-1.53 (2H, m, H-7), 1.20-1.25 (2H, m, H-8), 1.40 and 1.53 (2H, m, H-2), 
1.15 (3H, s, H-10), 0.98 (3H, s, H-12), 0.90 (3H, s, H-11). 13C NMR (CD3OD): δ 141.2 
(C-5), 125.6 (C-4), 69.7 (C-6), 69.4 (C-9), 67.5 (C-3), 40.9 (C-2), 36.1 (C-1), 29.5 (C-
11), 28.6 (C-12), 28.4 (C-7) 23.9 (C-8), 24.0  (C-10), 23.5 (C-13).  
Compound 73. (6Z,9S)-9-Hydroxy-4,6-megastigmadien-3-one (5 mg). [α]D25 +28.5o 
(0.5, CHCl3). 1H NMR (CDCl3):  δ 5.92 (1H, s, H-4), 5.74 (1H, t, J=7.0, H-7), 3.94 (1H, 
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m, H-9), 2.48 (2H, m, H-8), 2.30 (2H, s, H-2), 2.23 (3H, s, H-13), 1.25 (1H, d, J=6.0, H-
10), 1.18 (6H, s, H-11 and H-12). 13C NMR(CDCl3):  δ 199.1 (C-3), 155.9 (C-6), 144.6 
(C-5), 129.0 (C-4), 126.6 (C-7), 68.2 (C-9), 53.0 (C-2), 40.9 (C-1), 39.6 (C-8), 28.1 (C-
12), 28.0 (C-11), 24.8 (C-13), 23.5 (C-10).   
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RESULTS AND DISCUSSION 
 
Three spontaneous plants of the Mediterranean area have been investigated, Brassica 
fruticulosa, Chenopodium album, Malva silvestris, in order to study the metabolites 
they produce and to determine whether or not they possess biological activity. 
These plants were chosen because of their characteristics of  persistency and diffusion, 
both of which are promising features for plant allelopathy. 
Metabolites extraction was realised using two different techniques for the three plants. 
Simple infusions in hydroalcoholic solutions (10% MeOH/H2O) and then  pure 
methanol was used for  Brassica fruticulosa and Chenopodium album, while the 
extractor Naviglio (Naviglio 2003) was employed for Malva silvestris.  
Infusion procedure is conducted by immerging fresh plants in hydroalcoholic or 
alcoholic solvent for 7 days, and then filtering the infused plants to remove solid 
particles of macerated plants. Naviglio extractor was used to guarantee higher yields of 
extracted metabolites from Malva silvestris. Repeated extraction cycles were performed 
with the automatic extractor at high pressure values, to stimulate the releasing of the 
internal compounds of plants cells by suction effect. This mechanism allows the 
extraction of both hydrophobic and hydrophilic compounds from matrix cells simply by 
employing water as extracting solvent. Environmental and economic advantages are two 
of the benefits deriving from the use of the extractor, which also guarantees mimicking 
natural processes as well as possible.  
 All the extracts obtained were concentrated and fractionated with chromatographic 
techniques (CC, TLC, HPLC, DCCC). Identification of pure compounds has been 
carried out by using Mass Spectrometry (EI MS, MALDI MS, GC MS), NMR 
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spectroscopy on 1H and 13C by one-dimensional and two-dimensional experiments, IR, 
UV, CD.  
For each plant the isolated compounds are described one by one and the investigation 
modalities that allowed their structural elucidation are reported.   
 
Brassica fruticulosa 
Brassica fruticulosa is a terrestrial plant of Brassicaceae family. This family includes 
more than 2000 species distributed world-wide, abundantly represented in the boreal 
hemisphere. Italian varieties, including Brassica fruticulosa, are an important economic 
resource for the country. In fact, they are employed as vegetables, forage, fertilizers and 
for industrial or dressing oil extraction. Some varieties have medical properties (against 
scurvy), while some others are harvested for ornamental purposes.  
 
 
fig.1-Brassica fruticulosa  
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From Brassica fruticulosa Cyr. and B. oleracea L. derive different types of cabbages, 
while Brassica hirta, B. nigra, or B. juncea supply the seeds for mustard preparation. 
These plants are also used in medicine as a stimulant and diuretic, emetic, or 
counterirritant. Brassica fruticulosa is widely found in south Italy and it is deeply 
appreciated in Sicily as a salad ingredient and for the preparation of  pasta dishes.  
The extraction of secondary metabolites from Brassica fruticulosa was realized by 
infusing fresh plants in 10% MeOH/H2O for seven days, and then in pure MeOH. The 
extracts were partitioned between methylene chloride and water. The methylene 
chloride extracts were fractionated by silica gel column chromatography and the 
fractions were purified by preparative TLC, DCCC and HPLC, yielding four lignans, 
three neolignans, one sesquilignan, one dilignan (Cutillo et al., 2003) and four C-13 
nor-terpenes (Cutillo et al., 2005). The aqueous extracts were chromatographed on 
Amberlite XAD-2 and fractionated by Sephadex LH-20 column chromatography. The 
fractions obtained were purified with preparative TLC, DCCC and HPLC, yielding one 
lignan, two neolignans, one sesquilignan and one nor-terpene. 
Lignans are constituted by phenyl-propane monomers linked to give di-, tri- and 
tetrameric structures. Repeating units of lignans generate lignins, which are involved in 
the lignification of plant cell walls to generate solid structures and watering conduction 
systems in trees. 
C-13 nor-terpenes are molecules having a skeleton consisting of thirteen carbon atoms, 
identified in many common plants. They are generally found as aroma compounds in 
fruits and vegetables, but also in many leaf products such as tea or tobacco. C-13 nor-
isoprenoids are supposed to be structurally derived from higher molecular weight 
terpenoids such as carotenoids, through degradation processes. 
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Compound 1 was identified as (-)-pinoresinol by analysing the spectroscopic data of the 
molecule, and comparing them to literature (Lin-gen et al. 1982). It has a molecular 
formula C20H22O6 as deduced from the molecular peak m/z 358 in a EI MS spectrum. 
The 13C NMR spectrum shows ten signals, that from a DEPT experiment were deduced 
to be three methines (δC 108.6, 114.3 and 118.9) and  three quaternary carbons (δC 
132.9, 146.7 and 145.2), in the aromatic region. At higher fields the signals of a 
methylenic carbon at δ 71.6, a benzylic methine at δ 85.8, an aliphatic methine carbon at 
δ 54.1 and a methylic carbon at δ 55.9 are present. These data are in agreement with a 
dioxabicyclic system, having  two condensed furanic rings symmetrically substituted by  
phenylic rings.  
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According to this hypothesis,  1H NMR spectrum shows three aromatic protons of a 
1,2,4-trisubstituted system, a benzylic proton bonded to an oxygen atom at  δ 4.74 (d, 
J=4.0 Hz), two double doublet due to the two diastereotopic protons of the methylenic 
group at δ 4.25 (J= 7.0 and 9.0 Hz), and  δ 3.88 (J= 4.0 and 9.0 Hz), a multiplet at δ 3.10 
of  a methinic proton, and finally the signal due to three methoxyl protons at δ 3.91. 
Chemical shift values and couplings of the protons H-7 and H-9 define the relative 
configuration of the compound. The absolute configuration is estabilished by the 
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measure of the optical rotation ([α]D25 -10o) and comparing it to literature values (Lin-
gen et al. 1982). 
Compound 2  has been identified as (-)-isolariciresinol. In the 13C NMR spectrum 
nineteen signals are present, which were defined through a DEPT experiment as: seven 
quaternary carbons and five methins between δ 112.0 and δ 150.0, three methylenic 
carbons at δ 66.5, 62.8 and 34.1; two methylic carbons at δ 56.9; three methinic carbons 
between δ 40.0 and δ 49.0. In the 1H NMR spectrum five aromatic protons are present, 
attributed to two phenyl groups. One ring resonates as two methine doublet protons  at δ 
6.74 (d, J= 8.1 Hz, H-5) and at δ 6.67 (d, J=1.8 Hz, H-2), and a methine double doublet 
at  δ 6.62 (J= 8.1 and 1.8 Hz, H-6), while two methine singlets at δ 6.65 (H-5’) and 6.19 
(H-2’) are due to the second ring. At higher fields a methylene doublet is present at δ 
2.77, which is due to the H-7’ protons. From a 1H1H COSY experiment, it results that 
these protons are coupled to the multiplet at δ 2.00 (H-8’), which is also correlated to a 
multiplet due the methylenic group at δ 3.82 (H-9’). 
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The methine triple triplet at 1.74 (H-8) is correlated to a methine doublet at δ 3.83 (H-7) 
and to two methine double doublet at δ 3.81 (H-9a) and 3.40 (H-9b). Correlation 
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between H-8 and H-8’ confirms the presence of the cyclohexane ring that links the two 
C3 lateral chains. Finally the signals of the methyl group of two methoxyl protons are at 
δ 3.80 and 3.76. NOE experiments confirm the positions occupied by the two methoxyl 
groups on the aromatic rings. Couplings of H-7 (d, J=10.0 Hz), H-8 (tt, J=10.0 and 3.0 
Hz), H-7’ (d, J=7.2 Hz), H-9a (dd, J=11.0 and 3.0 Hz) define the relative configuration 
of the compound, while the absolute configuration (7S, 8R, 8’R)  is derived from the 
measure of the optical rotation ([α]D25  -30o) (Urones et al. 1987).  
Compound 3 is (+)-secoisolariciresinol. MALDI spectrum of the molecule shows a 
molecular peak at  m/z 362, which is compatible with a molecular formula C20H26O6.  
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The 13C NMR spectrum shows only ten signals due to the symmetry of the molecule. 
By means of a  DEPT experiment, we can define the presence of  three quaternary 
carbons, four methines, two methylenes and one methyl. 1H NMR  analysis shows two 
1,2,4-trisubstituted aromatic systems and two C3 side chains. The two protons at C-7 
give resonances at δ 2.56 and 2.67, each as a double doublet, H-8 resonates as a 
multiplet at δ 1.90, and the two H-9 protons appear as a unique multiplet at δ 3.60. 
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Comparison of the optical rotation measured ([α]D25 +28.1) with literature data allows 
the absolute configuration of the molecule to be assigned as 8R, 8’R (Fonseca et al. 
1978). 
Compound 4 is (±)-lariciresinol. A DEPT experiment assigned the eighteen signals of 
the 13C-NMR spectrum  to six quaternary carbons and six methines in the aromatic 
range, three methylenes at δ 32.3, 59.1 and 72.1 and three methine carbons at δ 82.3, 
42.1 and 52.2. The signals of two 1,2,4-trisubstituted aromatic systems are present in 
the 1H NMR spectrum between δ 6.40 and δ 6.90. Higher field signals of two multiplets 
were assigned to the methine protons H-8’ (δH 2.35) and H-8 (δH 2.74). The multiplet at 
δ 3.74, integrated for two protons, is attributed to both H-9’ protons, while the four 
double doublets at δ 3.80 (J=8.1 and 6.0 Hz), 4.00 (J=8.1 and 6.0 Hz), 2.45 (J=13.0 and 
10.0 Hz), and 2.87 (J=13.0 and 5.0 Hz) are due to H-9a, H-9b, H-7b and H-7a, 
respectively. The signals of the proton H-7’ is at δ 4.80 (d, J=6.0 Hz). The six methoxyl 
protons resonate at δ 3.82. 
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In a 1H1H COSY experiment the proton H-7’  was correlated to the proton H-8’ at δ 
2.35, which is, in turn, coupled to the two protons H-9’  both at δ 3.74. Proton H-7b at δ 
2.45 is coupled to the proton H-7a at δ 2.87, and both of them give correlations with the 
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proton  H-8 at δ 2.74, and the two protons H-9. The presence of a tetrahydrofuran ring is 
confirmed by the scalar correlation between H-8 and H-8’. Couplings settle the relative 
configuration of the isolated diastereoisomer (Fonseca et al. 1978).     
Compound 5 has been identified as tanegol. The molecular ion peak at m/z 376 in a 
MALDI MS spectrum is in agreement with a molecular formula C20H24O7.  The 13C 
NMR spectrum presents nineteen signals. In the aromatic area twelve signals are 
present, they were assigned by a DEPT experiment to six quaternary carbons and six 
methines; four methine carbons give resonances at δ 83.8 , δ 75.4,  δ 49.5 and  δ 52.3, 
two methylenes at δ 70.3  and  61.1, and finally the signals of two methyl carbons of 
two methoxy groups  are present at δ 55.2. The 1H1H COSY spectrum shows that two 
1,2,4-trisubstituited phenyl rings are present. Cross-peaks between the two methoxy-
groups and protons  H-2 and H-2’ in a NOESY experiment define the guaiacylic 
structure of the aromatic rings. Protons correlation experiments define the presence of 
two 1,3-dihydroxypropanolic units. The two C3 units are linked together through the 
carbons C-8/C-8’. The data obtained define the presence of a tetrahydrofuranic ring . 
The cross peaks present in a NOESY experiment between H-7/H-9a, 9b, 9’α;  H-8/H-2, 
6, 7’ and H-7’/H-9’β define the relative configuration of the molecule as 7R, 8R, 8’S, 
7’R or 7S, 8S, 8’R, 7’S (Abe et al. 1990).   
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Compound 6 has been identified as (±)-dehydrodiconiferyl alcohol. Because of the 
molecular ion peak at m/z 358 in the EI-MS spectrum and to the 13C NMR spectrum 
having nineteen signals, the molecular formula C20H22O6 was assigned. Carbon signals 
were assigned by a DEPT experiment as seven quaternary carbons, nine methines, two 
methylenes and two methyls. At δ 88.2 a highly deshielded benzylic carbon gives 
resonance, while between δ 50 and 66 there are the signals of two methylene carbons 
and two CH3 of a methoxyl-group. In the 1H NMR spectrum two aromatic systems 
1,2,4-trisubstituted and 1,2,3,5-tetrasubstituted resonate in the chemical shift range δ 
6.70-7.00, while at higher field the double triplet of the proton H-8’ (δH 6.18). is 
present. The 1H1H COSY experiment correlates the proton H-8’ to the doublet at δ 6.55, 
assigned to the proton H-7’, and to the double doublet of the two protons H-9’ at δ 4.29. 
The proton H-7 (δH 5.58) is correlated by the same experiment to the proton  H-8 at δ 
3.50. The latter  is coupled to the H-9 protons at  δ 3.79. Six protons resonating at δ 3.85 
are assigned to the methoxyl-groups. NOE experiments confirm the substituents 
position on the rings. Spectroscopic data define the relative configurations of the chiral 
centres. Compound 6 has been isolated as a racemic mixture (Yuen et al. 1998). 
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Compound 7 has been defined as (±)-threo-guaiacylglycerol-β-O-4’-coniferyl ether 
from the analysis of its spectroscopic data. Its molecular formula C20H24O7 has been 
derived from an EI-MS experiment, which shows a molecular ion peak at m/z 376. 
Twenty signals are present in the 13C NMR spectrum and they are distributed in the 
following manner: twelve signals in the aromatic area, which according to a DEPT 
experiment are due to six quaternary carbons and six methine carbons, two olefinic CH 
at  δ 133.8 and 122.2, two very deshielded aliphatic methine carbons at δ 73.8 and  80.0, 
two methylene groups whose chemical shift (δ 62.9 and δ 65.0) suggests they are 
directly linked to an oxygen atom. Finally the carbons of two methoxyls resonate at  δ 
56.6 and 55.8. 
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Two ABX-type spin systems are present in the 1H NMR spectrum and are attributed to 
two 1,2,4-trisubstituite aromatic rings. The large doublet at δ 6.51  is due to the olefinic 
proton H-7’ that in a 1H1H COSY spectrum is coupled to the olefinic proton at δ 6.23 
(H-8’). Trans configuration of the double bond derives from the couplings value 
(J=15.8 Hz). The proton H-8’ is in turn coupled to the signal at δ 4.20, attributed to the 
two methylenic protons in 9’. A second three-carbons side chain is also detected from 
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the correlation of the protons H-7 (δ 4.83)/ H-8 (δ 4.36)/ H-9a and b (δ 3.84 and δ 3.76). 
In HMBC experiment the proton H-7 shows cross-peaks with the carbons C-2 and C-6, 
while the olefinic proton H-7’ is correlated to the signals δ 110.2 and 119.7 of the two 
aromatic carbons C-2’ and C-6’. The two methoxyl groups are positioned on C-3 and C-
3’, by considering the NOE effect they give with protons H-2 and H-2’, respectively. 
The coupling J7-8 (6.0 Hz) defines a threo relative chirality at the C-7 and C-8. The 
compound has been isolated as a racemic mixture (Li et al. 1998). 
Compound 8 had a molecular ion peak in a ESI MS experiment at m/z 406, according to 
a molecular formula C21O8H26. The 13C NMR spectrum shows only nineteen signals, ten 
of which at high chemical shift values were assigned through a DEPT experiment to 
seven quaternary carbons and  five methines. At δ 131.7 and 130.1 there are the signals 
of two olefinic methines. Moreover two highly deshielded methine carbons are 
identified in the chemical shift range δ 70.0-90.0. Two methylene carbons give 
resonance at δ 61.7 and 63.8, and the high chemical shift values suggest the presence of  
carbons directly linked to oxygen atoms. Around  δ 56.0, the signals of three methoxylic 
carbons are present. 
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 In the 1H NMR spectrum there are thirteen signals, five of them are typical of two 
aromatic rings, one 1,2,4-trisubstituted and one 1,2,3,5-tetrasubstituted. The large 
doublet at δ 6.55 is assigned to the olefinic proton H-7’, which was correlated in a  
1H1H COSY spectrum to the olefinic proton at δ 6.30 (H-8’). The trans geometry of the 
double bond is defined by the coupling value of 15.8 Hz. Proton H-8’ is further coupled 
to the signal at δ 4.22  due to the two protons H-9’.  Correlated protons  H-7 (δ 4.92), H-
8 (δ 4.22) and H-9a and b (δ 3.87 and δ 3.55) are attributed to  the tri-
hydroxypropanolic carbons chain. The coupling constant value J7-8=5.1 Hz is indicative 
of a threo relative configuration of C-7 and C-8.  The absolute configuration 7R, 8R  
derives from the negative CD curve in the 210-250 nm range. Compound 8 is identified 
as (+)-threo-guaiacylglycerol-β-O-4’-synapyl ether, which had  been previously isolated 
as a glycoside from the bark of Eucommia ulmoides (Takeshi et al. 1987). 
Compound 9 has been isolated for the first time. It has been identified as (±)-erythro-
syringylglycerol-β-O-4’-sinapyl ether. The EI MS spectrum has a molecular peak at m/z 
436 consistent with a molecular formula C22H28O9. It shows only 17 carbon signals in 
the 13C NMR spectrum and a DEPT experiment defined the carbons as four methyls, 
two methylenes, eight methines and eight quaternary carbons. The 1H NMR spectrum 
shows four aromatic protons as two singlets at δ 6.69 and 6.58, which are typical of 
1,3,4,5-tetrasubstituted aromatic rings.  
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The 1H NMR spectrum and the 1H1H COSY allow us to identify the H-7' doublet at δ 
6.57 (J=15.8 Hz), the H-8' double triplet at δ 6.36 (J=15.8 and 5.8 Hz) and the H-9' 
double doublet at δ 4.36 (J=5.8 and 1.5 Hz), as well as the H-7 doublet at δ 4.99 (J=4.0 
Hz), the H-8 multiplet at δ 4.12 and the H-9 double doublets at δ 3.86 (partially 
obscured, H-9a) and 3.49 (J=12.0 and 3.0 Hz, H-9b). In the 1H NMR spectrum four 
methoxyl groups at δ 3.92, 3.90, 3.89 and 3.88 are also present. In accordance with the 
erythro relative configuration, a coupling value of 4.0 Hz between H-7 and H-8 is 
observed. 
Compound 10 has a molecular ion peak in a ESI MS at m/z 370, which indicates a 
molecular formula C20H18O7. The 1H NMR spectrum has the signals of an aromatic ring 
whose protons resonate in a ABX spin system, and of an olefinic system conjugated to 
an unsaturated function. The signal of a methoxyl is also present at δ 3.80. By 
comparison with previously reported spectroscopic data, this compound has been 
identified as 1-feruloyloxy-2-methoxy cinnamic acid (Huang et al. 2000). 
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Compound 11 has molecular formula C42H50O16 according to the molecular ion peak at 
m/z 833 [M+Na]+ in the MALDI/MS spectrum. In the 13C NMR spectrum only twenty-
one carbon signals are present indicating a highly symmetric molecule. Through a 
DEPT experiment these signals are attributed to fourteen quaternary carbons, eighteen 
methines, six methyls and four methylenes.  The 1H NMR and COSY spectra reveal the 
connectivities of four protons characteristic of the 3,7-dioxabicyclo [3.3.0] octane 
(4.79/H-7and 7’, 3.14/H-8 and 8’, 4.34/H-9a and 9’a, 3.98/H-9b and 9’b),  and propane 
1,2,3-triol groups (5.00/ H-7" and 7”’, 4.14/ H-8" and 8”’, 3.88/ H-9"a and 9”’a, 3.51/ 
H-9"b and 9”’b). Cross-peaks in an HMBC experiment confirm the carbons’ skeleton. 
Correlation between H-8”/8”’ and C-4/4’ defines the linking position of the 
guaiacylglicerol units on the rings. The above data match those reported by Matsuda et 
al. (1984) for hedyotisol-A isolated from Hedyotis lawsoniae and identified as a 
hexaacetate.  
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Compound 12 has been isolated for the first time. It had molecular formula C31H36O11 
according to the molecular ion peak at m/z 607 [M+Na]+ in the MALDI MS spectrum. 
The 13C and 1H NMR spectra show the presence of one aromatic ring with three coupled 
protons in a ABX spin system, and two aromatic rings, each one with two meta coupled 
protons. The presence of a trans double bond is confirmed by 1H NMR spectrum [δH 
6.51 (d, J=15.8 Hz) and 6.25 (dt, J=15.8, 5.8 Hz)]. The COSY spectrum enables us to 
define a glycerol moiety as C7"–C9" [δH 4.99 (d, J=4.5 Hz) H-7”, 4.10 (m) H-8” and 
4.00 (m) H-9”a, 3.50 (dd, J=11.0, 2.0 Hz) H-9”b] and a neolignan with a benzofuran 
ring C7’–C9’ [δH 5.65 (d, J=8.5 Hz), 3.67 (m) and 3.92 (obscured)]. In accordance with  
the erythro relative configuration, the coupling value of 4.5 Hz between H-7" and H-8" 
has been observed. 
 These data resemble that of the aglycone of alangisesquin A isolated from Alangium 
premnifolium (Kuima et al. 1998) and buddlenol B isolated from Buddleja davidii 
(Houghton et al. 1985). 
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Compound 13 has never been isolated previously. It reveals a [M+Na]+ peak at m/z 579 
in the MALDI MS spectrum, suggesting the molecular formula, C30H36O10.  
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The 13C NMR spectrum of 13 shows 27 carbon signals, and three methoxyl signals, 
indicating 13 to be a sesquilignan. The 1H NMR and 1H1H COSY spectra show the 
presence of three sets of ABX patterns in the aromatic region, a glycerol moiety and a 
tetrahydrofuran ring. The DEPT experiment defines the carbons as three methyls, four 
methylenes, fourteen methines and nine quaternary carbons. The HMQC experiment 
allows the protons to be assigned to the corresponding carbons.  
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The connection of functional groups has been determined on the basis of HMBC 
correlations. All NMR data resemble those reported by Yoshikawa et al. (1995) for the 
ehletianol B. 
Careful analysis of fragmentations of the molecular ion (fig.2), in the MALDI/MS, 
shows peaks at m/z 561 [M+Na-H2O]+ (18%), 549 [M+Na-CH2O]+ (10), 531 [M+Na-
H2O-CH2O]+ (37) and 382 [M+Na-guaiacylglicerol]+ (100). The significant relative 
abundances of peaks at m/z 412 [M+Na-CH2O-C8H9O2]+ and 342 [M+Na-C13H17O4]+ 
indicates the presence of a guaiacylglicerol unit at O-4' instead of the isomeric structure 
with this unit at O-4 as reported for ehletianol B, which has different pattern of 
fragmentation.  
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fig.2- MALDI/ MS fragmentation of compound 13  
 
 
Compound 14 has been identified as (6R,7E,9S)-9-hydroxy-4,7-megastigmadien-3-one. 
ESI-MS spectrum shows a molecular ion peak at m/z 208, in accordance with a 
molecular formula C13H20O2. The 13C NMR spectrum has thirteen signals that a DEPT 
experiment allows us to assign to five methinic carbons, four methyls, one methylene 
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and three quaternary carbons. The signal at δ 199.0 is typical of a α,β-unsaturated 
carbonyl carbon. The carbons of the conjugated double bond resonate at δ 161.7 (C-5) 
and 126.6 (C-4), while carbons of a second double bond give resonances at δ 138.5 (C-
8) and 125.7 (C-7). Carbons to protons correlation is performed by means of an HMQC 
experiment.  
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Protonic resonances confirm the presence of two olefinic systems and an alcoholic 
function. The two protons H-2 resonate as large doublet (J=17.0 Hz) at δ 2.34 and 2.08. 
A COSY experiment defines the correlation between H-6 (δH 2.52)/ H-7 (δH 5.53)/ H-8 
(δH 5.67)/ H-9 (δH 4.35)/ H-10 (δH 1.30), whose chemical shifts define the side chain as 
3-hydroxybutenilic type. Other methyl resonances are at δH 1.90 (H-13), δ 1.03 (H-11) 
and δ 0.97 (H-12). Optical rotation of compound 14  is +200°, which compared to 
literature values leads us to assign the configuration 6R, 9S to the chiral centres (Fraga 
et al.1995).  
Compound 15 has been isolated for the first time, and has been identified as 
(3S,4R,7E,9S)-3,4,9-trihydroxy-5,7-megastigmadiene. Its EI MS shows the molecular 
ion peak at m/z 226, which is in good agreement with the molecular formula of a bis-
nor-sesquiterpene C13H22O3. In the 1H NMR spectrum (Table 1) are present three 
methyls at δ 1.04, 1.06 and 1.84 as singlets, one methyl doublet at δ 1.26, two 
methylene protons as two double doublets at δ 1.80 and 1.43, three methine protons 
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geminal to hydroxyls as a double triplet at δ 3.75, a doublet at δ 3.85, and a quintuplet at 
δ 4.30, and two olefinic protons as a double doublet at δ 5.55 and a doublet at δ 6.03.  
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The 13C NMR spectrum (Table 1) shows 13 carbon signals, identified, by a DEPT 
experiment, as four methyls, one methylene, five methines and three quaternary 
carbons. All the carbons are correlated to the corresponding protons on the basis of the 
HMQC experiment. The COSY experiment shows a correlation series beginning with 
the methine carbinol at δ 4.30, assigned to H-9, which is coupled with the doublet 
methyl at δ 1.26 assigned to H-10, and with the H-8 olefinic proton at δ 5.55. This latter 
proton is correlated with the H-7 proton at δ 6.03. The signal at δ 3.75 is correlated to 
the proton at δ 3.85, and also with the methylene protons at δ 1.80 and 1.43. Two 
hydroxyls are positioned at the C-3 and C-4 on the basis of the HMBC and NOESY 
experiments. The correlations of the H-4, H-8  and H-13 protons with the C-6 carbon 
and those of  H-13 protons with C-4 carbon and C-5 carbons confirm the assumed 
structure.  The analysis of the NOESY spectrum evidences NOE between the H-13 
methyl and H-4 proton. The cis relative configuration at C-3 and C-4 is predicted on the 
basis of the small coupling constant 3JH3H4 (1.8 Hz). 
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Table 1. NMR data for compound 15 and MPTA derivativesa 
 
 
 15  15 R-MPTA 15 S-MPTA 
C δC DEPT δH HMBC δH δH 
1 38.2 C  2, 3, 11, 12   
2 42.1 CH2 1.80 dd (12.5,12.0) 4,  6, 11, 12 2.12 dd(12.5,12.0) 
1.95dd 
(12.5,12.0) 
   1.43 dd(12.5, 3.0)  1.62 dd (12.5, 3.0) 
1.59 dd 
(12.5, 3.9) 
3 68.4 CH 3.75 dt  (12.0, 3.0) 2, 4 5.22 dt  (12.0, 3.0) 
5.19 dt 
(12.0, 3.9) 
4 73.1 CH 3.85 d (3.0) 2, 3, 6, 13 4.06 d (3.1) 4.17 d (4.1) 
5 129.4 C  4, 7, 13   
6 142.9 C  
2, 4, 8, 11, 12, 
13 
  
7 127.3 CH 6.03 d (16.0) 9, 10 6.10 d (15.5) 6.19 d (16.0) 
8 141.0 CH 5.55 dd (16.0, 6.5) 9, 10 5.45 dd (15.5, 6.0) 
5.54 dd 
(16.0, 6.5) 
9 69.9 CH 4.30 qn (6.5) 7, 8, 10 5.62 qn (6.0) 5.64 qn (6.5) 
10 24.3 CH3 1.26 d (6.5) 9, 8 1.46 d (6.0) 1.42 d (6.5) 
11 30.8 CH3 1.04 s 2, 6 1.00 s 1.00 s 
12 28.2 CH3 1.06 s 2, 6 1.09 s 1.12 s 
13 20.3 CH3 1.84 s 4, 6 1.75 s 1.81 s 
aValues were recorded at 500 MHz for 1H and 125 MHz for 13C in CD3OD for 15 and CDCl3 for MPTA 
derivatives  with  J values in Hz in parentheses. 
 
The absolute configurations at the carbinol carbons have been established by Mosher’s 
method (Dale et al. 1973) converting compound 15 into the diasteromeric MTPA 
triesters. Comparison of the chemical shifts of the signals due to H-8 and H-10 protons 
in both the R and the S derivatives and the calculation of the corresponding differences, 
expressed as ∆δR-S, are in agreement with a S configuration for C-9. The negative and 
positive ∆δR-S values for the H-4 and H-2 protons, respectively, indicate an S 
configuration for C-3. For the C-4 carbon, a positive ∆δR-S for the H-3 and a negative 
 72 
value for H-13 have been found, indicating an R configuration for C-4 (Othani et al. 
1991). 
Compound 16 has been identified as (6R,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-
one, known as Blumenol A, by comparing the spectroscopic data with those reported in 
the literature (Weiss et al. 1973). The ESI MS spectrum shows a molecular ion  peak at 
m/z 224 in accordance with a molecular formula C13H20O3.  The signal at δ 199.0 in the 
13C NMR is indicative of a carbonyl carbon of an α,β-unsaturated system. The other 
twelve signals in the spectrum are attributed, by a DEPT experiment, to three olefinic 
methines, four methyls, one methylene, and three quaternary carbons.   
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Proton correlation experiments define the presence of a 3-hydroxybutenil chain: H-7 (δ 
5.78), H-8 (δ 5.84), H-9 (δ 4.41) and H-10 (δ 1.30). Complete structure is assigned by 
considering the remaining protons and carbons resonances correlated through HMQC 
experiment. The 6R configuration is defined by the CD (MeOH) spectrum, which shows 
∆ε241nm + 9.3, ∆ε319nm −0.7.  The R configuration at C-9 is confirmed by Mosher’s 
method. The Mosher derivative obtained by the reaction of compound 16 with (S)-(+)-
MPTA-Cl, in the 1H NMR spectrum, shows the following resonances of the protons 
adjoining the C-9: H-10 at δ 1.39 and H-8 at δ 5.88. The diastereoisomeric derivative of 
the (R)-(-)-MPTA-Cl, in the 1H NMR spectrum, shows the signal of  H-10 at δ 1.43 and 
H-8 at δ 5.77. Chemical shift difference between H-10 resonances in each Mosher 
derivative is -0.04, while for H-8 it is +0.11. These values allow an S configuration to 
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be assigned to the chiral centre C-9. The optical rotation measured for compound 16 is 
[α]D25 +50.9.   
Compound 17  has been identified as (3S,5R,6R,7E,9R)-5,6-epoxy-3,9-dihydroxy-7-
megastigmene. The 1H-NMR spectrum shows the signals of two olefinic protons at δ 
5.90 (H-7) and 5.76 (H-8), two alcoholic protons at  4.38 (H-9) and 3.89 (H-3), four 
methyls and two methylene groups.  
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A COSY experiment correlates protons H-2 (δ 1.60 and 1.37), H-3 (δ 3.89), H-4 (δ 2.36 
and 1.60). 13C NMR signals are indicative of the presence of an epoxy-system 
condensed at the cyclohexane ring (69.5/ C-6, 66.3/ C-5), while an HMBC experiment 
confirms the carbon skeleton. These spectroscopic data are in agreement with those 
reported by D’Abrosca et al. (2004) for nor-terpenes isolated from Cestrum parqui. 
Compound 18 reveals an [M+Na]+ peak at m/z 409 in the MALDI MS spectrum, 
suggesting the molecular formula of C19H30O8. The 1H and 13C NMR spectra show the 
presence of a β-glucopyranosyl unit and an aglycone moiety consisting of 13 carbon 
atoms.  
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The α,β-unsaturated system is revealed by the following signals of the 13C NMR 
experiment: δ 201.3 (C-3), 127.3 (C-4), 167.1 (C-5), which also presents the resonances 
of  two alkenic carbons (δC 134.2 and 134.0), four methyls, a methylene, a methine, and 
the typical pattern of a glucopyranosyl system. These spectroscopic data suggest that 18 
has the same skeleton as corchoinoside C previously isolated from Corchorus olitorius 
L. (Yoshikawa et al. 1997). 
 
Malva silvestris 
The young leaves and shoots of Malva silvestris have been eaten since the 8th century 
BC. The plant's many uses gave rise to the Spanish adage "A kitchen garden and 
mallow, sufficient medicines for a home". The flowers and leaves are emollient and 
beneficial for sensitive areas of the skin. It is applied as a poultice to reduce swelling 
and draw out toxins.  
 
fig.3 Malva silvestris 
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Taken internally, the leaves reduce gut irritation and have a laxative effect. When 
common mallow is combined with eucalyptus (Eucalyptus globulus), it makes a good 
remedy for coughs and other chest ailments. For its properties as anti-inflammatory, 
emollient, astringent, and laxative it is widely used in phytotherapy.  
Malva silvestris has a raised stem and can be 1 meter high. The leaves, with lobes 
indented in the edge, are dark green in color.  The flowers have a characteristic tone, 
which goes from the crimson reddish to violet. The fruit is a capsule that contains 
reniform seeds. It is a spontaneous plant widely diffused in the Mediterranean area. 
Fresh plants of M. silvestris has been extracted with water using Naviglio extractor 
(Naviglio 2003). This extractor is based on a suction effect, generated by a compression 
of an extracting solvent on solids at a pressure of about 8-9 bars for a determinated time, 
and followed by an immediate decompression to the atmospheric pressure. Rapid 
release of the extracting liquid from the inside of a solid matrix, because of pressure 
gradient, mechanically transports the extractable compounds contained in the solid 
matrix towards the outside. The water extract was shaken with ethyl acetate and the 
organic fraction was purified by silica gel column and the fractions purified by 
preparative thin layer chromatography and HPLC yielding twenty-one compounds.  
Compounds 19-29 share a common aromatic structure deriving from shikimic acid 
biogenetic pathway. Natural products deriving from shikimic acid range in complexity 
from the very simple, such as vanillin (used primarily as a flavoring agent), having a 
seven carbons skeleton, salicylic acid (the precursor of aspirin), lawsone (a 
naphthoquinone used in some sunscreens), and scopletin (a coumarin once used as a 
uterine sedative), to the more complex, such as lignans polymers. Compounds  30-36 
are terpenoid derivatives, all biosynthesized  from the mevalonic biogenetic pathway.         
 76 
Compounds 19-23 have been identified as benzoic acid derivatives, compounds 24 and 
27 as 4-hydroxybenzyl alcohol and tyrosol, compounds 25 and 26 as 4-hydroxy-
dihydrocinnamic acid and 4-hydroxy-3-methoxy-dihydrocinnamic acid, and 28 and 29 
as 4-hydroxy-cinnamic acid and ferulic acid by comparing  their spectral data with those 
of authentic samples.  
The 1H NMR spectrum of compound 19 shows two large doublets in the aromatic area, 
each due to two protons H-2, H-6 and H-3, H-5, respectively. The 13C NMR spectrum 
defines the presence of a carboxylic group and of a phenolic function. The IR spectrum 
has three main bands whose νmax is at 3280, 3000 and 1600 cm-1, confirming the 
aromatic and carboxylic functionalities. The spectroscopic data fit with those of  4-
hydroxybenzoic acid. 
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Compound 20 has an 1H NMR spectrum very similar to that of compound 19, but shows 
a further signal at δ 3.86 of a methoxyl group, whose carbon resonates at δ 56.0. The IR 
spectrum shows two significant  bands having a νmax at 3000 e 1710 cm-1 that can be 
attributed to the carboxylic system. All the spectroscopic data allow compound 20 to be 
identified as 4-methoxybenzoic acid. 
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Compound 21 has, in the 1H-NMR spectrum, the signals of an ABX spin system, which 
can be attributed to an aromatic ring 1,2,4-trisubstituted. The 13C NMR shows the 
presence of a carboxylic moiety and of a methoxyl. Mass spectrum has a molecular ion 
peak at m/z 152, which is in agreement with a molecular formula C8H8O3. These data 
establish compound 21 as 4-hydroxy-3-methoxy benzoic acid (Della Greca et al., 
2001). 
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Compound 22 has its molecular ion peak, in a EI/MS experiment, at m/z 138, in 
accordance with a molecular formula C7H6O3, while the ion peak at m/z 94 [M-CO2]+  
can be attributed to the loss of a CO2 molecule. The 1H NMR spectrum has a pattern of 
signals typical of an ortho substituted aromatic ring, that resonates as six signals in the 
13C NMR spectrum. This experiment also confirms the presence of a carboxylic 
function. Chemical shift values identify the other functionality on the aromatic ring as 
an hydroxylic group.  Compound 22 is thus identified as a  2-hydroxybenzoic acid.  
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Compound 23 has been identified as a 4-hydroxy-2-methoxy benzoic acid. The 1H 
NMR spectrum shows the signals of an aromatic ring ortho-para disubstituted (δH 7.57d, 
7.49 dd and 6.75d) having protons resonances typical of a benzoic acid derivative. A 
NOE experiment allows the methoxy group resonating at δ 3.89 to be located in ortho 
position relative to the benzoic functionality. The molecular ion peak at m/z 152 in a EI 
MS spectrum agrees with the assigned structure having a molecular formula C8H8O3. 
The mass spectrum also shows a peculiar peak at m/z 108, indicative of the loss of a 
CO2  moiety. 
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Compound  24  has a molecular ion peak in a EI-MS spectrum at m/z 124, which 
suggests a molecular formula C7H8O2. The mass spectrum also shows  ion peaks at m/z 
107 [M-OH]+ and m/z 93 [M-CH2OH]. The IR spectrum shows a significant band at 
νmax 3300 cm-1, due to O-H stretching motions.  
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The 1H NMR spectrum has a pattern of signals typical of a 1,4 disubstituted aromatic 
ring, and a singlet at δ 4.86  attributable to two protons of a benzyl alcohol moiety. The 
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13C NMR  spectrum has four signals in the aromatic area (δC 133.5/ C-1, 128.7/ C-2 and 
C-6, 115.9/ C-3 and C-5, 156.2/ C-4), and the signal of a benzyl carbon at δ 68.5. These 
data allow compound 24 to be identified as 4-hydroxybenzyl alcohol.  
Compound 25  has been identified as 4-hydroxy-dihydrocinnamic acid. The 1H NMR 
spectrum has four signals, two in the aromatic area, typical of a ortho-para disubstituted 
ring, and two generated by two protons each, at δ 2.80 and 3.11. Signal multiplicity 
indicates the latter protons are mutually coupled in an A2X2 spin system typical of an 
ethylic chain. The 13C NMR spectrum has the signal of a carboxylic function at δ 177.1 
and a quaternary carbon resonates at δ 154.8, indicating a phenolic structure.   
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Compound 26 is identified as 4-hydroxy-3-methoxy-dihydrocinnamic acid. The 13C 
NMR spectrum has ten signals, attributed by a DEPT experiment to four quaternary 
carbons, three methines, two methylenes and one methyl.  
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The resonances at δ 178.9, 146.4 and 144.0 are typical of a carboxylic group and of two 
oxygenated aromatic carbons, respectively. Protons resonances in a 1H NMR spectrum 
indicate a 1,2,4-trisubstituted aromatic ring, a propanoic side chain, and a methoxy 
function. The assigned structure is confirmed by comparison with literature data 
(D’Abrosca et al. 2004).  
Compound 27 has in the 1H NMR spectrum two large doublets at δ 7.02 and 6.89 of a 
para substituted aromatic ring, and two triplets at δ 2.71 and 3.67 mutually coupled to 
an ethylic side chain. Chemical shift values suggest the presence of two hydroxyl 
groups that functionalize the aromatic ring and the side chain. According to these data a 
tyrosol structure is assigned to compound 27.    
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Compound 28 is identified as 4-hydroxy-cinnamic acid. The 1H NMR spectrum has two 
large doublets (δΗ 7.60 and 6.30,  J=15.5 Hz) of  a trans disubstituted double bond, and 
two doublets of a para substituted aromatic ring (δΗ 7.44d and 6.80d, J=8.0 Hz). 
Literature data confirm the assigned structure (DellaGreca et al., 2001).  
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Compound 29 has been defined from  the 1H NMR  data as ferulic acid. The protonic 
spectrum shows the signals of an ABX spin system attributed to a 1,2,4-trisubstituted 
aromatic ring, and two large doublets due to the olefinic protons of a trans disubstituted 
double bond. After comparison with a commercial sample we have uncertainly settled  
the structure of compound 29 (DellaGreca et al., 2001). 
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Compound 30 has been determined to be linalool. The EI MS has the ion peak at m/z 
170, in accordance with a molecular formula C10H18O2. Moreover the signal at m/z 152 
[M-H2O]+ is generated by water loss. The IR spectrum mainly shows two absorption 
bands (νmax at 3600 and 3420 cm-1) caused by the stretching motions of a hydroxyl 
group. The 13C NMR spectrum shows ten signals, that a DEPT experiment estabilishes 
as two methyls, four methylenes, two methines, and two quaternary carbons.  
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The 1H NMR  spectrum defines the presence of two olefinic systems, whose protons 
resonate at  δ 5.42, 5.92, 5.22 and 5.08 respectively as  a triplet and three double 
doublets. Furthermore the methylene protons H-1, H-4 and H-5 give resonances at δ 
3.99, 2.10 and 1.55. Cross-peaks in a HMBC experiment correlate protons H-9 with the 
quaternary olefinic carbon at δ 134.9, and with the carbon at δ 125.7. In an HSQC 
experiment, this carbon is heterocorrelated to the olefinic proton at δ 5.42. The 1H1H 
COSY experiment correlates this proton to the signal at δ 2.10, which is coupled to 
protons at δ 1.55. The same experiment allows an ABX spin system typical of a vinyl 
group to be identified. The protons of this group are correlated in the HMBC 
experiment to the quaternary carbon at δ 73.3, which is also correlated to protons H-10, 
H-4, H-5. Optical rotation measurement allows this compound to be identified as 
(2E,6S)-2,6-dimethyl-2,7-octadien-1,6-diol  (Nicoletti et al. 1985).  
Compound 31 is identified as  linalool-1-oic acid. Ion peaks in the EI MS at m/z 184, 
156  and 144  are respectively attributed to the molecular ion, to the fragmented 
molecule obtained from the loss of a vinyl moiety ([M-C2H4]+) and the loss of a CO2 
moiety  ([M-CO2]+ ).  In the IR spectrum three peculiar bands are present; two are 
generated by stretching vibrations of an hydroxyl group at  νmax 3400 and 3050 cm-1, 
and one is caused by the C=O asymmetric stretching of a  carboxylic system at  1680 
cm-1 . The 1H NMR spectrum shows four olefinic protons at δ 6.84, 5.86, 5.20 and 5.06 
identified as H-3, H-7, H-8a and H-8b respectively, two triplets at δ 2.20 and δ 1.62 
attributed to H-4 and H-5, two singlets of the methyls H-9 and H-10 at δ 1.78 and δ 
1.28. 13C-NMR data show the presence of a carboxylic group, that in a HMBC 
experiment results correlated to protons H-3 and H-9.  These data define the structure of  
linalool oxidised  at C-1 (Nicoletti et al. 1985).  
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Compound 32 has been isolated for the first time. The EI MS of compound 32 shows a 
molecular ion peak at m/z 262, and prominent peaks at m/z 245 [M-OH]+, 234 [M-CO]+, 
and 219 [M-C3H7]+. The molecular formula is identified as C16H22O3 by EI MS. Its IR 
spectrum shows absorption bands of hydroxyl group (3300 cm-1) and phenyl group 
(1600 cm-1).  
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The structure of compound 32 has been established by using 1H NMR and 13C NMR 
including COSY, NOESY, HMQC, and HMBC experiments (Table 2). The 1H1H 
COSY experiment shows a correlation series beginning with the methine at δ 2.43, 
assigned to H-11, which is coupled with the two methyls at δ 1.14 and 1.13. The proton 
signals at δ 4.00 and 3.45 assigned to methylene H-14 are correlated with the H-10 
proton at δ 3.45, which is coupled with the H-9 protons at δ 1.97 and 1.49. These 
methylene protons are correlated with H-8 at δ 2.12 and 1.30. Present also in the 1H 
NMR are three singlets attributed to two methyls and a methine.  
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Table 2.  NMR spectral data of compound 32 in CDCl3 
Position δHa NOESY δC HMBCb 
1   125.1 (q)c  
2     142.9* (q)  
3   144.0 (q)  
4    127.0(q)  
5 6.69 s 12, 13, 15 115.8 (t) 1, 3, 7 
6   139.5 (q)  
7   74.7 (q)  
8 2.12 m, 1.30 m  27.3 (s) 6, 7, 9 
9 1.97 m, 1.49 m  23.6 (s) 1 
10 3.45 m  27.8 (t) 2, 6 
11 2.43 q (6.8)   31.2 (t) 6, 7, 12, 13 
12 1.14 d (6.8) 5 18.5 (p) 7, 11 
13 1.13 d (6.8) 5 17.8 (p) 7, 11 
14 4.00 dd (8.3, 2.4), 3.45 m   67.9 (s) 1, 7, 9, 10 
15 2.32 s 5, 12, 13, OMe 16.1 (p) 3, 4, 5 
OMe 3.81 s 15 60.7 (p) 3 
a
 
1H chemical shift values (δ ppm from SiMe4) followed by multiplicity and then the coupling constants (J 
in Hz). b HMBC correlations from H to C. c Letters, p, s, t and q, in parentheses indicate, respectively, the 
primary, secondary, tertiary and quaternary carbons, assigned by DEPT. 
 
The 13C NMR spectrum of  32 shows 16 carbon signals, which have been attributed by a 
DEPT experiment to four methyls, three methylenes, and three methines. An HMQC 
experiment allows the protons to be assigned to the corresponding carbons. The 
connection of functional groups is determined on the basis of HMBC correlations. In 
the HMBC spectrum the H-5 proton has been heterocorrelated to the C-1, C-3, and C-7. 
The methoxy group at δ 3.81 and the methyl at δ 2.32 are also heterocorrelated to the C-
3. The multiplet at δ 3.45 (H-10) gives correlations with aromatic carbons C-2, and C-6. 
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The methylene H-14 gives heterocorrelations to C-1, C-7, C-9, and C-10. These data 
completely define the structure of compound 32. According to the structure, the analysis 
of NOESY spectrum evidenced NOEs of the methyls at δ 1.14 and 1.13, with the H-5 
methine, and methyl at δ 2.32, and with the methoxyl at δ 3.81 (figure 4). 
 
fig.4 Selected NOE of compound 32.  
 
Spectral data of compound 33 identify it as  (+)-dehydrovomifoliol. The 1H NMR 
spectrum shows two doublets at δ 6.46 and 6.83, which are attributed to two olefinic 
protons in an α,β-unsaturated system.  
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The coupling between H-7 and H-8 (J=15.5 Hz) assigns the trans configuration  to the 
double bond. The singlet at δ 5.93 is due to the olefinic proton  H-4, and the two large 
doublets at δ 2.58 and 2.27 (J=17.4 Hz) are attributed to the geminal protons H-2. The 
signals of four methyls are present at δ 2.29, 1.88, 1.09, 1.01. Comparison with 
literature data  (Mori et al. 1974) confirms the structure assumed and defines the 
absolute stereochemistry.  
Compound 34 is defined to be (3R,7E)-3-hydroxy-5,7-megastigmadien-9-one. The 13C 
NMR spectrum shows thirteen signals attributed through a DEPT experiment to four 
quaternary carbons, two methylenes, three methines and four methyls. Chemical shift 
values identify the presence of a carbonyl carbon conjugated in α and γ, and of a 
carbinol carbon.  
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The 1H1H COSY experiment correlates the alcoholic proton at δ 4.05 to the double 
doublets of protons H-2 (δ 1.80 and 1.49) and H-4 (δ 2.44 and 2.08). The HMBC 
experiment confirms carbon skeleton and functionality positions (Della Greca et al. 
2004).   
Spectra data  of compound 35 allow the structure of the (3S,5R,6R,7E,9R)-3,5,6,9-
tetrahydroxy-7-megastigmene to be assigned. The 1H NMR and COSY experiments 
define the presence of a 3-hydroxy butenilic chain through the correlations of the 
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protons H-7 (δ 5.90)/ H-8 (δ 5.66)/ H-9 (δ H-4.28)/ H-10 (δ 1.22). Proton and carbon 
resonances define the presence of a cyclohexane ring having three hydroxyl functions in 
positions C-3, C-5 and C-6. HMBC experiment confirms the assigned structure through 
the correlations C-6/ H-8 and H-9, C-4/ H-2 (D’Abrosca et al. 2004).    
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Compound 36 shows a molecular ion peak at m/z 340, and peaks at m/z 325 [M-CH3]+, 
322 [M-H2O]+, and 297 [M-C3H7]+. The molecular formula has been determined as 
C20H36O4 by EI MS and 13C NMR. The four oxygen functions have been ascribed to 
two secondary hydroxyl groups (δH 3.93 and 3.23, δC 79.2 and 79.5) and the remaining 
two have been attributed to tertiary hydroxyl groups (δC 74.3).  
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The structure of 36 has been characterized by 1H NMR and 13C NMR including COSY, 
NOESY, HMQC, and HMBC experiments. The 1H NMR spectrum of 36 shows five 
singlet methyls, ten aliphatic protons of five methylenes, and seven methines attributed 
to two carbinolic and five olefinic protons. The 1H1H COSY experiment shows 
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correlation of the olefinic methine at δ 5.94, assigned to H-2, with the H-1 methylene δ 
5.16 and 5.03. The broad triplet at δ 5.34, assigned to H-6, is correlated with the H-5 
methylene at δ 2.08, which is correlated to methylene H-4 at δ 1.52. The broad triplet at 
δ 5.16, assigned to H-10, is correlated with methylene H-9 at δ 2.24, which is correlated 
to the methine H-8 at δ 3.93. The double doublet at δ 3.23, assigned to H-14, is 
correlated to methylene H-13 (δΗ 1.70 and 1.34), which is correlated to methylene H-12 
(δΗ2.24 and  2.05). 
 
fig.5- Selected NOE of compound 36 
 
 
The 13C NMR spectrum shows 19 carbon signals, identified, by a DEPT experiment, as 
five methyls, six methylenes, and five methines. All the carbons are correlated to the 
corresponding protons on the basis of an HMQC experiment. The tertiary hydroxyl 
groups have been positioned at C-3 and C-15 on the basis of an HMBC experiment that 
shows correlations between the C-3 carbon with the H-1, H-2, H-4 protons, and C-15 
with the H-14, H-16, and H-17 protons. 
 Furthermore, NOESY correlations of H-8 with H-6, H-10, and H-19, and H-14 with H-
16 and H-17 confirm the structure of diterpene 36. 
1 
3 
6 
8 
10 
14 
20 19 
18 
16 
17 
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Table 3.  NMR spectral data of compound 36 in CD3OD 
Position δHa NOESY δC HMBCb 
1 5.19 dd 5.03 dd (17.0, 10.5, 1.5)  112.6 (s)c 2, 3 
2  5.94 dd (17.0, 10.5)  146.7 (t) 3 
3   74.3 (q)  
4 1.52 dd (8.0, 7.6)  43.5 (s) 2, 3, 5, 6, 20 
5 2.08 ddd  (8.0, 7.6, 7.0)  23.8 (s) 4, 6, 7 
6 5.34 brt  (7.0) 4, 8 127.9 (t) 4, 5, 8, 19 
7   138.4* (q)  
8 3.93 t (6.8) 6, 10, 19 79.2 (t) 6, 7, 9, 10, 19 
9 2.24 m  35.2 (s) 7, 8, 10, 11 
10 5.16 brt (7.0) 8, 12 122.4 (t) 12, 18 
11   138.2* (q)  
12 2.24 m, 2.05 m  38.5 (s) 10, 11, 13, 18 
13 1.70 m, 1.34 m  31.2 (s) 12 
14 3.23 dd (10.4, 2.0) 12, 16, 17 79.5 (t) 12 
15   74.3 (q)  
16 1.16 s 14 25.5 (p) 14, 15, 17 
17 1.15 s 14 26.1 (p) 14, 15, 16 
18 1.63 s  16.9 (p) 10, 12 
19 1.60 s 8 11.9 (p) 6, 7, 8 
20 1.25 s  28.1 (p) 2, 3, 4 
 
a
 
1H chemical shift values (δ ppm from SiMe4) followed by multiplicity and then the coupling constants (J 
in Hz).b HMBC correlations from H to C. c Letters, p, s, t and q, in parentheses indicate, respectively, the 
primary, secondary, tertiary and quaternary carbons, assigned by DEPT. 
 
The absolute configurations at the C-8 and C-14 secondary carbinol carbons have been 
established by Mosher’s method, converting compound 36 into the diasteromeric 
MTPA diesters.  The chemical shift differences of protons, at β position of C-8 and C-
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14 chiral carbons, has been assigned by 1H1H COSY experiment. The chemical shifts 
comparison of the signals due to H-9 and H-6/H-19 protons in both the R and the S 
MPTA derivatives and the calculation of the corresponding differences, expressed as 
∆δR-S, are in agreement with an S configuration for C-8. For the C-14 carbon, the 
positive ∆δR-S for  H-16/H-17 and a negative value for H-13 have been found, indicating 
an R configuration for C-14. Therefore, the structure of 36 has been deduced to be 
(6E,8S,10E,14R)-3,7,11,15-tetramethylhexadeca-1,6,10-trien-3,8,14,15-tetraol. 
The three nor-terpenes 14, 16 and 17  isolated from the hydroalcoholic extract of 
Brassica fruticulosa have been also isolated from Malva silvestris. 
 
Chenopodium album 
Chenopodium album L. is an annual dicotyledonous belonging to Chenopodiaceae 
family, commonly known as lambsquarter. It is rich in iron and vitamin B1, and it is 
greatly used for edible purposes in Mediterranean countries and in North America, 
where it was one of the fundamental components of Indian diet. It is an infesting species 
of summer-autumn cultivations, easy to find in subcosmopolitan areas.   
This plant has elliptical cotyledons with rounded tip, while the leaves are ovate or 
triangular, irregularly dentate. The adult plant reaches a height of  200 cm, with a 
simple or branched stem. Its flowers are small, greenish, grouped in whitish farinose, 
glomerules in panicle. Mallik et al. (1994) have reported the presence of growth 
inhibitory substances in this plant. They observed that the aqueous extract inhibited the 
germination and growth of radish and wheat seeds, attributing the activity to the 
presence of phenols. Horio et al (1993) have reported the isolation of a phenolic amide 
with attractant activity toward zoospores of Aphanomyces cochlioides. We 
reinvestigated this plant to define its metabolites composition. 
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fig.6- Chenopodium album 
 
Fresh plants of Chenopodium album were separated into leaves, twigs and roots, and the 
different parts were infused for 7 days into a hydroalcoholic solution (10% MeOH/H2O) 
and four days in MeOH. The aqueous solution of hydroalcoholic extract of C. album, 
after acetone precipitation, was partitioned between methylene chloride and water. The 
methylene chloride extract was fractionated by silica gel column chromatography and 
the fractions purified by preparative TLC, DCCC and HPLC, yielding compounds 1, 14, 
16, 21, 28, 29, 33, 34, 38, 39, 41-43, 45, 50, 51, 60-73. The aqueous layer however, was 
been fractionated by Amberlite XAD-2 and Sephadex LH-20 column chromatography 
to isolate compounds 4, 37 and 49. The aqueous solution of hydroalcoholic extract of C. 
 92 
album twigs, after acetone precipitation and chromatographic purification led to the 
isolation of compounds 40, 44, 46, and 48. Compounds 37-51 (Cutillo et al. in press) 
were identified as phenols derivatives and lignans, while compounds 60-73 were 
classified as nor-isoprenoids (Della Greca et al. 2004). 
The methanol infusion of fresh plants of Chenopodium album, after removal of the 
solvent in vacuum, was suspended in water and precipitated with acetone. The surnatant 
was extracted with ethyl acetate and the organic layer separated  into an acidic and a 
neutral fraction. The neutral portion was fractionated by silica gel column 
chromatography and the fractions was purified by preparative layer chromatography 
and HPLC yielding seven cinnamic amides 52- 58 (Cutillo et al. 2003). Instead 
compound 59 was isolated from the MeOH extract of roots. The concentrated infused 
was partitioned between EtOAc and H2O. EtOAc-soluble materials were subjected to 
different silica gel column chromatographies and then purified by RP-18 HPLC to 
afford Chenoalbicin, which is a new molecule constiting of an alkaloid moiety linked to 
cinnamic acid amide (Cutillo et al. 2004).  
Compound 37 has been identified as cinnamic acid. 1H NMR data define the presence 
of a monosubstituted aromatic ring, and of a double bond conjugated to a carboxylic 
function whose protons resonate at δ 7.61 and 6.41 as two doublets having a coupling 
constant typical of a trans configuration (J=15.5 Hz). 13C NMR spectrum confirms the 
presence of an unsaturated side chain containing a carboxylic group. Comparison with a 
commercial sample of cinnamic acid confirms the structure. 
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When we compared 1H NMR data of compound 38 with those of compound 29 an extra 
signal related to a methyl group (δH 3.72) of an esteric function was detected. 
Compound 38 is therefore identified as methyl- (4-hydroxy-3-methoxy)cinnamate 
(Bohlmann and Zdero, 1977). 
 
OCH3
O
HO
OCH3
 
38 
 
In the 1H NMR spectrum compound 39 has a singlet in the aromatic area at δ 6.75 that 
integrates for two protons, and two doublets of  a trans di-substituted olefinic system at 
δ 7.58 (J=15.8 Hz, H-7) and δ 6.28 (J=15.8 Hz, H-8). The signals of  six protons 
belonging to two methoxyl groups are also present. These data  identify compound 39 
as 4-hydroxy-3,5-dimethoxycinnamic acid (DellaGreca et al., 2001).  
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Compound 40 has a molecular ion peak in a EI MS experiment at m/z 210, while the 
base peak is at m/z 137 [M-CO2-C2H5]+ . The assigned molecular formula is C11H14O4. 
Two  coupled triplets at δ 2.88 and 2.59 define the presence of an aliphatic ethyl, and 
the ABX spin system in the  aromatic area is indicative of  a 1,2,4 trisubstituted ring.  
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Two different methoxyl groups resonate at δ 3.88 and 3.80. 13C NMR spectrum shows 
the presence of a carbonyl carbon of an esteric group. These data identify compound 40 
as methyl 3-(4-hydroxy-3-methoxyphenyl)-propanoate (Takayuki et al., 1993). 
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Compound 41 in a EI MS spectrum has a molecular ion at m/z 168, in accordance with a 
molecular formula  C9H12O3. The 13C NMR spectrum shows nine signals, attributed on 
the basis of a DEPT experiment to four methines, two methyls, three quaternary 
carbons.  
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In the 1H NMR spectrum, the signals of a 1,2,4-trisubstituted aromatic ring are present. 
The quartet of a proton at δ 4.68, coupled to a doublet at δ1.49 due to three protons, 
suggests the presence of an ethanolic chain. These spectra data allow compound 41 to 
be identified as 4-(1-hydroxyehtyl)-2-methoxyphenol (Carro et al., 1995). 
Compound 42, in a EI MS spectrum, has a molecular ion at m/z 168, according to a 
molecular formula  C9H12O3. The 1H NMR spectrum has two coupled triplets at δ 4.00 
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and 3.18 of an aliphatic C2 chain,  a singlet at δ 3.95 of a methoxyl group, and, in the 
aromatic area of the spectrum, the signals of an ABX spin system attributed to a 1,2,4-
trisubstituted benzene. These spectral data identify compound 42 as 2-(4-hydroxy-3-
methoxyphenyl)-ethanol (Della Greca et al., 2001). 
 
OH
OCH3
HO
 
42 
 
Compound 43 is identified as 4-hydroxy-3-methoxy-benzylic alchool. The EI MS 
spectrum shows a molecular ion peak at m/z 154  according to a molecular formula C8 
H10O3. In the aromatic area the 1H NMR spectrum shows the signals of  an ABX spin 
system that has been attributed to a 1,2,4-trisubstituted phenyl ring (δ 6.90d H-5, 6.88d 
H-2, 6.84dd H-6). At higher field, two singlets of a methoxy group and of a benzylic 
methylene are present (δ 3.90s 3-OMe, 4.60s H-7). 
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Compound 44 has a molecular ion peak in a EI-MS experiment at m/z 120, which 
suggests a molecular formula C8H8O. The 1H NMR spectrum shows the signal of an 
ABX spin system at δ 5.59 (d, J=17.6 Hz, H-8a), 5.12 (d, J=10.8 Hz, H-8b) and 6.64  
(dd, J=17.6 and 10.8 Hz, H-7) that is typical of a vinylic group. In addition two aromatic 
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doublets, integrated for two protons each, resonate at  δ 7.29 and 6.78. The assigned 
structure is of p-hydroxystyrene (Teai et al., 2001). 
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Compound 45 has the molecular ion peak in a EI MS  spectrum at  m/z 108 according to 
a molecular formula C8H8O. The 1H NMR spectrum has the signal of a highly 
deshielded proton which resonates as a singlet at δ
 
9.95, indicative of an aldehydic 
function. The signals of a para substituted aromatic ring (δH 7.77d and 7.32d) and of a 
methyl (δH 2.43) are also present. These data identify compound 45 as 4-
methylbenzaldehyde.  
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Spectra analysis univocally defines compound 46 as acetyl tryptamine. 13C NMR 
spectrum has twelve signals which are attributed, on the basis of a  DEPT experiment, 
to five methins, two methylenes, one methyl and four quaternary carbons. Chemical 
shift values of both protons and carbons spectra are indicative of an indolic 
monosubstituted structure. The 1H1H COSY correlations suggest the presence of an 
ethyl chain, directly linked to a nitrogen atom. An amidic carbon resonates in the 13C 
 97 
NMR at δ 170.7, and an acetyl carbon at δ 24.0. These data are indicative of a 
triptamine skeleton acetylated on the side chain (Moro et al., 1975).  
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Compound 47 has the molecular ion peak in a EI MS  spectrum, at  m/z 418 according 
to a molecular formula C22H26O8. The 1H NMR spectrum has the signals of a 
tetrasubstituted aromatic ring, and of a C3 side chain.  
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The latter in a 1H1H COSY experiment results consisting of a doublet at δ 4.72 scalarly 
coupled to a multiplet at 3.09, which, in turn, is correlated to two different multiplets at 
4.26 and 3.61. These chemical shift data are typical of a dioxabicyclo octanic system. A 
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singlet integrated for twelve protons appears at 3.89. Spectral data univocally define 
compound 47 as (±)-syringaresinol (Briggs et al., 1968). 
Compound 48 is  (±)-5,5’-dimethoxylariciresinol. The 1H and 13C NMR spectra have 
the signals of two aromatic rings tetrasubstituted, and of a furanic ring. The signals of a 
benzilic methylene and of an alcoholic methylene are also present. The 1H-1H COSY 
experiment shows a correlation series beginning with the methine at δ 4.80, assigned to 
H-7’, which is coupled with the methine at δ 2.73 (H-8’), that, in turn,  is correlated to 
the methine at δ 2.43 (H-8) and the methylene protons at δ 3.80 (H-9’). In the same 
experiment H-8 is also correlated to the methylene protons H-7 (δH 2.93 and 2.54) and 
H-9 (δH 4.06 and 3.85). HMBC correlations confirm the structure and define the 
position occupied by the methoxy groups (Kinjo et al., 1991).   
 
HO
OMe
MeO
O
MeO
OH
OMe
OH
7'
7
8'
9
 
48 
 
Sesquilignan 49 has been identified as threo-guaiacylglycerol-β-O-4-syringaresinol 
ether on the basis of its spectroscopic data. The 1H and 13C NMR spectra have the 
signals of three aromatic rings, two of them tetrasubstituted with the remaining protons 
in meta position, and one 1,2,4 trisubstituted. The resonances of protons H-7, H-8, H-9 
and H-7’, H-8’, H-9’ suggest the presence of a dioxabyciclo octanic system, which is 
confirmed both by carbon resonances and 1H1H COSY correlations. The correlated 
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protonic system δ 5.01/ 4.13/ 3.88/ 3.50 is typical of a glycerol moiety. HMBC 
correlations confirm the structure, and the correlation H-8’’/ C-4’ is significant in 
defining the guiacylglicerol linking position.       
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These data resemble that of Buddlenol C (Houghton, 1985) isolated as erythro and threo 
diastereoisomeric mixture. The absolute configurations at C-7” and C-8” of compound 
49 are established on the basis of the CD spectroscopic data and coupling constant in 
the 1H NMR spectrum. The coupling of 6.9 Hz between the H-7” and H-8” protons 
indicates a threo relative configuration, and the positive CD curve in the 210-260 nm 
range agrees with 7”S, 8”S configuration (Arnoldi et al., 1985 and Fang et al., 1992).  
Compound 50 has been isolated for the first time. Its molecular formula C33H40O12 has 
been assigned according to the molecular ion at m/z 628 [M]+ in the ESI/MS spectrum. 
The 1H NMR (Table 4) and COSY spectra reveal the connectivity of protons 
characteristic of the 3,7-dioxabicyclo [3.3.0] octane and the propane 1,2,3-triol groups. 
The COSY spectrum enables us to define a glycerol moiety as C-7"–C-9" [δH 4.56 (d, 
J=6.8 Hz), 4.13 (m) and 3.80 (obscured), 3.52 (dd, J=2.9 and 11.7 Hz)]. In accordance 
with the threo relative configuration, the coupling constant value of 6.8 Hz between H-
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7" and H-8" has been observed (Della Greca et al., 1994). Moreover the presence of 
one aromatic ring with three coupled protons in an ABX system, and two aromatic 
rings, each with two protons located at meta sites, are evident.  
The 13C NMR spectrum of 50 shows only 27 carbon signals, which, on the basis of a 
DEPT experiment, are attributed to six methyls, three methylenes, thirteen methines and 
eleven quaternary carbons. 
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An HMQC experiment allows the protons to be assigned to the corresponding carbons. 
The connection of functional groups has been determined on the basis of HMBC 
correlations. In the HMBC spectrum the H-7 and H-7’ protons are heterocorrelated to 
the C-2 and C-2’ of the two tetrasubstituted aromatic rings and to the C-8, C-9 and C-8’, 
C-9’ of the furofuran lignan unit. The doublet at δ 4.56 attributed to H-7” gives 
correlations with C-1”, C-2”, C-6”, C-8”, C-9” and MeO-7”. These data completely 
define the structure of sesquilignan 50.  
According to the structure the analysis of NOESY spectrum  evidences NOEs of the 
methoxyls at δ 3.82-3.86 with  H-2, H-6, H-2’, H-6’ and H-2”, and of the methoxyl at δ 
3.22 with H-7”. The threo relative configuration and the positive CD curve in the 210-
260 nm range agree with 7”S, 8”S configuration. 
 
 101 
Table 4. NMR spectral data of compound 50 measured in deuteroacetone 
Position 1Η−NMRa NOESY 13C-NMR HMBC(C)b 
1   134.1 (C)c  
2 6.70 (s) MeO-3, 7 104.5 (CH) 1, 3, 4, 7 
3   152.8 (C)  
4   148.3 (C)  
5   152.8 (C)  
6 6.70 (s) MeO-5, 7 104.5 (CH) 1, 4, 5, 7 
7 4.67 (d, 3.9) 2, 6, 9 86.8 (CH) 2, 8, 9 
8 3.09 (m)  55.2 (CH)  
9 4.24 (dd, 7.1, 15.0), 
3.90 (obscured) 
 72.3 (CH2) 7, 8 
1’   134.3 (C)  
2’ 6.68 (s) MeO-3’, 7’ 104.2 (CH) 4’, 7’ 
3’   152.0 (C)  
4’   136.7 (C)  
5’   152.0 (C)  
6’ 6.68 (s) MeO-5’, 7’ 104.2 (CH) 4’, 7’ 
7’ 4.71 (d, 3.9) 2’, 6’, 9’ 86.6 (CH) 2’, 8’, 9’ 
8’ 3.09 (m)  55.4 (CH)  
9’ 4.24 (dd, 7.1, 15.0), 
3.90 (obscured) 
 72.3 (CH2) 7’, 8’ 
1”   129.5 (C)  
2” 6.98 (d, 1.5) MeO-3” 111.9 (CH) 4”, 6”, 7” 
3”   148.5(C)  
4”   146.9 (C)  
5” 6.81(d, 7.5)  115.1 (CH) 1”, 3” 
6” 6.84 (dd, 1.5, 7.5)  121.7 (CH) 4” 
7” 4.56 (d, 6.8)  83.5 (CH) 1”, 2”, 6”, 8”, 9”, 
MeO-7” 
8” 4.13 (m)  86.5 (CH)  
9” 3.80 (obscured), 
3.52 (dd, 2.9, 11.7) 
 60.6 (CH2) 7” 
MeO-3, 5 3.82 s 2, 6 57.4 (CH3)* 3, 5 
MeO-3’, 5’ 3.84 s 2’, 6’ 56.8 (CH3)* 3’, 5’ 
MeO-3” 3.86 s 2” 57.0 (CH3)* 3” 
MeO-7” 3.22 s 7” 58.1 (CH3) 7” 
a1H chemical shift values (δ ppm from SiMe4) followed by multiplicity and then the coupling constants (J 
in Hz). b HMBC correlations from H to C.* Assignments may be interchanged.  
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Compound 51 has never been isolated before. It has molecular formula C34H42O13 
according to the molecular ion at m/z 658 [M]+ in the ESI/MS spectrum. The 13C and 1H 
NMR spectra show the presence of three aromatic rings, each with two protons, which 
are located at meta sites relative to each other. The COSY spectrum enables us to define 
a glycerol moiety as C-7"–C-9" [δ
 
4.43 (d, J=6.7 Hz), 4.22 (m) and 3.90 (m), 3.70 (dd, 
J=2.0, 11.0 Hz)]. The coupling constant value of 6.7 Hz between H-7" and H-8" defines 
a threo relative configuration.  
 
O
O
H H
O
OCH3
OH
OCH3
H3CO
OCH3
H3CO
OH
H3CO
HO OCH3
 
51 
 
The 13C NMR spectrum of 51 shows 23 carbon signals, and a DEPT experiment 
attributes the signals to seven methyls, three methylenes, twelve methines and twelve 
quaternary carbons. An HMQC experiment allows the protons to be assigned to the 
corresponding carbons. The connection of functional groups is determined on the basis 
of HMBC correlations. In the HMBC spectrum the H-7 and H-7’ protons are 
heterocorrelated to the C-2 and C-2’ of the two tetrasubstituted aromatic rings and to the 
C-8, C-9 and C-8’, C-9’ of the furofuran lignan unit. The doublet at δ 4.43 attributed to 
H-7” gives correlations with C-1”, C-2”, C-6”, C-9” and MeO-7”.  
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Table 5. NMR spectral data of compound 51 in deuteromethanol 
Position 1H-NMRa NOESY 13C-NMR HMBC (C)b 
1   136.0 (C)  
2 6.62 (s) MeO-3, 7  104.7 (CH) 1, 3, 4, 7 
3   154.2 (C)  
4   148.9 (C)  
5    154.2 (C)  
6 6.62 (s) MeO-5, 7 104.7 (CH) 1, 4, 5, 7 
7 4.73 (d, 3.8) 2, 6, 9 87.7 (CH) 2, 8, 9 
8 3.13 (m)  56.2 (CH)  
9 4.60 (dd, 7.0, 14.8), 
3.90 (obscured) 
 73.4 (CH2) 7, 8 
1’   135.0 (C)  
2’ 6.66 (s)  MeO-3’, 7’  105.0 (CH) 4’, 7’ 
3’   154.0 (C)  
4’   138.2 (C)  
5’   154.0 (C)  
6’ 6.66 (s) MeO-5’, 7’ 105.0 (CH) 4’, 7’ 
7’ 4.73 (d, 3.8) 2’, 6’, 9’ 88.1 (CH) 2’, 8’, 9’ 
8’ 3.13 (m)  56.2 (CH)  
9’ 4.60 (dd, 7.0, 14.8), 
3.90 (obscured) 
 73.4 (CH2) 7’, 8’ 
1”   131.1 (C)  
2” 6.58 (s)               MeO-3” 106.6 (CH) 4”, 6”, 7” 
3”   150.2(C)  
4”   146.0 (C)  
5”   150.2 (C)  
6” 6.58 (s)  106.6 (CH) 4” 
7” 4.43 (d, 6.7)  84.5 (CH) 1”, 2”, 6”, 9”, 
MeO-7” 
8” 4.22 (m)  86.7 (CH)  
9” 3.90 (obscured),  
3.70 (dd, 2.0, 11.0) 
 62.4 (CH2) 7” 
MeO-3, 5 3.80 s 2, 6 57.3 (CH3)* 3, 5 
MeO-3’, 5’ 3.81 s 2’, 6’ 57.1 (CH3)* 3’, 5’ 
MeO-3”, 5” 3.84 s 2” 58.0 (CH3)* 3” 
MeO-7” 3.77 s 7” 58.2 (CH3)* 7” 
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a1H chemical shift values (δ ppm from SiMe4) followed by multiplicity and then the   coupling constants 
(J in Hz). b HMBC correlations from H to C.* Assignments may be interchanged. 
These data completely define the structure of sesquilignan 51. According to the 
structure, the analysis of NOESY spectrum evidences NOEs of the methoxyls at δ 3.80-
3.84 with  H-2, H-6, H-2’, H-6’ and H-2”, H-6” and methoxyl at δ 3.77 with H-7”. The 
threo relative configuration and the positive CD curve in the 210-260 nm range agrees 
with 7”S, 8”S configuration.  
Compounds 1, 4 , 21, 28 and  29 already described as metabolic products of  Brassica 
fruticulosa and Malva silvestris, have been also found in Chenopodium album.  
Compound 52  has been identified as an amidic compound constituted by a dopamine 
unit linked to a cinnamic acid derivative. It is known as N-trans-feruloyl 4’-O-
methyldopamine, isolated previously by Horio et al. (1993).  
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The 13C NMR shows nineteen signals that are attributed to two aromatic rings, a 
carbonyl of an α, β-unsaturated system, an ethylic chain, two methoxyls.  The  1H NMR 
shows the two rings as trisubstituted, having the protons coupled in a ABX spin system. 
H-7/ H-8 coupling defines the trans geometry of the double bond. Positions occupied by 
the two methoxy groups on the rings are defined by a NOESY experiment that shows 
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cross-peaks between the methoxy protons and the two protons H-2 and H-5’, 
respectively.    
Spectroscopic analysis of compound 53 has led to its identification as N-trans-feruloyl 
3’-O-methyldopamin. This compound has already been isolated from Spinacia oleracea 
(Suzuki et al., 1981). Molecular formula  C19H21O5N is assigned from the molecular ion 
peak at m/z 343. The 1H NMR spectrum defines the presence of two aromatic rings, 
each having three protons of an ABX spin system. Two protons resonate as doublets at   
δ 7.44 and 6.41 with a coupling constant indicative of a trans double bond. Two triplets 
at δ 3.49 (2H, t, J=7.1 Hz, H-8’) and  2.77 (2H, t, J=7.1, H-7’) define the presence of an 
ethlylic side chain. An HMQC experiment allows the protons to be assigned to the 
corresponding carbons. The 13C NMR experiment shows the signal of a carbonyl carbon 
at δ 169.2 , which in an HMBC experiment is heterocorrelated to protons H-7, H-8. 
Long-range couplings also allow the methoxyl positions to be assigned.  
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Compound 54 has the molecular ion peak of a EI-MS spectrum at m/z 313, which is 
indicative of the molecular formula C18H19O4N. The 1H NMR spectrum shows the 
signals of two aromatic rings having protons coupled in a ABX and an AA’XX’ spin 
system, respectively. The 1H1H COSY spectrum correlates the signals of the  olefinic 
proton H-7 to H-8, and of the two protons of the methylene group H-7’ to the two H-8’. 
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Spectral data reveal the presence of one methoxyl group assigned through an HMBC 
experiment to position C-3. Long-range heteronuclear correlations also indicate the 
presence of an α-β unsaturated system. These data agree with the ones reported by 
Hussain et al. (1982) for the N-trans-feruloyl tyramine isolated from Hypecoum sp. 
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Compound 55 has a molecular ion peak at  m/z 371  in a EI MS spectrum. This value 
suggests a molecular formula C21H25O5N. 13C NMR shows 17 signals that NMR 
experiments assign to two aromatic rings, an olefinic bond, an ethylic chain, a carbonyl 
and four methoxy groups.  The two aromatic rings are defined as 1,2,4 trisubstituted on 
the basis of an  1H NMR experiment, besides functional groups correlation derives from 
an HMBC experiment, which also leads to the assignment of methoxyl positions. All 
these data allow compound 55 to be identified as N-trans-4-O-methylferuloyl 3’,4’-O-
dimethyldopamine, which has been described already by Adesina et al. (1989) in their 
studies of Zanthoxylum rubescens. 
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Table 6.  13C NMR data of 52-58 
C 52 b 53a 54a 55b 56a 57c 58 b 
1 127.3 128.3 122.7 127.7 128.2 126.7 127.8 
2 109.7 111.6 111.0 109.5 111.5 109.8 109.5 
3 146.8 149.9 149.3 149.1 149.9 147.2 149.1 
4 145.4 149.0 148.7 150.5 147.6 147.6 150.5 
5 114.8 116.5 116.0 111.0 116.5 114.9 111.0 
6 122.1 123.2 127.8 121.9 123.2 121.8 122.0 
7 141.1 142.0 141.6 140.9 142.0 140.7 140.9 
8 118.2 118.8 118.2 118.4 118.7 117.5 118.5 
9 166.4 169.2 168.7 166.1 169.2 167.0 166.1 
1’ 132.1 132.1 130.8 131.4 133.5 111.9 132.1 
2’ 115.0 113.5 130.3 111.9 113.0 122.2 114.9 
3’ 145.4 149.3 115.8 149.1 149.3 111.1 145.7 
4’ 145.7 146.1 156.0 147.7 147.5 118.7 145.3 
5’ 110.9 116.2 115.8 111.3 116.4 121.4 110.9 
6’ 120.2 122.3 130.3 120.6 120.9 118.1 120.2 
7’ 34.9 36.2 35.9 35.1 36.0 24.9 35.0 
8’ 40.8 42.5 42.1 40.8 42.4 39.7 40.8 
1a’      127.1  
3a’      136.2  
3-OMe 55.9 56.4 55.9 55.9  55.4 55.9 
4-OMe    55.9 56.5  55.9 
3’-OMe  56.4  55.9 56.5   
4’-OMe 56.0   55.9   55.9 
aCD3OD     bCDCl3  cCDCl3:CD3OD (4:1). 
 
Compound 56 in a 1H NMR experiment has the signals of two aromatic rings 1,2,4 
trisubstituted and of an olefinic bond with a trans geometry. The signals of two triplets 
integrated for two protons are indicative of an ethylic chain.  
Two methoxy groups resonating at δ 3.83 and 3.89 are also present. The molecular 
formula deduced from the molecular ion peak, in a EI MS spectrum, at m/z 343, is 
C21H25O5N. In the 13C NMR spectrum the carbonylic function resonates  at δ 169.2. 
Substituent positions derived from HMBC and NOESY experiments. This compound is 
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identified as N-trans-4-O-methylcaffeoyl 3’-O-methyldopamine. It is the first time this 
compound has been isolated from natural sources, though it has already been 
synthesized by Tanaka et al. (1989). 
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Compound 57 is defined to be N-trans-feruloyl tryptamine. This compound has been 
previously obtained by synthesis (Ehmann,1974), but it is reported for the first time as 
natural compound. The molecular formula deduced from the EI-MS (m/z 336 [M]+)   is 
C20H20O3N2. The 13C NMR has 20 signals, which are indicative of a tryptaminic system, 
a carbonyl belonging to an α,β unsaturated group, an aromatic ring, and a methoxyl. 
The signal at δ 39.7 is attributed through a DEPT experiment to a methylene carbon (C-
8’), whose protons, correlated in an HMQC experiment, resonate at δ
 
3.56. The 1H1H 
COSY experiment shows H-8’ correlated to H-7’ (δH 2.92), while in a HMBC 
experiment the same H-8’ give cross-peaks with C-1’ and C-9. Long-range correlations 
are also observed between H-7’ with C-1’ and C-1’a. 
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The indolic system resonates in the 1H NMR spectrum in the aromatic range δ 6.90-7.70 
overlapping the aromatic ring signals. HSQC and 1H1H COSY experiments allow 
proton resonances in this area to be assigned. The cross-peak between 3-OMe protons 
and H-2 in the NOESY experiment confirms methoxyl position. 
Compound 58 has been identified as N-trans-4-O-methylferuloyl 3’-O-
methyldopamine. It has been isolated for the first time. Its molecular formula is 
C20H23NO5 according to the molecular ion at m/z 357 in its EI MS spectrum. The 13C 
NMR spectrum (Table 6) shows the presence of only eighteen signals, with the methyls 
of three methoxyl groups having the same chemical shift.   
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The DEPT experiment defines the carbons as three methyls, two methylenes, eight 
methines and seven quaternary carbons. In the 1H NMR spectrum the H-2', H-5' and H-
6' protons of the dopamine moiety are present as a narrow doublet, a large doublet and a 
double doublet at δ 6.84d, 6.86d and 6.76dd respectively, while the H-2, H-5 and H-6 
protons of the ferulic moiety are at δ 7.06d, 6.90d and 7.11dd, respectively. Furthermore, 
the spectrum shows the H-7' and H-8' methylenes as two triplets at δ 2.79 and 3.62, 
respectively, and the H-7 and H-8 olefinic protons as two doublets at δ 7.60 and 6.25.  
According to the structure, in a NOE experiment, the protons of the methoxyl group at δ 
3.88 relate with the proton doublet at δ 6.84,  and the protons of the methoxyls at δ 3.90 
relate with the protons doublets at δ 7.06 and 6.90. Finally the HMBC experiment 
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evidences the following correlations: H-2' with C-4', H-5' with C-1' and C-3', H-6' with 
C-4' and C-7', H-8' with C-1', H-2 with C-4, H-5 with C-1 and C-3, H-6 with C-4 and C-
7, H-7 with C-9 and, H-8 with C-1.  
Compound 59 has been isolated for the first time. The name assigned is Chenoalbicin. It 
has a molecular formula C36H34N2O7 in accordance with the molecular ion at m/z 645 
[M+ K]+ in its MALDI/MS spectrum. The 13C NMR spectrum (Table 7) shows the 
presence of only thirty-one signals, including nineteen different aromatic carbons 
instead of the expected twenty-four signals. A close inspection of the 1H and 13C NMR 
spectra of  59 (Table 7) by DEPT and HSQC experiments reveals the presence of the 
following functionalities: two carbonyl groups, four secondary sp3-carbons (C-7’, C-8’, 
C-5” and C-6”), two aliphatic methines (C-13” and C-13a”), two methyls (3-OMe and 
4’-OMe), two methines (C-7 and C-8) of an olefine group, three trisubstituted and one 
disubstituted aromatic rings (C-1–C-6; C-1’–C-6’; C-9”–C-12”, C-8a”, C12a” and C-
1”–C-4”, C-4a”, C-1a”). The connection between these functional groups, determined 
on the basis of 1H1H COSY and HMBC correlations (Table 7), justifies the carbon 
skeleton of 59. The protons at δ 7.11 and 7.02 are attributed to the H-2 and H-6 protons 
owing to the heterocorrelations with the C-7 carbon in a HMBC spectrum. 
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The protons at δ 6.75 and 7.06 are attributed to H-2’ and H-6’ on the basis of the 
heterocorrelations long-range with the C-1’ and C-7’. The H-2’ gives also cross peaks 
with the C-3’ and C-4’ and C-3’ is also correlated to the H-5’ and H-13” at δ 6.72 and 
5.89, respectively. The H-13” is heterocorrelated to the C-8”, C-12”, C-1a” and C-8a” 
carbons of the alkaloid unit. The proton at δ 4.14, attributed to H-13a”, gives 
correlations with C-8”, C-6” and C-13”. Finally the C-11” and  C-8a” carbons give 
cross peaks with the H-12” and H-9”.  The coupling constant of 8.0 Hz between the H-
13” and H-13a” protons is consistent with a dihedral angle of about 0° or 145°. The 
minimized structures corresponding to relative cis and trans configurations at H-13” 
and H-13a” protons, obtained by MM2 calculations (Allinger et al. 1980) generate 
dihedral angles of  45° and 175° respectively. These values correspond  to 4.0 and 9.5 
Hz couplings, respectively. Consequently, the measured value is compatible with a 
trans relative configuration. In accordance with this hypothesis, an analysis of the 
NOESY (fig. 7) spectrum evidences a NOE between 4’-OMe and H-13a”. The zero 
value of [α]D25 indicates that the compound is a racemic mixture. 
 
 
fig. 7. Selected NOEs of 59. 
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Table 7. NMR Spectral Data of Compound 59 in CD3OD 
Position δHa) NOESY δC HMBC (C)b) 
1   131.4 (q)c)  
2 7.11 (d, 1.1) MeO-3, 7, 8  113.4 (t) 3, 4, 7 
3   151.4 (q)  
4   146.2 (q)  
5 6.74   116.8 (t)  
6 7.02 (d, 8.5)  130.6 (t) 1 
7 7.43 (d, 15.5) 2, 6 141.8 (t) 2, 9 
8 6.38 (d, 15.5) 2, 6 119.4 (t) 9 
9   169.4 (q)  
1'   130.4 (q)  
2' 6.75   116.7 (t)  
3'   157.3 (q)  
4'   149.4 (q)  
5' 6.72  116.8 (t)  
6' 7.06 (d, 8.0)  130.6 (t)  
7' 2.76  2', 6' 36.0 (s)  
8' 3.45  42.4 (s)  
MeO-3 3.89 s 2 57.0 (p)  
MeO-4' 3.82 s 5', 12'', 13a'' 56.5 (p)  
1'' 6.76  116.7 (t)  
2'' 6.79                                 120.3 (t)  
3'' 6.75  118.3 (t)  
4'' 7.02 (d, 8.5) 5'' 130.6 (t)  
5'' 2.75 m 4''    35.7 (s)  
6'' 3.54 (dd, 13.2, 6.3); 3.45 
(dd, 13.2,  6.8) 
 42.8 (s)  
8''   172.9 (q)  
9'' 7.06 (d, 8.0)  130.7 (t)  
10'' 6.74  116.7 (t)  
11''   148.2 (q)  
12'' 6.91 (d, 1.2)  110.6 (q) 11'', 13'', 8a'' 
13'' 5.89 (d, 8.0) 12 ''  90.0 (s) 8'', 1a'', 12'', 8a'' 
1a''   129.6 (q)  
4a''   131.2 (q)  
8a''   120.4 (q)  
12a''   132.9 (q)  
13a'' 4.14 (d, 8.0) 1'', MeO-4' 59.0 (s) 8'', 13'' 
 
a)
 
1H chemical shift values (δ ppm from SiMe4) followed by multiplicity and then the   coupling constants (J in Hz). b) 
HMBC correlations from H to C.c) Letters, p, s, t and q, in parentheses indicate, respectively, the primary, secondary, 
tertiary and quaternary carbons, assigned by DEPT. 
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Compound 60 has been isolated for the first time. It shows an absorption maximum at 
329 nm, suggesting the presence of a carotenal type chromophore (Britton et al. 1995). 
The molecular formula is determined as C18H26O2 by EI MS. Of the two oxygen 
functions, one is ascribed to a secondary hydroxyl group (δH 4.26, δC 65.8) and the 
remaining one is attributed to a carbonyl group (δC 198.6), on the basis of  1H NMR and 
13C NMR data. The structure of 60 is established by using 1H NMR and 13C NMR 
including COSY, ROESY, HMQC, and HMBC experiments. The 1H1H COSY 
experiment shows a correlation series beginning with the olefinic methine at δ 5.58, 
assigned to H-4, which is coupled with a carbinol methine at δ 4.26 (H-3) that is also 
coupled with two double doublets at δ 1.84 and 1.40 assigned to the H-2 methylene. 
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The proton signal at δ 6.20 assigned to H-8 is correlated with the H-7 proton  (δ 5.69), 
which is coupled with the proton at δ 2.44  (H-6). The double doublet at δ 7.58, 
assigned to H-11 is correlated with H-12 and H-10 at δ 6.20 and 6.18 respectively. Five 
singlet methyls are also present in the 1H NMR spectrum. ROESY correlations 15-
CH3/H-6, 16-CH3/H-3 and H-7, 17-CH3/H-4 and H-8 revealed the stereo structure of 60 
as shown in figure 8. The CD spectrum showed a positive Cotton effect (∆ε330.0 +12.0), 
which establishes C-6 configuration as R (Harada et al. 1983). Therefore, the structure 
of 60 has been deduced to be (3R,6R,7E,9E,11E)-3-hydroxy-13-apo-α-caroten-13-one.  
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fig.8. Selected NOE interactions of compound 60 
 
Compound 61 shows an absorption maximum at 323 nm. The molecular formula has 
been determined as C18H24O3 by EIMS. Of the three oxygen functions, one is ascribed 
to a tertiary hydroxyl group (δC 80.1) and the remaining two are attributed to carbonyl 
groups (δC 198.4). The partial structure of the 3-oxo-α-end group and the polyene chain 
in 61 are characterized by 1H NMR and 13C NMR including COSY, ROESY, HMQC, 
and HMBC experiments. Present in the 1H NMR spectrum of 61 were five methyls as 
singlets, two aliphatic protons as douplets, and six olefinic protons  as one singlet, four 
doublets and one double doublet. The 1H1H COSY experiment shows correlation of the 
olefinic methine at δ 5.96, assigned to H-7, and with H-8 at δ 6.47. The double doublet 
at δ 7.55, assigned to H-11 is correlated with H-10 and H-12 at δ 6.26 and 6.24 
respectively. The 13C NMR spectrum shows 16 carbon signals, identified, by a DEPT 
experiment, as five methyls, one methylene, eight olefinic carbons, two of them 
tetrasubstituted, two quaternary carbons and two carbonyls. All the carbons are 
correlated to the corresponding protons on the basis of an HMQC experiment. The 
tertiary hydroxyl group is positioned at C-6 on the basis of an HMBC experiment that 
shows correlations between C-6 and the  H-7, H-8, H-15, H-16, and H-17 protons. The 
CD spectrum shows a positive Cotton effect, ∆ε320.0 +43.0, suggesting C-6 has the S 
configuration (Harada 1983). Furthermore, ROESY correlations 15-CH3/H-7, 16-
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CH3/H-2eq and H-7, 17-CH3/H-4 and H-8 confirm the stereo structure of 61. Therefore, 
the structure of 61 is deduced to be (6S,7E,9E,11E)-3-oxo-13-apo-α-caroten-13-one, 
never reported previously.  
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Compound 62 has been identified as S-(+)-abscisic alcohol The molecular formula 
assigned to compound 62 is C15H22O3 and is derived from the molecular ion peak in a 
EI MS at m/z 250 [M]+ (80), which also shows the signal at m/z 235 ([M-Me]+). The 1H 
NMR spectrum shows two large doublets at δ 6.34 and 7.74 (J=15.5 Hz) integrated for 
two protons, which are assigned to an olefinic systems. The singlet at δ 5.92 is also 
attributed to a trisubstituted double bond, and the proton H-10 resonates at δ 5.73. The 
large singlet integrated for two protons at δ 4.35 is indicative of a methylene  
functionalized by an hydroxyl. Finally the two large doublets at δ 2.27 and 2.45 (J=16.6 
Hz) are the geminal protons of a cyclohexane. This structure is confirmed by 
comparison with previously reported spectroscopic data (Lunz et al., 1992). Literature 
data also defines the configuration of the chiral centre, by considering  the measured 
value of  [α]D 25 +210.   
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The spectral data of  compounds 63-65 indicate the presence of an allenic group in these 
molecules. The 1H NMR spectra present the olefinic proton at δ 5.84, 5.85 and 5.97, 
respectively, and in each 13C NMR spectrum two sp2 and one sp carbons are present. 
The data of compound 63 well match those of grosshopper ketone isolated from ant-
repellant secretions of a large flightless grasshopper, Romalea microptera (Shiraga et 
al., 1988). The isomeric 64 and 65 have been identified by comparison with previously 
reported spectroscopic data of the synthetic allenic zeaxanthin end group (Hlubucek et 
al., 1974 and Baumeler et al., 1990). Absolute stereochemistry for each compound is 
assigned through the measured [α]D 25 values, by comparison with literature data. 
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Compound 66 has been identified as (3R,6R,7E)-3-hydroxy-4,7-megastigmadien-9-one. 
The 1H NMR spectrum shows the signals of three protons on unsaturated systems, two 
of them disposed in the trans geometry of a double bond (J=15.5 Hz). The multiplet at δ 
4.27 is of an alcoholic methine, which correlates in a 1H1H COSY experiment to two 
protons geminally coupled on a cyclohexane ring and to an olefinic proton. The 
spectrum also presents the signals of four  singlets attributed to four methyls. The CD 
spectrum shows a positive Cotton effect (∆ε293nm = +24), establishing the C-6 
configuration as R. The [α]D25 measurement compared to literature values, defines the R 
configuration at C-3 (D’Abrosca et al.,  2004). 
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Structurally related to the last compound but having a lower oxidation state is 
compound 67, identified as (3R,6R,7E,9R)-3,9-dihydroxy-4,7-megastigmadiene. Its 
structural characterisation has been realized through the 1H NMR data, which perfectly 
match previously reported results (D’Abrosca et al., 2004). The two double doublets at 
δ 5.59 and 5.38 are assigned to the protons of the olefine system, H-8 and H-7, 
respectively.  
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The first is correlated in a 1H1H COSY experiment to H-9 (δH 4.33), whose complex 
multiplicity is due to the coupling with the adjacent methyl protons H-10 (δH 1.28). The 
remaining broad singlet due to an olefinic proton at δ 5.52 is attributed to H-4, which is 
coupled to H-3 at δ 4.21. The double doublet at δ 1.82 (J=13.5 and 5.8 Hz) is due to the 
H-2 proton in pseudo-axial position, while H-2eq. resonates as a doublet at δ 1.36 
(J=13.5 and 6.3 Hz). The four mehtyls give resonances at δ 1.28, 1.61, 0.99 and 0.84. A 
NOESY experiment confirms the relative configuration from the cross peaks between 
H-3 and H-7, H-8 (figure 9). The absolute configuration is defined by comparison of the 
measured [α]D25 with literature values.  
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fig. 9- Selected NOE of compound 67. 
 
The oxidation of the hydroxy-functions in 3 and 9 of compound 67 gives compound 68 
that has been identified as   (6R,7E)-4,7-megastigmadien-3,9-dione. The double doublet 
at δ 6.68 is due to the olefinic proton H-7, while H-8 resonates as a doublet at δ 6.17. 
The singlet at δ 5.99 is attributed to the proton H-4, while H-2 protons resonate at δ 2.70 
and 2.18 as doublets. Comparison with literature data (Behr et al. 1985) confirms the 
characterisation described and defines the absolute streochemistry. 
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Compound 69 is defined as (6R,9R)-9-hydroxy-4-megastigmen-3-one through its 
spectral data. The 13C NMR spectrum defines the presence of an α,β-unsaturated system 
(δC 199.6/C-3, 125.1/C-4, 165.8/C-5) and of a carbinol carbon (δC 68.0), four methyls 
(δC 24.6, 28.8, 27.2 and 23.7), three methylenes (δC 26.2, 38.6, 47.1) and a methine (δC 
51.1).  
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In the 1H NMR spectrum two methylene protons resonate as two large doublets at δH 
2.39 and 2.04, while the two remaining methylenes resonate in the range δΗ 1.00-1.90. 
An olefinic proton resonates as a singlet at δH 5.84. The four methyl resonances are at 
1.99 (H-13), 1.21 (H-10), 1.07  (H-11) and 1.02 (H-12). Previously reported data 
confirm the described structure (D’Abrosca et al. 2004). 
Compound 70 has been identified as 3,9-dihydroxy-4-megastigmene. The 13C  NMR 
shows the presence of an olefinic system that a DEPT experiment settles as consisting 
of a quaternary carbon and a methine.  
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The methine proton resonates at δ 5.38 and it is correlated by an 1H1H COSY 
experiment to a proton at δ 4.28, assigned to H-3. The latter is also coupled to H-2 
protons at δ 1.82 and 1.36. The 1H1H COSY experiment also defines the presence of a 
C-4 side chain. Comparison with literature data confirms the assigned structure 
(Prestwich et al.,1976).    
Spectral data of  compound 71 identify it as 4-megastigmen-3,9-dione. The 13C NMR 
spectrum shows the signals of  two carbonyl carbons at δ 207.0 and 199.1. The latter is 
conjugated to a double bond, whose carbons resonate at δ 125.6 and 164.8. Three 
methylenes are also present, two of them are mutually coupled in a C-2 alkanic chain as 
it is shown in a  1H1H COSY experiment. This experiment also highlights the 
correlation of the H-7 protons to H-6, which  resonates at δ 1.74. An  HMBC 
experiment confirms the assigned carbon skeleton (Aasen et al. 1974 and D’Arcj 1997).     
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Compound 72 has been identified as 3,6,9-trihydroxy-4-megastigmene. The  13C NMR 
spectrum shows the signals of two olefinic carbons and three carbinols. Three 
methylenes and four methyls are also present. In the 1H NMR spectrum the two signals 
at δ 4.10 and 3.65 are attributed to H-3 and H-9, respectively. The proton H-3 is coupled 
in a 1H1H COSY experiment to the olefinic proton at δ 5.35 and the two H-2 protons at 
δ 1.40 and 1.53. Proton H-9, instead, correlates to H-8 protons distributed in the 
chemical shift range δ 1.20-1.25, and H-10 (δH 1.15). The H-8 protons are also 
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correlated to the protons resonating in the chemical  shift range δ 1.47-1.53, attributed 
to H-7. C-3 and C-6 resonances define hydroxyl positions. Literature data agrees 
perfectly with the assigned structure (Straus et al., 1986). 
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Compound 73 has been identified as (6Z,9S)-9-hydroxy-4,6-megastigmadien-3-one, 
previously obtained by reduction of dehydroionone (D’Abrosca et al., 2004). The four 
olefinic carbons resonate at δ 129.0, 144.6, 155.9 and 126.6 (C4, C-5, C-6, C-7 
respectively), while corresponding protons, correlated through an HSQC experiment, 
resonate at δ 5.92 (H-4), and 5.74 (H-7). Proton H-7 appears in a 1H NMR spectrum as 
a triplet, because of its coupling to the adjacent H-8 protons, as it is shown by the 1H1H 
COSY experiment. The same experiment shows H-8 protons correlated to the carbinol 
proton H-9, which also gives cross-peaks with H-10 (δ 1.25, d, J=6.0 Hz). The singlet 
integrated for two protons at  δ 2.30 is due to H-2 protons. Methyls resonate at δ 2.23 
(H-13), 1.25 (H-10), 1.18 (H-11 and H-12).   
 
OH
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Nor-terpenes 14, 16, 33 and 34, already isolated from Brassica fruticulosa and Malva 
silvestris, have also been found  in Chenopodium album extracts. 
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BIOASSAYS 
 
The chemical analysis of the three Mediterranean plants has lead to the isolation of  
secondary metabolites having different structures and biogenetic origins. In particular 
there have been isolated: seven lignans (1-5, 47, 48),  four neolignans (6-10), five 
sesquilignans (12, 13, 49-51), one dilignan (11), eight C-13 nor-terpenes (14-18, 33-35), 
three degraded carotenoids (60-62), two monoterpenes (30, 31), one sesquiterpenes 
(32), one diterpenes (36), nineteen phenol derivatives (19-29, 37-44), one triptammine 
(46), one benzaldeid derivative (45), three allenes (64-66) and eight cinnamic amides 
(52-59).  
Some of the isolated compounds have been tested on seeds of standard plants to 
evaluate their biological activity. The assays have been run in accordance with the 
procedures optimised by Macias et al. (2000). The results are reported by grouping the 
molecules for structure similarities and common biogenetic origins.  
Lignans, neolignans, sesquilignans and dilignans biogenetically derive from the 
oxidative coupling of phenylpropanoic units through radicalic processes. The 
phenylpropanoic units are in turn biosynthesized along the shikimic acid pathway.  
Cinnamic amides are constituted by a unit of cinnamic acid bonded through an amidic 
link to a dopamminic unit. The two aromatic groups constituting the molecules are both 
derived from the shikimic acid pathway. The phenolic, triptamminic and benzaldeidic 
derivatives originated from the same  metabolic path. Nor-terpenes, monoterpenes, 
sesquiterpenes, diterpenes, carotenoids and allenes are all terpenoids originating from  
the mevalonic acid pathway.  
Obtained data are shown as percentage differences of germination, root elongation and 
shoot elongation from the control. 
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Phytotoxic activity of  lignans, neolignans, sesquilignans and dilignans. 
 
Compounds 1-13, except compound 9, isolated from B. fruticulosa have been tested on 
two dicotyledons, Lactuca sativa L (lettuce) and Lycopersicon esculentum M. (tomato), 
and on the monocotyledon Allium cepa L. (onion), to evaluate the inhibitory or 
stimulatory effects on germination and seedling growth. The results are reported as 
percentage differences of germination (figure 10), root elongation (figure 11) and shoot 
elongation (figure 12) from the control. The most relevant effect observed is a strong 
inhibition of germination of L. sativa produced by compounds 2-4, 6, 7, 11 and 13 
(figure 10A). Lignan 4 is the most active and retains 75% inhibition at the lower 
concentration (10-9 M). Also the lignans 2 and 3 are toxic and showed 50%  inhibition at 
10-9 M. Among the neolignans, compounds 6 and 7 have inhibitory effects: 
dehydroconiferyl alcohol (6) shows about the 70% inhibition at all the tested 
concentrations.  The dilignan 11 and the sesquilignans 12 and 13 are also active on the 
lettuce germination. The effects on the germination of L. esculentum and A. cepa are not 
particularly notable (figure 10B and 10C). The root length of the dicotyledon species 
shows similar trends but the effects are weak. All the compounds have a light 
stimulatory effect on the onions, with the exception of the lignan 2 (figure 11). The 
shoot elongation of the three test species have a variable behaviour within the 25-30% 
of the stimulatory or inhibitory effect (figure 12). In conclusion, compounds 2-4, 6, 11 
and 13 are the most active products for inhibiting lettuce germination and their 
inhibiting activity is retained also at 1 nM concentration. The high values of inhibiting 
activity due to compounds 2, 4 and 6, suggests their potential use as natural herbicides. 
Therefore, these three natural compounds have been compared with two commercial 
herbicides widely used in agriculture, Pendimethalin and Glyfosate. The first is a pre-
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emergence pesticide, while the second is a broad spectrum, post-emergence herbicide.  
The results, reported in figure 13 show greater phytotoxic activity on lettuce 
germination of compounds 4 and 6 in respect to the pesticides. Both the lignans reveal 
over 70% inhibition also at 1 nM concentration (figure 13A). Compound 2 is less active 
than Pendimethalin but more toxic than Glyfosate, especially at the lower 
concentrations (10-8 and 10-9 M). The root length is slightly affected by the natural 
tested compounds in respect to the pesticides, as reported in figure 13B.  The shoot 
length is stimulated by lignans, and they show effects comparable to those of 
Pendimethalin (figure 13C). Literature data reported that this herbicide acts as an 
inhibitor for cell division and elongation (Hess et al. 1997 and Richard et al. 1999). 
Furthermore, studies on the alga Protosiphon botryoides indicated that growth rate, cell 
number, chlorophyll level and dry weight decrease with increasing Pendimethalin 
concentration (Shabana et al. 2001). The variety of biological activities displayed by 
lignans is remarkable and antitumor, antimitotic antiviral and other activities are widely 
reported in the literature (Macrae et al. 1993). Not much evidence is reported for their 
germination inhibitory activity. Szabo and Garay (1970) reported that the lariciresinol-
O-glucoside and some monoepoxylignans (Lavie et al. 1974 and Yoshihara et al.1982) 
show germination inhibition. Recently, Rimando et al. (1999), have reported the 
isolation of phytotoxic furofuran lignans from Leucophyllum frutescens. The results 
indicated that diastereoisomeric compounds have different inhibitory activities on L. 
sativa and A. cepa. Furthermore, Oliva et al. (2002) have reported the phytotoxic 
activity of some aryltetralin lignans from plants of the genus Podophyllum on lettuce, 
onion, and rye. The results of the phytotoxic activity of the lignans from B. fruticulosa 
confirm their potential phytotoxic role and the relative natural abundances of these 
metabolites suggest their potential use as selective natural pesticides. 
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figure 10. Effect of compounds 1-8, 10-13 on germination of Lactuca sativa L.  (A), Lycopersicon 
esculentum (B), and Allium cepa (C). Values presented as percentage differences from control. 
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figure 11. Effect of compounds 1-8, 10-13 on root length of Lactuca sativa L.  (A), 
Lycopersicon esculentum (B), and Allium cepa (C). Values presented as percentage 
differences from control. 
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figure 12. Effect of compounds 1-8, 10-13 on shoot length of Lactuca sativa L.  
(A), Lycopersicon esculentum (B), and Allium cepa (C). Values presented as 
percentage differences from control. 
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figure 13. Effect of compounds 2, 4, 6 on  germination of Lactuca sativa L.  (A), Lycopersicon 
esculentum (B), and Allium cepa (C), compared to commercial herbicides Pendimethalin (P) 
and Glyfosate (G). Values presented as percentage differences from control. 
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Phytotoxic activity of nor-terpenes, monoterpenes, sesquiterpenes, diterpenes, 
carotenoids and allenes 
 
Some of the isolated terpenoids have been tested for their phytotoxicity on the seed of 
Lactuca sativa.  Aqueous solution of  14, 16, 17, 30-33, 35, 60-71, 73, ranging between 
10–4 and 10–7 M, have been tested on germination, root length and shoot length of 
treated lettuce seeds. 
Compounds 69 and 70, differing only for the oxidation state of C-3, show small effects 
on seed germination (figure 14A), which is at most 6%. Effects on root elongation are 
almost absent for compound 70 (12%) and completely absent for 69 (figure 14B). Both 
compounds inhibit shoot elongation by 10% (figure 14C). Slightly more significant are 
the effects of  71, 73  whose inhibiting activity on germination is 16% and 12% at 10-4 
M, respectively. Root and shoot elongation are inhibited  25% by compound 71.  
 The new apocarotenoids (60-61) reduce the germination by 20% at 10-4 M (figure 
15A). The structurally similar compound 62 almost completely inhibits (90%) lettuce 
germination at 10-4 M (figure 15A), and reaches 100% inhibitory effect on root and 
shoot elongation at this concentration (figure 15B and C). Among compounds 63-65, 
only the allene 65 reduces the shoot length  (30%) and root length (20%) at 10-7 M 
(figure 15C and B) , while they do not affect seed  germination. 
Compounds 14  and 67 differing for the oxidation state of C-3  have almost no effects 
on seed germination (at most 6% at 10-6 M for 67) (figure 16A), and a bare effect on 
root and shoot length (figure 16B and C). Compounds 16 and 33 are slightly more 
active, inhibiting germination by 16% and 10% respectively, at 10-3 M (figure 16A). 
Bioactivity of compounds 66 and 68 is more intense. They inhibit germination by  30% 
( at 10-7M) and 33% ( at 10-4M), respectively (figure 16A).    
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Compounds 17, 31 and 35 do not show any significant activity on either germination or 
seed growth (figure 17). Compound 32 instead has a satisfactory action on germination 
(45% at 10-6 M) (figure 17A), while it shows almost no action on root and shoot growth 
(figure 17 B and C). Compound 30 is the most bioactive, inhibiting germination by 
90% at 10-4 M  (figure 17A). 
Bioactivity of the isolated terpenoids shows a variable response on the tested specie and 
for some compounds no dose dependence effects are observed. The reason for this 
response may be due to differences in seed size, seed coat permeability, differential 
uptake and metabolism (Macias et al. 1997).  
Inhibitory power showed by bioactive compounds is comparable to that of 4-
hydroxybenzoic acid, which is known to be an effective germinator inhibitor (Cutillo et 
al. 2003). 
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figure 14- Effects on Lactuca sativa germination, root elongation and shoot elongation of 
compounds 69-73. 
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figure 15- Effects on Lactuca sativa germination, root elongation and shoot elongation of 
compounds 60-65. 
 
 134 
A
-35
-30
-25
-20
-15
-10
-5
0
5
%
 
ge
rm
in
at
io
n
14 16 33 66 67 68
compounds
 
B
-35,0
-30,0
-25,0
-20,0
-15,0
-10,0
-5,0
0,0
5,0
10,0
15,0
%
 
ro
o
t e
lo
n
ga
tio
n
14 16 33 66 67 68
compounds
 
C
-35,0
-30,0
-25,0
-20,0
-15,0
-10,0
-5,0
0,0
5,0
10,0
%
 
sh
o
o
t e
lo
n
ga
tio
n
14 16 33 66 67 68
compounds
10(-4) 10(-5) 10(-6) 10(-7)
 
figure 16- Effects on Lactuca sativa germination, root elongation and shoot elongation of 
compounds 14, 16, 33, 66-68. 
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figure 17- Effects on Lactuca sativa germination, root elongation and shoot elongation of 
compounds 17, 30-32, 35. 
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Phytotoxic activity of cinnamic amides and Chenoalbicin 
 
The seven amides 52-58 have been tested on lettuce, tomato and onion to evaluate the 
effects on germination and seedling growth. Compounds 53, 55-58 cause about 15% 
inhibition on the germination of lettuce in the tested concentration range and no dose 
dependence effects have been observed (figure 18A).  
Compound 52 is not active, while compound 54 causes 45% inhibition at the highest 
concentration tested. Comparable effects have also been found on tomato (figure 18B). 
The responses on onion germination are different: compounds 53, 56 show inhibitory 
effects, compounds 57, 58 are inactive and compounds 52, 54 stimulate the germination 
(figure 18C).  
The effects of amides on the root length of dicotyledons are quite small (figures 19A 
and 19B). At 10-4 M concentration about 15% inhibition is observed on lettuce, while 
on tomato only compounds 54, 55 and 57 cause the same inhibition. On the contrary the 
root length of onion is stimulated by amides, with exception of 56 which causes 50% 
reduction at 10-5 M (figure 19C).   
The compounds stimulate the shoot length of lettuce, while tomato response is the 
opposite with exception of compound 55 (figures 20A and 20B). Onion shoot length is 
inhibited by the compounds at all concentrations tested (figure 20C). Bioactivity of 
cinnamic acid amides varies with the tested species and for some compounds no dose 
dependence effects has been observed.   
Also for compounds 52-58 a bioactivity comparison was conducted with 4-
hydroxybenzoic acid, which is recognized to be an effective herbicide (Sebeson et al. 
1969 and Mizutani 1999). Data are reported in figure 18. 
 137 
 The inhibition value at 10-4 M on lettuce for 4-hydroxybenzoic acid is comparable to 
that of amides 53, 57 and 58 but lower for 54.  The effects on tomato at the highest 
concentration tested are about the same as for compounds 57 and 58, while amide 54 
results six-fold more toxic than the control. Anti-germination effects on onion are 
higher for 4-hydroxybenzoic acid than for amides.  
 
 138 
-50
-40
-30
-20
-10
0
10
%
 
ge
rm
in
a
tio
n
52 53 54 55 56 57 58
compounds
A 10(-4) M 10(-5) M 10(-6) M 10(-7) M
 
-70
-60
-50
-40
-30
-20
-10
0
10
%
 
ge
rm
in
at
io
n
52 53 54 55 56 57 58
compounds
B 10(-4) M 10(-5) M 10(-6) M 10(-7) M
 
-40
-30
-20
-10
0
10
20
30
%
 
ge
rm
in
at
io
n
52 53 54 55 56 57 58
compoundsC 10(-4) M 10(-5) M 10(-6) M 10(-7) M
 
 
figure 18- Effect of compounds 52-58 and pHBA (4-hydroxybenzoic acid) on germination of Lactuca sativa L.  
(A), Lycopersicon esculentum (B), and Allium cepa (C). Value presented as percentage differences from control. 
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figure 19 - Effect of compounds 52-58 on root length of Lactuca sativa L.  (A), Lycopersicon esculentum (B), 
and Allium cepa (C). Values presented as percentage differences from control. 
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figure 20 - Effect of compounds 52-58 on shoot length of Lactuca sativa L.  (A), Lycopersicon esculentum 
(B), and Allium cepa (C). Value presented as percentage differences from control . 
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Compound 59 has been tested on  Lactuca sativa L. (lettuce). Figure 21 reports the results on 
germination, root elongation and shoot elongation in a concentration range from 10-4 to 10-7 
M. Chenoalbicin shows a low inhibitory effect, about 15 %, on the seedling growth, while it is 
almost inactive on seed germination. The correspondent molecule without the alkaloid moiety 
(compound 53) is scarcely active as well (figure 20). 
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figure 21 - Effect of compounds 59 on germination, root length and shoot length of Lactuca sativa L.  
(A).Values presented as percentage differences from control. 
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Phytotoxic activity of phenolic  derivatives 
 
 Compounds 20-24, 29, 39, 40, 44  have been tested for their activity on the seeds of Lactuca 
sativa. Aqueous solutions of the compounds ranging between 10–4 and 10–7 M, have been 
tested for the germination, root length and shoot length of treated lettuce seeds (figure 22). 
Compounds 21, 28, 38, 39, 40 and 44 have been tested also at concentration 10-8 M and 10-9 
M. The p-methoxy-benzoic acid (20) reduces the germination by 20% at 10-4 M in respect to 
the control (figure 22A). Compound 21, differing from compound 23 for the relative position 
of the substituents on the ring, shows an inhibiting activity of 25% on germination, while 
compound 23  is inactive at all the tested concentrations. Compounds 28 and 38 inhibit 
germination by the 20% at concentrations 10-4 M and 10-7 M, respectively. Compounds 29, 39 
and 44  have a really weak effect on germination. Among the tested compounds only 20 has a 
strong effect of about 40% on root length, while 21, 28, 40 and 44 inhibit root growth by 
about 20% (figure 22B). Activity of 20- 25% on the shoot length at 10-4 M has been observed 
for compounds 20, 23, 28 and 29  in respect to the control (figure 22C). 
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figure 22 - Effect of compounds 20, 21, 23, 24, 28, 29, 38, 39, 40 and 44 on germination, root length and 
shoot length of Lactuca sativa L.  (A).Values presented as percentage differences from control. 
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CONCLUSIONS 
 
During the three years of my PhD studies three Mediterranean plants have been analysed, 
Brassica fruticulosa, Chenopodium album and Malva silvestris.  
Two different extracting procedures have been used to obtain plant-produced secondary 
metabolites. Brassica fruticulosa and Chenopodium album have been treated by  infusion 
procedure with an hydroalcoholic solution (10% MeOH/H2O)  and then methanol. Malva 
silvestris has been extracted by using an automatic extractor (extactor Naviglio) (Naviglio 
2003) that executes a series of working cycles of compression and decompression of the solid 
matrix, leading to metabolites release.  
The extracts obtained have been concentrated and fractionated by different chromatographic 
techniques (CC, TLC, HLPC, DCCC), while the structural characterisation of pure 
compounds has been performed by spectroscopic and spectrometric techniques (1H and 13C 
NMR, UV, IR, CD, ESI MS, MALDI MS, GC MS). 
The investigation of the three Mediterranean plants has led to the identification of: seven 
lignans (1-5, 47, 48), four neolignans (6-10), five sesquilignans (12, 13, 49-51), one dilignan 
(11), eight C-13 nor-terpenes (14-18, 33-35), three degraded carotenoids (60-62), two 
monoterpenes (30, 31), one sesquiterpene (32), one diterpene (36), nineteen phenol 
derivatives (19-29, 37-44), one triptammine (46), one benzaldeid derivative (45), three allenes 
(64-66) and eight cinnamic amides (52-59).  
The two neolignans 8 and 9, the sesquilignans 12 and 13, the dilignans 50 and 51, the 
cinnamic amide 58, the alkaloidic derivative of the cinnamic amide 59,  the norterpene 15, the 
two apo-carotenoids 60 and 61, the sesquiterpene 32 and the diterpene 36 have been isolated 
for the first time.  
Absolute stereochemistry of compounds 15, 16 and 36 has been defined through the 
application of  Mosher’s method (Othani et al. 1991).  
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Some of the isolated compounds have been tested on seeds of standard plants (Lactuca sativa 
L (lettuce), Lycopersicon esculentum M. (tomato), Allium cepa L. (onion)) to evaluate 
biological activity. The assays have been run in accordance with the procedures optimized by 
Macias et al. (2000).  
The results reported have shown a strong inhibiting effect of many lignans, which inhibit 
germination and growth of the standard species down to 1 nM concentration. At these 
concentrations commercial herbicides are usually inactive. Such a potent bioactivity for very 
diluted solution of lignans suggests further in vitro and in fields investigations, to fully 
evaluate the potential use of these molecules as natural herbicides.    
Monoterpene 30 is significantly bioactive, inhibiting germination of Lactuca sativa by 90% at 
10-4 M. Linalool is widely produced by  many plants and trees, which are used as commercial 
sources of this monoterpene, employed as fragrance in cosmetics and essential oils. Moreover 
linalool is a well-known insecticide, in fact it is a contact poison that heightens sensory nerve 
activity in insects, causing massive over-stimulation of motor nerves that leads to convulsion 
and paralysis. When applied topically to some laboratory animals, linalool can irritate the 
skin, eyes and mucous membranes. However, the symptoms are usually temporary, lasting 
from several hours to several days, and the animals usually recover their vital functions fully. 
Recent studies have proved the ecological role of linalool. Many plants producing linalool 
have been demonstrated to have an insect deterrent power. Aharoni et al. (2003) demonstrate 
that in choice assays aphids are deterred from Arabidopsis plants that constitutively produce 
high levels of linalool. Field experiments using wild tobacco species genetically modified for 
linalool overexpression (Kessler et al. 2001) show that linalool inhibits oviposition of moths. 
The results obtained on Lactuva sativa seeds suggest further investigation of linalool 
phytotoxic activity to fully understand the ecological role of this monoterpene and to evaluate 
its potential use as a herbicide. 
 146 
The phytotoxic data presented enlighten the role covered by plant-originated compounds in 
the research of new eco-compatible herbicides.  Natural substances still represent a fruitful 
field of investigation to detect unknown molecules having new structures and functionalities 
that evolution has refined for highly specific biological roles.  
This thesis has also led to the identification and structural characterisation of some molecules 
having a new interesting carbon skeleton, that might contribute to the complicated process of 
discovery and definition of natural substances. 
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FTICR: Fourier Transform Ion Cyclotron Resonance. Investigation upon the charge 
state, conformation and RS20 interaction  of Calmodulin.  
(Marie Curie project into the Improving Human Potential research programme).  
 
Introduction 
In the last forty years mass spectrometry has become one of the most used techniques for 
structural characterisation. The technique was born over a century ago, when the Nobel prize-
winning physicist J.J. Thomson created the first mass spectrometer. Early mass spectrometers 
were massive, arcane instruments capable of analyzing only small, stable, volatile compounds. 
Although these original machines bear little resemblance to today’s sophisticated models, the 
underlying principles are remarkably similar and simple. Then as now, molecules had to be 
vaporized in the vacuum of the mass spectrometer and then converted into charged ions. The 
ions, which may be broken into even smaller pieces called fragment ions, can be steered and 
focused by the magnetic, electrostatic, and radiofrequency fields used as lenses within the 
mass analyzer. The ionized molecule’s mass and charge together determine its trajectory.  
The improvement of the ionisation and analysing  procedures has widened the range of 
application of  mass spectrometry, and increased the information provided by a mass spectrum. 
The first ionisations techniques (EI, CI) only allowed the study of very volatile compounds, 
and did not assure molecules would not be broken in the process. With the incoming of soft 
ionisation instruments (FAB, MALDI, ESI) also high polar and labile molecules became good 
targets for spectrometric investigation. Even proteins that with the earlier ionization protocols 
were often destroyed before they could be effectively ionized, began to be manageable for 
focusing in a detectable spectrum. Since then, protein study has become one of the most 
successful fields of investigation by mass spectrometric techniques.  
A recent breakthrough that has further increased mass spectrometry potential is  the correlation 
between the number of charges that a macromolecule possesses and its three-dimensional 
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structure. In fact it is a commonly accepted assumption that the ESI ionisation allows a 
macromolecule such as a protein to be vaporised, while preserving the tertiary structure it has 
in solution (Gaskell et al. 1997). That implies the possibility of studying non-covalent 
complexes between proteins, or proteins and peptides in solution. The ESI ionisation allows 
the systematic study of enormous molecules to be performed, only by interfacing an ESI 
source to a suitable mass spectrometer analyser, having features of high resolution, sensitivity 
and mass accuracy. 
Depending on the required parameters of mass accuracy and resolution, the kind of ionisation 
method used and the mass range submitted to analysis, different mass analysers can be chosen. 
 
FT-ICR Mass Spectrometry 
During the past decade a new mass spectrometer has received  increasing interest due to its 
features of ultra-high resolution and mass accuracy: the Fourier transform ion cyclotron 
resonance (FT-ICR) mass spectrometer  (Barrow et al. in press).  
FT-ICR mass spectrometry (fig.1a) is a very versatile technique that can be employed with 
practically every known ionisation procedure to perform high-resolution mass spectra, tandem 
mass spectrometric measurements, and to examine chemistry and photochemistry of ions.  
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Fig. 1a- FTICR with ESI source 
Instrument working is based on the possibility of inducing and detecting the cyclotronic 
motion of an ion population generated in the ionisation chamber, whose circular frequency is 
an inverse function of the mass to charge ratio of the ions (fig.2a). Thus the time-domain 
spectrum obtained by measuring the circular motion of the ions is converted through the 
mathematical function of Fourier transformation into a frequency-domain spectrum. The 
mathematical correlation existing between the frequency of the ions and their mass to charge 
ratio, provides the mass spectrum. 
 
Fig 2a-Cyclotronic motion inducing an image current. 
A fundamental component of an FTMS instrument is a magnet, which can be a permanent 
magnet, an electromagnet or a superconducting magnet. Since resolution is directly dependent 
on magnetic field strength, the common tendency is to resort to very strong magnetic fields by 
using superconducting magnets.  
In the FTMS instruments ions produced by an external source are driven by a system of optics 
(fig. 1a) having a selected potential to the analyser cell (Infinity cell), where ions are stored, 
and mass analysed and detected. Analyser cells are composed of six metallic plates arranged in 
the shape of a cube, coupled in pairs through an external electric circuit (fig.3a). The cell is 
oriented in the magnetic field so that one couple of opposite plates is orthogonal to the 
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magnetic field lines, while the remaining two lie parallel to the field. The trapping plates are 
perpendicular to the magnetic field, the application of a variable potential to these plates 
allows the entrance and the  accumulation of the ions in the cell for the required time. The 
other two couples of plates are used for ion excitation and detection.  
                   
Fig 3a-Infinity cell 
  
In the analyser cell the ions experience a force due to the action of the magnetic field which is 
perpendicular to ion velocity and to magnetic field lines (fig 4a).  This force, called the 
Lorentz force, causes an ion to travel in a circular orbit that is perpendicular to the magnetic 
field. 
 
Fig. 4a-Lorentz force on a charged particle. 
 
 Cyclotron motion is periodic and is characterised by its cyclotronic frequency, which is the 
frequency with which an ion repeats its orbit. The cyclotron frequency is a function of the 
strength of the applied magnetic field B, of the charge q and the mass of an ion m, according to 
the equation 1: 
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fc = qB / 2pim                                                                                      
     eq.1 
In FTMS the magnetic field is kept constant, therefore the measurement of the cyclotronic 
frequency directly provides the mass to charge ratio of the ion.  
Having arrived in the Infinity cell the charged particles start a chaotic motion on circular orbits 
which have  a radius too small to be detected. To obtain an intelligible signal, ions must be 
excited to detectable radii, and that occurs through the application of a radiofrequency 
potential through the two excitation plates. When ions are irradiated by a radiofrequency that is 
coincident to their cyclotronic frequency, they absorb energy and start to move coherently into 
a larger orbit.  All the ions having the same mass to charge ratio are excited 
contemporaneously to form a packet of rotating ions, whose motion generates an alternating 
current detected by two electrodes, the detection plates. The experiments are usually conducted 
by applying a  rapid frequency sweep that performs the excitation of a wide range of  ions 
having different mass to charge ratios. The image current obtained is a composite of sinusoids 
of different frequencies and amplitudes. The Fourier transform of this time domain transient 
provides a frequency spectrum that is converted into a mass spectrum by applying a calibration 
formula derived from the cyclotron equation. 
Mass resolution improves in direct proportion to the length of the transient that is recorded, 
according to equation 2, where fc is the cyclotron frequency and T is the duration of the 
transient. The amplitude of the transient  signal decays with time as collisions between the ions 
and neutrals in the analyser cell destroy the coherence of the ion packet. Thus FTMS requires 
an ultra-high vacuum in the cell, to minimize collision frequency.       
    
R= fcT/2 
          eq.2 
 
 162 
ESI and nano-ESI 
Electrospray ionisation (fig.5a) is one of the most used ionisation techniques coupled to an FT-
ICR mass spectrometer. As a low energy ionisation technique it can be safely applied to study 
labile molecules without risks of fragmentation. ESI frequently leads to the formation of 
multiply charged ions. As ions become more highly charged the m/z becomes lower and the 
space between the isotopomers (peaks due to the presence of other isotopes) becomes 
narrower.  As a result it becomes more difficult to resolve signals and the resolution of the 
mass analyser becomes more important, considering that the charge state of an ion can be 
determined by examining the space between the isotopomers signals. 
 
 
Fig. 5a-ESI instrumental setting. 
 
The electrospray process (Gaskell et al. 1997) is realized using a capillary held at high 
potential, through which a solution of the analyte is passed. The capillary tip is very thin and is 
always kept at high potential. The application of a  positive potential causes positive ions to 
accumulate on the surface solution, which is thus drawn out in a down field  direction to 
estabilish a Taylor cone (fig.6a). When the imposed field is high enough  the cone is stretched 
to a filament which produces positively charged droplets when the surface tension is exceeded 
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by the electrostatic applied field. The gradient of potential and of pressure that the droplets 
experience moving towards the analyser of the mass spectrometer causes the solvent 
evaporation and reduction of droplet diameters. When the internal charges repulsion is 
sufficient to overcome the surface tension holding the droplet together (Rayleigh limit), droplet 
fission occurs, generating droplets with smaller diameter. The reiteration of the described 
process finally produces a droplet containing a single ion, which after further evaporation 
releases the fully desolvated ion. Usually a bath gas is applied to the interface to promote 
droplet evaporation. 
 
Fig.6a-Taylor cone and ions generation 
 
The mechanism underlying electrospray ionisation determines the properties of the gas-phase 
ions generated. A really important feature of this ionisation technique is that the charge states 
of the gaseous ions reflect the charge states in the condensed phase.  
Electrospray spectra of proteins detected at different pH show different discrete charge states 
distributions, which have been interpreted as corresponding to solution populations with 
different conformations. Different three-dimensional structures in fact can acquire a different 
number of charges depending on different availability of protonation sites. This observation 
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has been confirmed by experiments based on hydrogenous/deuterium exchange in condensed 
phase and in gas phase (Wagner et al. 1994). 
Also non-covalent interactions existing between molecules in solution can be preserved during 
the ionisation process. Protein-ligand complexes can be successfully detected by a mass 
spectrometer composed of an ESI source coupled to an FT-ICR analyser (Ganem et al. 1991). 
The sample solution flow rate in an electrospray interface is most commonly in the range of 3-
20 µl / min. A recently developed electrospray ionisation technique is the nano-ESI (Jurasheck 
et al. 1998) which allows operation at very low flows of nl/min. The main advantage deriving 
from lower ionisation flows has been demonstrated to be the high efficiency of conversion of 
condensed-phase analyte to gas-phase. The application of low solvent flow generates very 
small droplets which after one or just a few offspring events release the solvent-free ions. ESI 
processes compared to nanoESI involve initial charged droplets of higher radius, thus a more 
elevated evaporation is required before reaching a sufficient charge density for fission. The 
result is the concentration increase of both analyte and salt in the droplets, which leads to 
cluster generation, and to more noisy mass spectra. These features cause nanoESI to be a 
technique which allows a cleaner spectrum from a less pure analyte to be obtained.   
During the nine months I spent at Warwick University (UK) supported by a Marie-Curie 
fellowship, I benefited from the use of an FT-ICR mass spectrometer equipped with both a ESI 
and a nano-ESI source. In particular I have been studying the charge states distribution of 
Calmodulin and modalities of interaction of this protein in a biological environment. 
 
Calmodulin structure and its biological rule 
Calmodulin (CaM) is a small, highly conserved, calcium binding protein found in all 
eukaryotic  cells. It is composed of 148 residues, bound to form a dumbbell shaped molecule 
with two globular domains linked by a short, flexible seven turn alpha-helix (fig.7a). Each 
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domain houses two calcium binding sites consisting of  a loop-helix-loop structure with high 
calcium affinity.  
This profile fits calmodulin as a calcium sensor protein and in fact calmodulin is involved in 
many calcium regulated signalling pathways that settle crucial processes such as growth, 
proliferation and movement. How calmodulin interacts with calcium and target proteins is a 
fundamental issue for enlightening signalling transmission pathways, but is still unclear. 
Calcium binding at specific EF hand sites induces conformational modification of the 
calmodulin structure that leads to the exposure of the hydrophobic protein residues to the 
solvent. These hydrophobic sites are able to link target peptides and consequently to activate 
proteins (Chin et al. 2000).   
 
                          
                                     
 
 
Fig.7a-Calmodulin primary and tertiary structures. 
 
This mechanism does not seem to be the only one apt to describe the interaction between CaM 
and other CaM-binding peptides. The binding process of CaM with RS20 (a synthetic peptide 
analogue derived from the phosphorylation site of smooth muscle Myosin Light Chain 
NH2ADQLTDDEQIAFKEAFSLFDKDGDGITITT(30)KELGTVMRSLGQNPTEAELQDMI
NEVDADG(60)NGTIDFPEFLNLMARKMKDTDSEEELKEAF(90)RVFDKDGNGFISAAEL
RHVMTNLGEKLTDEEVDEMIREAD(130)VDGDGQVYEEFVQVMMAK(148) COOH 
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Kinase) has been described as involving the generation of a complex CaM-Ca4 or CaM-Ca2, 
followed by the bridging of the peptide between the N-terminal and C-terminal domains of 
CaM (Wintrode et al. 1997). 
 
 Results and discussion 
Calmodulin interaction with RS20 and calcium has been studied through FT-ICR mass 
spectrometry interfaced with both ESI and nano-ESI sources. 
Calmodulin mass spectrum in figure 8a (Hill et al. 2000) has been registered in 5 mM 
ammonium acetate buffer, pH 5.9, in the absence of an organic solvent, using an ESI source. 
The monoisotopic mass experimentally determined is 16 616.84 ±0.02 Da , which agrees with  
the theoretical mass of the isotopically pure protein obtained from the sequence (16 616.82  
Da) within experimental error. 
 
 
[C]8+ 
[C]9+ 
[C]14+ 
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Fig.8a: ESI-FTICR mass spectra of calmodulin in ammonium acetate buffer. Inset shows the isotopically 
resolved pattern of the 8+ charge state. 
 
Each peak has been assigned to calmodulin molecules ionized by a different number of 
protons. Thus, for example, [C]8+ represents [C+8H]8+  where calmodulin is the neutral 
protein.  The spectrum shows two different charge-distribution patterns attributable to two 
different calmodulin conformations in buffer solution. The higher charge state distribution is 
centred around the 12+ charge state, and it is attributed to an unfolded conformation. The 
lower charge state envelope exhibits the main peak corresponding to eight attached protons, 
and it is proposed to correspond to a more compact calmodulin conformation.  
Experimental data obtained spraying Calmodulin from methanol or acetonitrile/water solution 
confirm the hypothesised conformation attributions. Figure 9a shows the spectrum of 
calmodulin in organic solvent solution, which promotes the unfolding process of the protein.  
                                                                                                                                                             
Fig.9a : ESI-FTICR mass spectra of calmodulin in CH3CN/H2O 1:1 and 1% formic acid. 
    
[C]11+ 
[C]10+ 
 168 
The charge envelope has a maximum corresponding to 12 attached protons, according to a 
more open structure in denaturant conditions.  
Switching from an ESI source to a nano-ESI, we obtain a calmodulin spectrum (fig.10a) in 
buffer solution with a charge state envelope focused around the main peak corresponding to a  
7+ charge state. 
 
 
Fig.10a: nanoESI-FTICR mass spectra of calmodulin in ammonium acetate buffer. 
 
Correlations between charge-state distribution pattern observed in ESI mass spectra and the 
equilibrium of protein conformation which exist in solution have been illustrated for other 
proteins (Katta et al. 1991, Hamdam et al 1994, Loo et al. 1991, Feng et al. 1993).  
Mass spectra of the peptide RS20 in 5 mM ammonium acetate buffer show as the main 
species, the one with three attached protons [RS20+3H]+ . The experimentally determined 
monoisotopic mass is 2293.293± 0.01 Da, in good agreement with theoretical mass of pure 
peptide. 
[C]7+ 
[C]8+ 
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The spectrum obtained from a calcium free solution containing CaM and RS20 in a 
concentration ratio 1:1.5, indicates the presence of a 1:1 calmodulin–RS20 complex, without 
any associated calcium ion (Hill et al. 2000) (fig 11a).  
For example the signal at m/z = 2103.46 represents a species with a charge state of 9+ and the 
correspondent mass of 18 922.14 ± 0.02 Da, which is consistent to a CaM-RS20 complex. 
The precence of a complex between apocalmodulin and RS20 is unambiguous evidence of the 
binding of CaM to the target site of MLCK in absence of calcium (Hill et al. 2000).  
 
 
Fig.11ah: ESI-FTICR mass spectra of calmodulin in ammonium acetate buffer in presence of  RS20. 
 
The spectrum obtained for a solution of calcium chloride and calmodulin (molar ratio 1:0.4) is 
not very different from that of apocalmodulin (fig12a.). The main species have not changed 
their charge-state, in fact the highest peak remains the 8+. Calcium binding is observed with 
one, two, three and four calcium ions found for each charge state.  
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Fig.12a: ESI-FTICR mass spectra of calmodulin in ammonium acetate buffer in presence of calcium. 
 
In the presence of RS20 (CaM:RS20:Ca2+ = 1:1.5:0.4) the most intense peak in the spectrum 
becomes the complex CaM-RS20-Ca4 in the 8+ charge state (Hill et al. 2000). There are strong 
peaks due to the calmodulin-RS20 complex as well, but there is no evidence of complexes 
CaM-Ca with no peptide bound (fig13a).   
The absence of calmodulin-RS20 complexes with two calciums bound and the dominance of 
the calmodulin-RS20-Ca4 complex is consistent with the idea of two globular domains 
functioning cooperatively. 
The ESI-FTICR mass spectra of calmodulin, RS20, and calcium in higher concentration 
(molar ratio 1:1.5:4) continues to show the complex calmodulin-RS20-Ca4 as main peak, and 
no other peaks corresponding to complexes binding more than four calcium are present. 
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Fig 13a.: ESI-FTICR mass spectra of calmodulin in ammonium acetate buffer in presence of calcium and RS20. 
 
 
Experimental procedures 
Protein Synthesis and Purification. DNA-encoded calmodulin was obtained as previously 
described and purified by column chromatography (Craig et al. 1987 and  Roberts et al. 
1985). The purity of the protein was checked by SDS PAGE and high-pressure capillary 
electrophoresis, and it was found to be approximately 99% pure. Ultrapure water (Elga 
system) and plastic ware which had been washed in 1 N HCl were used to minimize metal 
cation and other contamination. Calmodulin (2.5 mg) was dissolved in 2.0 mL of ammonium 
acetate (5 mM, pH 5.9) and purified over a desalting PD 10 column (Pharmacia Uppsala) 
which had been previously equilibrated with ammonium acetate. The calmodulin 
concentration in the fraction used was determined by UV absorption on a Jasco V-550 
spectrophotometer using a molar extinction coefficient for calmodulin of ε280 nm ) 1560 M-1 
cm-1 (Gilli et al. 1998). 
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Calmodulin-RS20 Sample Preparation. The RS20 peptide was synthesized and purified 
(greater than 99% pure) as described in literature (Lukas et al. 1986 and Guimard et al 1994). 
A stock solution of the peptide was prepared by dissolving a 1.3-mg sample of lyophilized 
peptide in 565 µL of ammonium acetate (5 mM, pH 5.9) giving a concentration of 1.0 mM. 
Small aliquots of peptide stock were added to calmodulin solutions to achieve desired 
calmodulin to RS20 molar ratios. The calmodulin concentration was typically 25 µM (0.4 
mg/mL), and peptide concentrations were varied from approximately 40 µM to several 
hundred micromoles. Where necessary, small aliquots (10 µL) of a concentrated CaCl2  
(Aldrich) stock were added to calmodulin-peptide solutions to give the required CaCl2 
concentrations. The use of physiologically relevant conditions is recognized to be important 
for maintaining the integrity of noncovalent complexes. 
Electrospray Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry. 
Mass spectrometry measurements were made using an FTICR mass spectrometer (Bruker 
Daltonics, Billerica, MA) equipped with a passively shielded 9.4 T superconducting magnet 
(Magnex Scientific Ltd., Abingdon, UK), a cylindrical infinity ICR cell with 0.06-m diameter, 
and an external ESI source (Analytica of Branford, Branford, CT). This FTICR instrument 
has been described in literature (Lavanant et al. 1998 and Palmblad et al 2000). 
 The ESI source was equipped with a Pyrex capillary which was coated on both ends with 
platinum paint. The voltages on the nozzle and the skimmer were kept appropriately low 
(typically 60 and 3 V, respectively).Carbon dioxide was used as the drying gas in the 
electrospray source, and its temperature was carefully controlled. The background pressure in 
the ICR analyzer cell was typically below 2 x 10-10 mbar. 
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